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Myelination drastically speeds up action potential propagation along axons, which is 
fundamental for the correct function of neuronal circuits. However, axon-
oligodendrocyte interactions regulating the onset of myelin formation remain 
unclear. I sought to determine how reticulospinal axons control myelination, as they 
are the first myelinated in the zebrafish spinal cord. I genetically manipulated 
zebrafish in order to either remove such axons from a region of the spinal cord, or to 
increase their number, and characterized oligodendrocyte-lineage cells following this 
axonal loss- or gain-of-function. 
In kinesin-binding protein (kbp) mutants, reticulospinal hindbrain neurons start 
axonogenesis but axons fail to grow along the entire spinal cord as in wildtype, 
providing an axon-deficient posterior spinal cord and an intact anterior region. I 
found that early stages of oligodendrocyte development, such as the specification of 
oligodendrocyte precursors, their distribution and migration were not affected in the 
posterior spinal cord of these mutants. However, both the proliferation and the 
survival of late precursors were impaired, resulting in a significant reduction of 
mature oligodendrocytes in the posterior region of mutants at the onset of 
myelination. Since the anterior spinal cord of mutants is indistinguishable from 
wildtype, these results demonstrate that reticulospinal axons provide a mitogenic and 
a survival signal to a subset of developing OPCs, enabling their differentiation and 
lineage progression.  
I then found that the absence of reticulospinal axons did not affect the timing of 
oligodendrocyte differentiation, which matured on time, suggesting that this follows 
an intrinsic timer, as previous studies suggested. Oligodendrocytes also did not 
myelinate incorrect axonal targets, but instead adapted to the reduced axonal surface 
by elaborating fewer myelin sheaths. Additionally, oligodendrocytes made shorter 
sheaths, and also incorrectly ensheathed neuron somas in the mutant spinal cord, 
suggesting that either kbp function or a precise amount of axonal surface are required 
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to prevent ectopic myelination of somas and to promote the longitudinal growth of 
myelin sheaths. 
In wildtype animals, the two reticulospinal Mauthner axons are the very first 
myelinated in the spinal cord. In animals where Notch1a function is temporarily 
abrogated or hoxb1 genes are temporarily upregulated, supernumerary Mauthner 
neurons are generated. I found that these extra axons are robustly myelinated, with 
no impairment of myelination of adjacent axons. Surprisingly, the number of 
oligodendrocytes was not altered, but I found that each individual oligodendrocyte 
elaborated more myelin sheaths, whose total length was also longer than in 
wildtypes. Additionally, dorsal oligodendrocytes, which normally myelinate only 
small-calibre dorsal axons, readily extended processes ventrally to myelinate the 
supernumerary large-calibre Mauthner axons, in addition to small-calibre axons. 
These results suggest that oligodendrocytes are plastic and are not destined to 
myelinate a particular type of axon, and conversely, that axonal signals that induce 
myelination are similar for different axons. The long-standing observation that 
oligodendrocytes tend to myelinate either few large axons or many small axons thus 
reflects local interactions of oligodendrocyte processes with the nearby axons, rather 
than different subtypes of oligodendrocytes specified by an intrinsic programme of 
differentiation. 
Collectively, this work shows that axons extensively influence both oligodendrocyte 
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Escaping a predator, swinging a baseball bat or writing a PhD thesis all require very 
fast and concerted nerve impulse propagation, despite the protracted duration of 
some of these activities (Davis and Parker 1997). During evolution, vertebrates 
accomplished this fast propagation by forming myelin sheaths around the axons of 
nerve cells. Myelin sheaths are a specialized extension of the plasma membrane of 
glial cells, which concentrically wrap around the axon, insulating them (Sherman and 
Brophy 2005). In the central nervous system (CNS), after generating neurons, neural 
progenitor cells switch to originate cells of the oligodendrocyte (OL) lineage, which 
are responsible for CNS myelination, the culminating event in CNS maturation 
(Rowitch 2004). Many CNS axons become myelinated, hinting at the importance of 
myelination. In fact, disruption to myelin sheaths results in devastating diseases such 
as multiple sclerosis or leukodystrophies (Gustavsson, Svensson et al. 2011). In 
mammals, myelination starts from birth, and continues into adulthood (Wang and 
Young 2014), and recent work has shown that myelination in adulthood may underlie 
novel forms of neural plasticity, and that oligodendrocytes may provide more than 
just text-book insulation. These underappreciated roles may contribute to the 
underlying pathology of a range of neurodegenerative or neuropsychiatric diseases, 
not traditionally thought to be related to myelin dysfunction. 
The myelin sheath structure is a remarkable example of communication and 
collaboration between two very different cells. Despite its importance, our 
understanding of how it comes to be formed during development in an intact 
organism is limited, especially compared with inter-neuronal interactions. We may 
know exactly what makes an axon growth cone turn left or right (Colak, Ji et al. 
2013), or the precise splice isoforms that guide the matching of that axon with its 
dendritic target, amidst a very complex milieu (Takeichi 2007, Hong, Mosca et al. 
2012). Yet, we don’t know of a single molecule displayed on CNS axons that is 
absolutely required for myelination (Emery 2010), and we are only now starting to 
glimpse the cellular interactions that drive the initial wrapping of oligodendrocyte 
membrane around a target axon in vivo (Snaidero, Mobius et al. 2014). In this thesis, 
I will explore the developmental interactions between two cell types, neurons and 
oligodendrocytes, which result in the appropriate myelination of a complex region of 
the vertebrate CNS: the spinal cord. By live imaging of the zebrafish spinal cord, I 
11 
 
identified that a number of steps of oligodendrocyte-lineage cell development can be 
regulated by axons: proliferation and survival. Furthermore, during myelination, 
axons can also locally regulate the extension of myelin sheaths at the level of 
individual oligodendrocytes, unambiguously demonstrating the plasticity of these 
cells in vivo. Hopefully, further elucidation of the fundamental cellular and 
molecular mechanisms of developmental myelination will open new avenues for 
myelin repair in pathological conditions.  
In this introduction, I will briefly summarize the known functions of myelin and the 
consequences of its dysfunction, and how oligodendrocyte-lineage cells develop and 
elaborate myelin sheaths. 
 
 Function of Myelin 1.1
Myelin has classically been described as a lipid-rich membrane that repeatedly wraps 
around axon, ‘insulating’ them and permitting fast, ‘saltatory’ conduction of action 
potentials. How does the formation of such a structure speed up the propagation of 
electrical impulses? 
The axonal membrane (axolemma) separates charges, and strongly maintains a 
positive extracellular side and a negative intracellular surface. In unmyelinated 
axons, voltage-gated sodium channels are distributed throughout the axonal 
membrane. When sodium channels open, sodium cations flow into the negative 
cytoplasmic surface and depolarize the membrane in that region. The voltage change 
induces a conformational change in nearby channels, opening them. More sodium 
ions flow in through these channels, which will in turn depolarize the membrane a 
little further down. The depolarization wave will continue down the axon, where it 
will eventually arrive at synaptic terminals and culminate in neurotransmitter vesicle 
release into another neuron. In unmyelinated axons, given the diffuse distribution of 
channels, the propagation of the action potential occurs in a continuous, slow manner 
down the axon (Hartline and Colman 2007).  
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In myelinated axons (Figure 1.1), long stretches of the axolemma are covered by 
myelin (internodes). The myelin sheath insulates the axon along the internode and 
prevents charges from accumulating near the membrane, that is, prevents the 
axolemma from depolarizing. Internodes are interrupted only at short (~1µm) 
unmyelinated gaps, thought to be regularly spaced, the nodes of Ranvier, in which 
voltage-gated sodium channels accumulate (Salzer 2003). Since they are 
unmyelinated, nodes are the only regions along the axolemma that can be 
depolarized. When this happens, sodium ions can flow through the channels. The 
myelin sheath along the internode also increases the membrane resistance to leakage 
of the ionic current (Bakiri, Karadottir et al. 2011), which is carried down the 
cytoplasm and is sufficient to depolarize the next node. This in turn opens its sodium 
channels, allowing more sodium ions to flow in, which regenerates the action 
potential. Thus, in myelinated axons, the depolarizing wave of the action potential 
does not slowly propagate along the membrane in the internodal segment. Instead it 
‘hops’ from node to node, in what is known as saltatory conduction (from the Latin 
saltare, to leap).  
Saltatory conduction results in several advantages at the level of individual axons, 
and of the whole organism (Hartline and Colman 2007). It is much faster than 
continuous propagation (tenfold faster for axons larger than 1µm in diameter). It is 
more energetically efficient, since the active transport of ions back across the 
membrane to restore the resting potential only occurs at nodes. Finally, it economizes 
space: the alternative solution for faster propagation is an increase in axonal 
diameter, but to achieve the same ten-fold improvement in conduction speed, axons 
would need to be a hundred times thicker. 
Thus, myelin and saltatory conduction increase the conduction velocity of electrical 
impulses, which decreases reaction times to external stimuli such as a predator, for 
instance, but also improves temporal precision and potential synchronization of 
impulses. In sum, it allowed for the evolution of nervous systems with much higher 




Figure 1.1 – Axonal domains in myelinated axons.  
The unmyelinated axolemma at the node of Ranvier is highly concentrated in voltage-gated 
sodium channels. It is flanked by paranodes (PN) on each side, where the myelin is anchored 
to the axon by an axoglial adhesion complex. Next to it are the juxtaparanodes (JPN), which 
contain voltage-gated potassium channels. The internode (IN) comprises most of the space 
under the myelin sheath. 
 
 
CNS myelin sheaths in vertebrates vary in their thickness and length. Myelin 
thickness has long been predicted to influence conduction speed: for a given axonal 
diameter, there is an optimal myelin sheath thickness that maximizes conduction 
speed (Rushton 1951, Waxman 1980, Ritchie 1982). A number of researchers have 
predicted that the g-ratio (quotient between axon diameter and the diameter of the 
axon with its myelin sheath) that maximizes conduction speed falls between 0.6-0.7 
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(Waxman 1980, Chomiak and Hu 2009). Strikingly, most myelinated axons in the 
CNS of any vertebrate have g-ratios that fall between those values (Hildebrand and 
Hahn 1978, Sherman and Brophy 2005). This means that smaller axons have thinner 
sheaths, and larger axons have thicker sheaths, with more wraps or lamellae around 
them. Thus, the thickness of the myelin sheath seems to be perfectly adapted to the 
particular axon it wraps.  
Myelin sheath length determines the distance between nodes of Ranvier, which must 
not be too short (Court, Sherman et al. 2004) or too far (Wu, Williams et al. 2012) to 
allow the action potential to regenerate and permit saltatory conduction. It is 
remarkable that in some instances the internodal length seems optimized not to 
maximize conduction speed, but to ensure the temporal accuracy of impulse 
propagation. One interesting example is the auditory pathway, where the distance 
between nodes of Ranvier is adjusted in different neurons of the cochlear nucleus to 
ensure synchronicity of arrival of auditory information, effectively delaying the 
conduction in some axons. This and other examples are reviewed in (Waxman 1997, 
Seidl 2014).   
These observations suggest that axons can locally regulate some parameters of 
myelin sheath formation, such as the number of wraps, or the length of myelin 
sheaths. This implies that axons and oligodendrocytes must communicate intimately 
during development. Interestingly, recent work has revealed that the fine structure of 
myelin is not fixed, and is probably refined throughout life, implying a continued 
communication between these cells. Refinement in white matter tracts (where most 
myelinated axons are located) could occur in response to neuronal activity itself. This 
is reviewed in (Boulanger and Messier 2014, O'Rourke, Gasperini et al. 2014, Wang 
and Young 2014), and I will mention some of this work in more detail in Chapters 3 
and 4. Briefly, white matter changes are increasingly being reported to occur in the 
normal, mature CNS, which may be due to addition of new internodes to myelinated 
axons (for instance, reflecting myelin turnover), or de novo myelination of 
unmyelinated axons. A recent study demonstrated that individual adult cortical 
neurons are intermittently myelinated along their length (Tomassy, Berger et al. 
2014), suggesting that addition of internodes may occur in partially myelinated axons 
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as well. At the level of a single axon, small alterations in internodal length or myelin 
thickness may have a small effect on the axon’s conduction speed. However, even  
small variations in conduction velocity can have pronounced effects on the functional 
output of the entire neuronal network, by affecting synchronicity and oscillation 
patterns, for instance (Pajevic, Basser et al. 2014). Thus, higher-order functions of 
the nervous system and its information processing capacity may be actively 
influenced by myelination, which may be allowing more than a faster escape from a 
predator.  
The importance of myelin in permitting efficient saltatory conduction is underscored 
by those conditions where it is disrupted. The most prevalent of demyelinating 
diseases in young adults is multiple sclerosis, in which inflammatory insults destroy 
the myelin sheath, leading to neurodegeneration, and severe functional impairment. 
Primary demyelination of axons is associated with impaired conduction speed 
(McDonald and Sears 1970, Rasminsky and Sears 1972, Waxman 2003). 
Demyelinated axons also present with an increased number of mitochondria, which 
is thought to be an adaptation to the energetically inefficient redistribution of the ion 
channels that occurs in the demyelinated axolemma (Mutsaers and Carroll 1998, 
Mahad, Lassmann et al. 2008, Campbell and Mahad 2011). This observation further 
hints at one of the benefits of myelin and saltatory conduction: that of energetic 
savings.  
Interestingly, remyelination often occurs, whereby nearby adult OPCs are mobilized 
to the demyelinating lesion, induced to proliferate and differentiate and remyelinate 
the denuded axon. These new myelin sheaths associated with remyelination are 
thinner than normal myelin sheaths, and shorter, but seem enough to restore function 
(Blakemore 1974, Smith, Blakemore et al. 1979, Ludwin and Maitland 1984, 
Franklin and Ffrench-Constant 2008). However, in multiple sclerosis, remyelination 
eventually fails, and the chronically demyelinated axons undergo degeneration, 
causing neuronal damage and death – which is associated with the severe clinical 
decline of later stages of the disease (De Stefano, Matthews et al. 1998). Are thinner 
sheaths not able to support function in the long-term? OPCs migrate into lesioned 
areas, but why do they fail to differentiate and remyelinate chronic lesions? The 
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molecular mechanisms behind the failure to remyelinate are not fully understood and 
the extent to which developmental myelination is recapitulated in during 
remyelination is also under debate (Franklin and Ffrench-Constant 2008, Fancy, 
Chan et al. 2011). 
A range of neuropsychiatric diseases have recently been associated with alterations 
in white matter integrity, which could result from disruption to the molecular 
organization of myelinated axons. These include schizophrenia, autism, bipolar 
disorder, among others, reviewed in (Bernstein, Steiner et al. 2009, Faivre-Sarrailh 
and Devaux 2013, Amlien and Fjell 2014, Arancibia-Carcamo and Attwell 2014). It 
could be that these conditions reflect impairment in the refinement of myelin sheaths 
in mature axons in the adult CNS, which could affect higher-order functions in the 
nervous system, as I mentioned previously. 
The view presented so far suggests that oligodendrocytes respond to axon-derived 
signalling and modulate the structure of myelin sheaths to maximize the function of 
axons. However, the picture is more complex, and oligodendrocytes do more for 
axons than permit saltatory conduction to occur. For instance, mice which 
completely lack the oligodendrocyte-specific proteolipid protein (plp) gene, which 
encodes a protein found in CNS myelin, still form compact myelin and develop fully 
myelinated axons (Klugmann, Schwab et al. 1997). Strikingly, despite the mostly 
normal myelin, these mice develop a very late onset, slowly progressing primary 
neurodegeneration (Griffiths, Klugmann et al. 1998). Another example is that of 
mice deficient for 2',3'-cyclic nucleotide 3'-phosphodiesterase (gene cnp1), an 
enzyme found in myelin: mice develop normally early on and form myelinated 
axons, but present with a primary axonal degeneration later on (Lappe-Siefke, 
Goebbels et al. 2003), despite the formation of compact myelin around the axons. 
This strongly suggests that oligodendrocytes support the axons and preserve their 
function in ways that are independent of their myelinating role (Nave and Trapp 
2008). It may well be that such a support function emerged during evolution 
precisely because the development of the insulating myelin sheath physically prevent 
access of axons to nutrients and trophic factors.  
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Strikingly, recent studies confirmed that oligodendrocytes do in fact directly provide 
metabolic support to the axons they myelinate (Figure 1.2) (Morrison, Lee et al. 
2013, Saab, Tzvetanova et al. 2013). Specifically, oligodendrocytes are thought to 
export lactate through transporter MCT1 to the internodal space, which is taken up 
by axons, where it can be used as an alternative energy source to glucose 
(Funfschilling, Supplie et al. 2012). Disruption of MCT1 in oligodendrocytes caused 
axon degeneration and motor neuron death in vitro as well as in vivo. Furthermore, 
(Lee, Morrison et al. 2012) found that expression of MCT1 was decreased in tissue 
from patients with amyotrophic lateral sclerosis as well as in a mouse model of the 
disease. These observations suggest that the loss of oligodendrocyte-mediated 
metabolic support may directly contribute to the pathology of this disease, and 
highlight that communication and interaction between neurons and glia is 
bidirectional, and sustained support between the two is crucial for the maintenance of 
a healthy CNS. 
 
 
Figure 1.2 – Oligodendroglia provide metabolic support to axons.  
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Oligodendrocytes are thought to export lactate through the MCT1 transporter along the 
internode, which can be taken up by axons and provide a substrate for glycolysis and ATP 
production. Image adapted from (Morrison, Lee et al. 2013). 
 
Furthermore, it implies that we must re-evaluate the role of oligodendrocyte loss in 
neurodegenerative diseases. Especially in ‘primarily demyelinating’ diseases, such as 
multiple sclerosis, it may be that much of the axonal and neuronal loss observed later 
in the disease is due to the chronic loss of metabolic support from oligodendrocytes. 
Despite the clear importance of oligodendrocytes and myelin for the function of the 
nervous system, our understanding of how myelination occurs during development is 
incomplete. The factors that mediate communication and interaction between 
neurons and oligodendrocytes and that control the onset of CNS myelination in vivo, 
during development, remain incompletely understood, although we now have a 
notion of some intrinsic factors that regulate the initial stage of oligodendrocyte 
specification and differentiation. I will briefly outline how oligodendrocytes develop 
in the CNS next. 
 
 Oligodendrocyte development  1.2
Oligodendrocyte-lineage cells first arise from a discrete domain in the ventral spinal 
cord, the pMN domain (Figure 1.3) (Richardson, Kessaris et al. 2006). These 
domains in the embryonic neural tube are patterned along the dorsal-ventral axis by a 
gradient of morphogens. For instance, Sonic hedgehog (Shh) is secreted ventrally 
from the notochord and floor plate; and Bone morphogenetic proteins are secreted 
dorsally from the dorsal roof plate. At each dorsal-ventral level, their particular 
concentrations induce the expression of specific transcription factors in multipotent 
neural progenitor cells (Mitew, Hay et al. 2014). The unique combination of 
transcription factors in each domain specifies the identity of the neural progenitors, 
and ultimately defines the cellular subtypes produced in that region (Rowitch 2004). 
In the pMN domain, Shh induces expression of Olig2, a basic helix-loop-helix 
transcription factor that is required for the generation of all pMN offspring – motor 
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neurons and oligodendrocyte-lineage cells (Ligon, Fancy et al. 2006, Meijer, Kane et 
al. 2012). During embryonic development, Olig2+ pMN progenitors first give rise to 
motor neurons, and subsequently switch to generate oligodendrocyte-precursor cells 
(Colognato and ffrench-Constant 2004, Rowitch and Kriegstein 2010). For instance, 
in the mouse neural tube, motor neurons are born in the pMN domain at embryonic 
days E9-E10.5, and OPCs at E12.5 (Rowitch 2004). In zebrafish, most Olig2+ motor 
neurons are born between 24-51hpf (Reimer, Norris et al. 2013); and Olig2+ OPC 
specification in the spinal cord starts around 36hpf (Kirby, Takada et al. 2006). 
Interestingly, post-translational modifications of Olig2 within pMN progenitors can 
regulate the switch of motor neuron production to OPC generation (Li, de Faria et al. 
2011). Olig2 expression persists throughout the developmental stages of OPC, from 
specification through to myelination, and has recently been shown to also regulate 
later aspects of oligodendrocyte development (Mei, Wang et al. 2013).  
After their specification in the pMN domain, OPCs migrate, proliferate and distribute 
throughout the grey and white matter. They extend dynamic filopodia-like processes 
into their vicinity. An OPC will retract its processes upon contact with another OPC, 
and OPCs often migrate away subsequently. Following death of an OPC, 
neighbouring OPCs proliferate and invade the region. These OPC-OPC interactions 
seem to resemble a tiling mechanism that ensures their uniform distribution, in 
preparation for myelination, both in the developing zebrafish spinal cord (Kirby, 
Takada et al. 2006) and in adult rodent grey matter (Hughes, Kang et al. 2013). OPC 
processes may also survey the territory for potential axonal targets, and it is thought 
that the selection of axons that become myelinated occurs at this stage (Almeida and 
Lyons 2013, Czopka, Ffrench-Constant et al. 2013). Some molecules that regulate 
long-range OPC migration have been identified (de Castro, Bribian et al. 2013), 
including some axonal regulators (Akiyama, Hasegawa et al. 2014). However, the 
molecular mechanisms that regulate either the repulsive OPC-OPC interactions or 
recognition and selection of potential axonal targets remain unknown.  
In Chapter 3, I will investigate the role of axons in these earlier steps in the 
development of oligodendrocyte-lineage cells. 
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Later in embryonic development, closer to the postnatal period, several intrinsic and 
extrinsic factors regulate OPC differentiation and maturation, thoroughly reviewed in 
(Li, He et al. 2009, Emery 2010, He and Lu 2013). Oligodendrocyte processes 
contacting axonal targets extend and loosely ensheath the axon and myelin genes 
start to be expressed. Transcription factors such as Olig1 and Sox10 are intrinsic 
regulators of OPC development and are important for the final differentiation and 
production of myelin structural components. For instance, Olig1 regulates 
transcription of myelin components such as Myelin basic protein (Mbp) and 
Proteolipid protein (Plp), and may also serve to suppress alternative astrocyte fates. 
In Olig1-null mice, OPC generation is not affected, but these cells fail to fully 
differentiate and to form compact myelin (Xin, Yue et al. 2005). Sox10 physically 
interacts with Olig1/2 and directly activates the promoter of mbp in mammals, 
although interestingly, in zebrafish, Sox10 only interacts with Olig1 (Li, Lu et al. 
2007, Kuspert, Hammer et al. 2011). Similarly to olig1-null mice, sox10-null mice 
generate OPCs, but their terminal differentiation is disrupted (Stolt, Rehberg et al. 
2002). Sox10 may also be required to promote oligodendrocyte survival following 
axonal ensheathment, as sox10 mutant zebrafish generate OPCs that die following 
ensheathment (Takada, Kucenas et al. 2010). Later, Nkx2.2, an homeodomain 
transcription factor, is also required from the OPC stage to promote differentiation of 
a subset of myelinating oligodendrocyte-lineage cells  (Zhou, Choi et al. 2001, Liu, 
Hu et al. 2007, Kucenas, Snell et al. 2008). These transcription factors can be used as 
markers for the oligodendrocyte-lineage from the OPC stage. Their presence, 
sequential order of expression and presumed function are remarkably well conserved 
in zebrafish (Figure 1.3). 
Subsequently, these cells must initiate a timely differentiation program that elicits 
biochemical and biophysical mechanisms capable of synthesizing, transporting, 
assembling and compacting a specialized lipid membrane (Baumann and Pham-Dinh 
2001). Unlike the myelinating Schwann cell in the peripheral nervous system, which 
only associates with one segment of one axon, oligodendrocytes can associate with 
numerous segments on different axons, therefore they must be able to support myelin 
biosynthesis at the end of several processes. As they exit the cell cycle, these 
premyelinating oligodendrocytes express a particularly specific transcription factor 
21 
 
required for this program of differentiation, Myelin Regulatory Factor (Emery, 
Agalliu et al. 2009). Together with Sox10, MyRF stimulates expression of myelin 
components, such as Mbp and Plp (Bujalka, Koenning et al. 2013, Hornig, Frob et al. 
2013). Expression of myelin structural proteins can be used a marker for the 
oligodendrocyte stage. Continued MyRF expression is required for the maintenance 
of myelin and of a differentiated oligodendrocyte phenotype in adults (Koenning, 
Jackson et al. 2012).  
Interestingly, not all OPCs differentiate into myelinating oligodendrocytes 
(Richardson, Young et al. 2011). Some OPCs remain undifferentiated into adulthood, 
even if less proliferative than developmental OPCs (Psachoulia, Jamen et al. 2009, 
Young, Psachoulia et al. 2013). These adult OPCs can differentiate into 
oligodendrocytes in pathological or demyelinating conditions, for instance (Rivers, 
Young et al. 2008, Zhu, Bergles et al. 2008, Zhu, Hill et al. 2008, Kang, Fukaya et al. 
2010, Tripathi, Rivers et al. 2010). Adult OPCs represent around 5% of all cells in 
the adult brain, but their full range of functions remains unknown (Trotter, Karram et 
al. 2010, Boda and Buffo 2014). They may orchestrate de novo myelination, myelin 
turnover or remodelling, which is now thought to occur under normal conditions in 





Figure 1.3 – Overview of oligodendrocyte-lineage cell development and markers. 
OPCs are specified in the pMN domain in the ventral spinal cord (1). Subsequently, OPCs 
migrate (2) and proliferate (3) to populate the spinal cord. OPC processes contact target 
axons (4), which potentially promotes their survival and differentiation (5), after which 
oligodendrocytes form myelin sheaths around their targets (6). Developmentally regulated 
genes that regulate myelination are indicated below, in bold are those of particular interest 
(see main text for details).  
 
 Myelin sheath formation and structure 1.3
 
 
Oligodendrocyte-lineage cells undergo a remarkable morphological transformation 
as myelination occurs: OPCs initially extend multiple branching processes, and this 
arborisation decreases when OPCs mature into oligodendrocytes, which have fewer 
processes, supporting a myelin sheath at their end (Hardy and Friedrich 1996). A 
number of factors regulating the initial protrusion of processes and the cytoskeletal 
remodelling that must accompany these changes have been identified (Simons and 
Trotter 2007, Richter-Landsberg 2008, Bauer, Richter-Landsberg et al. 2009). These 
dynamic processes likely explore and sense their environment. Cell bodies or 
dendrites are not myelinated, therefore, axon-OPC contacts must be preferentially 
formed or stabilized, and transport of myelin components must be targeted to these 
contacts preferentially (Simons and Trotter 2007). Additionally, only contact with 
those axons that are competent for myelination should be stabilized. Recent work 
identified that spinal cord oligodendrocytes will elaborate all of their myelin sheaths 
within 5 hours, and 75% will remain stable, with only 25% of retractions within 2 
days (Figure 1.4) (Czopka, Ffrench-Constant et al. 2013). In a milieu where over 
90% of the axons are unmyelinated, this means that OPCs and oligodendrocytes are 
remarkably accurate when the time comes to form myelin sheaths, implying that 
oligodendrocytes do not select axons at random, and that selection of axonal targets 
occurred prior to actual myelination. The molecular regulators of this axonal 
selection in the CNS remain to be fully elucidated, particularly those that promote or 
stabilize the interaction between axon and OPC process (some inhibitory signals 




Figure 1.4 – Onset of oligodendrocyte myelination. 
Following the formation of their first myelin sheath, zebrafish spinal cord oligodendrocytes 
quickly form all of their myelin sheaths in a short period (~5 hours), after which point they 
may occasionally retract a sheath; but from two days after the onset of myelination, the 
number of sheaths per oligodendrocyte is stable. Image taken from (Czopka, Ffrench-
Constant et al. 2013). 
 
When myelination ensues, the axon-OPC contact must be converted into a myelin 
sheath. In the case of the PNS, where each Schwann cell wraps only a segment of 
one axon, it is generally accepted that the Schwann cell first extends its membrane 
along the full length of what will become that myelin sheath, then it curves around 
the axon, and the myelin sheath tip grows under the previously generated membrane 
layer, in what is known as the “carpet crawler” or “jelly roll” model (Bunge, Bunge 
et al. 1989). This model does not seem to represent the principal mode of CNS 
myelin sheath formation, since the number of wraps can vary along the length of a 
myelin sheath in the CNS (Knobler, Stempak et al. 1976). A recent study followed 
CNS myelin ensheathment at high resolution in vivo (Snaidero, Mobius et al. 2014) 
and determined that initially, the oligodendrocyte process flattens upon axonal 
contact, but oligodendrocyte membrane does not fully extend before curving around 
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the axon. The short inner tongue ‘crawls’ around the axon and grows under the 
already existing oligodendrocyte membrane. This inner edge of the sheath is smaller 
longitudinally than the outer layers; if the growing myelin sheath were unfurled, it 
would look like a spade (Figure 1.5). The myelin sheath is then formed by growth of 
the inner tongue under the deposited membranes, and by the longitudinal, lateral 
growth of the membranes until they reach their full extent along the axon. A network 
of cytoplasmic channels appears to exist in compact myelin, containing microtubules 
and vesicular carriers, which can provide a route for transport of materials to the 
inner tongue, where radial growth of the myelin sheath occurs. Additionally, in the 
lateral edges of each wrap are cytoplasmic pockets which remain in contact with the 
axon even as the sheath grows longitudinally. Delivery of membrane components to 
these cytoplasmic pockets permits the longitudinal, lateral growth of the myelin 
sheath. Interestingly, unlike the channels that lead to the inner tongue which close 
when myelination is finished, these lateral pockets will remain open even in mature, 
myelinated fibers, possibly for adjustment and refinement of myelin sheath length 
(Snaidero and Simons 2014).  
Which components must be delivered to the growing myelin sheath? Early 
biochemical studies identified the gross molecular composition of myelin, and 
determined that myelin has a very high lipid content (about 75% of its dry weight) in 
comparison to other eukaryotic plasma membranes. It has unusually high levels of 
cholesterol, glycosphingolipids (such as galactosylceramyde, GalC, which can be 
used as a marker for immature oligodendrocytes), and plasmalogens (Jahn, Tenzer et 
al. 2009, Aggarwal, Yurlova et al. 2011). The remainder of myelin’s dry weight are 
proteins which are embedded or attached to the lipid bilayer. These include 
Proteolipid protein (Plp) and Myelin basic protein (Mbp), which together may form a 
quarter of all myelin protein (Jahn, Tenzer et al. 2009). Other examples include 
Myelin associated glycoprotein (MAG), Myelin/oligodendrocyte protein (MOG), or 
2′-3′-cyclic nucleotide-3′-phosphodiesterase (CNP), which has catalytic functions 





Figure 1.5 – Model of axonal ensheathment and myelin biogenesis in the CNS. 
Myelin sheaths grow when the leading edge of the inner tongue wraps around the axon, and 
by the lateral extension of the layers of myelin towards what will become the nodes (left). 
Unwrapped growing myelin sheath on the right shows cytoplasmic channels, which provide 
a path for trafficking of myelin components to the region of active growth, the inner tongue. 
Compaction then proceeds from the outer towards the inner layers. Taken from (Snaidero, 
Mobius et al. 2014). 
 
One other myelin protein, P0, an evolutionarily old immunoglobulin (Hartline and 
Colman 2007), is present in CNS myelin in zebrafish but only in PNS myelin in 
mammals (Brosamle and Halpern 2002, Schweitzer, Becker et al. 2003, Bai, Sun et 
al. 2011). Zebrafish express an array of growth-promoting molecules following a 
lesion, including P0 (Schweitzer, Becker et al. 2003), which may explain the 
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different regenerative capabilities of vertebrates: zebrafish are capable of 
regenerating axons (Becker and Becker 2007) and full-thickness myelin sheaths 
following an optic nerve lesion (Munzel, Becker et al. 2014). In mammals, Schwann 
cells which express P0 are highly regenerative, in contrast to oligodendrocytes in the 
CNS.  
Oligodendrocytes appear to synthesize myelin components in a regulated sequence: 
for instance, glycosphingolipids specific to oligodendrocytes such as GalC are 
produced before major protein components such as Plp and Mbp. These components 
will then be delivered to the area of myelin sheath growth, the inner tongue, where 
they may self-assemble into myelin (Aggarwal, Yurlova et al. 2011). Synthesis and 
transport of myelin lipids starts in the endoplasmic reticulum, and proceeds through 
the secretory pathway, during which some myelin lipids may preassemble in lipid 
rafts. Some proteins, such as Plp (which interacts with cholesterol), may also 
associate with myelin lipids before they reach their destination. Vesicular and non-
vesicular transport mechanisms may then exist in parallel for the final delivery of 
these components to the myelin membrane (Simons and Trotter 2007). Interestingly, 
mbp mRNA is transported in granules, on microtubules, to the myelinating process, 
where it is locally translated in response to a stimulus (possibly, neuronal activity 
(Wake, Lee et al. 2011)). This delivery as mRNA is likely related to its function. 
Mbp is a highly positively charged molecule, which upon translation quickly adheres 
to the negatively charged cytoplasmic membrane surfaces, bringing the two 
cytoplasmic membrane surfaces in close apposition. This also prevents diffusion of 
proteins with large cytoplasmic domains into myelin (Aggarwal, Yurlova et al. 
2011), facilitating compaction of the several wraps of the myelin sheath. When 
targeting of mbp mRNA to oligodendrocyte processes is impaired by disruption of its 
transporter Kif1b, cytoplasmic translation of mbp mRNA results in ectopic myelin-
like membrane close to the cell body (Lyons, Naylor et al. 2009). In a growing 
myelin sheath, Mbp translation seems to occur at the inner tongue, but the 
compaction of cytoplasmic membranes may be actively delayed by other myelin 
components (such as CNP) to prevent premature compaction of the growing zone 
(Snaidero and Simons 2014).  
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Following the growth of myelin sheaths, a mature, myelinated axon has distinct 
functional domains (Figure 1.1). The unmyelinated nodes of Ranvier, where voltage-
gated sodium channels accumulate on the axon, are the site of action potential 
propagation. Flanking each node are paranodes, where the myelin membrane forms 
paranodal loops that are tightly anchored to the underlying axon by septate-like 
junctions. The lateral cytoplasmic pockets of each layer in a growing sheath move 
towards the ends of the myelin sheath, where they align and form these paranodal 
loops. Three cell adhesion molecules are the main known components of these 
axoglial junctions: on the axonal side, Contactin and Contactin-associate protein 
(Caspr); on the glial side, Neurofascin 155 (Nfasc155). Interestingly, disruption of 
this complex slows down the migration of the lateral edges of a growing myelin 
sheath (Zonta, Tait et al. 2008, Susuki, Chang et al. 2013), indicating that this 
axoglial junction is required for the longitudinal growth of myelin. This longitudinal 
migration of the axoglial junction may help form the nodes of Ranvier, by ‘pushing’ 
sodium channels along the axon, until two adjacent sodium channel clusters fuse into 
a single node of Ranvier (Zonta, Tait et al. 2008). Just next to the innermost 
paranodal loop, under the myelin sheath, lies the juxtaparanode, a short region where 
potassium channels accumulate in the axolemma, which are thought to regulate 
axonal excitability. Finally, the internode extends between juxtaparanodes and 
comprises most of length under the myelin sheath. The molecular composition and 
modes of assembly of these domains are reviewed in (Poliak and Peles 2003, Salzer 
2003, Buttermore, Thaxton et al. 2013). 
 
 Axonal signals regulating oligodendrocyte-lineage cell 1.4
development 
Which signals underlie axon-oligodendrocyte communication and the development 
of such an intricate structure? Drawing on in vitro evidence and knowledge of 
peripheral nervous system myelination, a number of extrinsic signals have been 
identified that regulate oligodendrocyte-lineage cell development; I will briefly refer 




Platelet-derived growth factor (PDGF) 
PDGF was the first major secreted mitogen for OPCs identified in vitro, and 
confirmed in vivo: PDGF-A global knockout mice have greatly reduced numbers of 
OPCs, oligodendrocytes and myelin in their spinal cords and several brain regions; 
while overexpressing PDGF-A in neurons results in excess proliferation of OPCs and 
excess oligodendrocytes early on. (Calver, Hall et al. 1998, Fruttiger, Karlsson et al. 
1999). Delivery of exogenous PDGF to the optic nerve reduces the normal levels of 
developmental oligodendrocyte apoptosis in control animals (Barres, Hart et al. 
1992). PDGF is known to be produced by retinal ganglion cells (RGCs), which 
project axons to the optic nerve (Yeh, Ruit et al. 1991, Mudhar, Pollock et al. 1993). 
However, it is also well established that astrocytes produce the relevant form of 
PDGF. In fact, given that PDGF secretion by RGCs is restricted to their somas and 
not axons (Fruttiger, Calver et al. 2000), it seems more likely that this particular 
pathway is involved in a paracrine interaction between astrocytes and OPCs in the 
optic nerve. In other regions such as the spinal cord, where neuronal cell bodies exist 
in the vicinity of OPCs, it remains to be determined to what extent the endogenous 
neuronal production of PDGF contributes to the levels of this mitogen in the milieu.  
 
Neuregulin1(Nrg1)-ErbB signaling 
Nrg1 is a member of the epidermal growth factor family of proteins that function as 
extracellular ligands for the ErbB family of receptor tyrosine kinases. The nrg1 gene 
generates numerous alternatively spliced isoforms of Nrg1, including secreted (e.g., 
type I) and transmembrane isoforms (e.g., type III) (Mei and Xiong 2008). In the 
peripheral nervous system, it is well established that Nrg1 expressed on axons 
activate ErbB receptors in Schwann cells, where they can regulate proliferation, 
survival, differentiation and even the thickness of the myelin sheath (Michailov, 
Sereda et al. 2004). In the CNS, early in vitro work established that oligodendrocyte-
lineage cells are responsive to Nrg1 treatment (Vartanian, Corfas et al. 1994, Canoll, 
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Musacchio et al. 1996, Raabe, Suy et al. 1997, Shi, Marinovich et al. 1998, Canoll, 
Kraemer et al. 1999, Flores, Mallon et al. 2000, Calaora, Rogister et al. 2001). For 
instance, addition of Nrg1 prevents normal apoptosis of newly-differentiated 
oligodendrocytes in culture (Fernandez, Tang et al. 2000). Embryonic spinal cord 
explants from Nrg1 knockout mice specifically fail to generate mature 
oligodendrocytes; but the origin of these ligands was not clearly addressed 
(Vartanian, Fischbach et al. 1999). An axonal origin of Nrg1 was hinted by co-
culture studies with dorsal root ganglia neurons - this alone was sufficient to prevent 
oligodendrocyte apoptosis. If direct contact was blocked at ligand or receptor level 
with anti- Nrg1 antibodies or antagonistic ErbB4 immunoglobulins, the survival 
induced by axons was mostly inhibited  (Fernandez, Tang et al. 2000). Thus, 
oligodendrocyte survival seems to be mediated at least in part by axonal Nrg1 and to 
involve axonal contact. 
In vivo, early expression of Nrg1 (and Shh) in the growing RGCs in the optic nerve 
induces the specification of primordial OPCs from the optic stalk, which 
subsequently migrate and colonize the nerve (Gao and Miller 2006). At later stages, 
normal oligodendrocyte developmental apoptosis in the optic nerve is increased with 
delivery of ErbB4 immunoglobulin, and decreased with exogenous Nrg1, without 
affecting OPC proliferation. Nrg1 also decreases the apoptosis that is induced by 
optic nerve transection during the period of active myelination (Fernandez, Tang et 
al. 2000). Collectively, these results poised Nrg1 to be a main axonal regulator of 
oligodendrocyte development, including their specification and their survival.  
However, a more recent study showed normal myelination following conditional 
neuronal ablation of Nrg1 in specific CNS regions, from embryonic or postnatal 
stages. It was also normal following conditional Nrg1 knockout from all neuronal 
and glial lineages in a particular region of the forebrain. Conditional Nrg1 ablation 
from the entire developing CNS did not hamper myelination at birth in the earliest 
myelinated tracts, including generation of a normal density of Olig2+ and MBP+ 
cells in spinal cord and forebrain (Brinkmann, Agarwal et al. 2008). Long-term co-
cultures of wildtype oligodendrocytes with Nrg1-null dorsal root ganglia neurons 
readily formed myelinated axons, suggesting that continued axonal Nrg1 expression 
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is dispensable for CNS myelination, unlike the PNS. In agreement with these results, 
conditional ablation of ErbB signaling in oligodendrocytes also did not prevent 
normal myelination of CNS tracts (Brinkmann, Agarwal et al. 2008). It may be that 
axonal NRG1 acts in redundancy with additional factors in the CNS that can also 
promote survival of oligodendrocytes and regulate myelination in vivo. It is 
conceivable, for instance, that survival of oligodendrocyte lineage cells may also be 
promoted by astrocyte-derived factors, for instance. If this is the case, in vivo, these 
can compensate for the lack of Nrg1, but in vitro, in the simpler co-culture studies, 
such additional factors may be absent, and Nrg1 signaling would seem to play a more 
important role.  
Consistent with a role in myelination, though, animals that overexpress Nrg1 type I 
or III in neurons have hypermyelinated axons with many additional wraps. 
Additionally, more myelinated axons (particularly of smaller diameter) were found in 
the cortex of over-expressing animals, and in the optic nerve at P6, indicating that 
oligodendrocytes prematurely initiated myelination of Nrg1 expressing RGCs 
(Brinkmann, Agarwal et al. 2008). Since the number of oligodendrocytes was not 
altered, it is likely that the myelinating capacity of each individual oligodendrocyte 
was increased. Interestingly, socially isolated mice show an hypomyelinating 
phenotype in the prefrontal cortex, which is at least partly explained by a reduction in 
the myelinating capacity of individual oligodendrocytes, concomitantly with  
reduced Nrg1 expression (Makinodan, Rosen et al. 2012). The phenotype can be 
phenocopied in otherwise normal mice by loss of oligodendrocyte ErbB3 receptors. 
Thus, in vivo, Nrg1 seems capable of regulating later aspects of myelination, 
including oligodendrocyte myelinating potential at the level of the single 
process/myelin sheath. This is agreement with the multiple functions of Nrg1 
signaling in PNS myelination. 
 
Notch ligands  
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Notch1 is a transmembrane receptor whose signaling pathway may play multiple 
roles during oligodendrocyte lineage progression. Genetic ablation of Notch1 ligands 
DeltaA/D or of the requisite enzyme for the signaling pathway, Mindbomb, resulted 
in excess neuron production and decreased OPCs in the zebrafish spinal cord. The 
Notch1 pathway may thus be required early on to maintain a pool of proliferative 
precursors that later gives rise to OPCs, subsequent to neuron production (Park and 
Appel 2003). Conversely, a mutation in fbxw7 (encoding F-box/WD repeat-
containing protein 7), which normally targets Notch1 for degradation, increases 
Notch1 function and resulted in excess production of OPCs from neural precursors 
(Snyder, Kearns et al. 2012).  
Manipulation  later on during development suggested that Notch1 also regulates the 
OPC-oligodendrocyte transition: in vitro, activation of the Notch1 pathway 
prevented differentiation of purified optic nerve OPCs into oligodendrocytes and 
maturation of newly differentiated oligodendrocytes, with no effect on OPC 
proliferation (Wang, Sdrulla et al. 1998). In vivo, constitutively active Notch1 also 
prevented maturation of OPCs into oligodendrocytes in the zebrafish spinal cord 
(Park and Appel 2003), resulting in excess OPCs. In the rodent spinal cord and 
forebrain, conditional ablation of Notch1 from OPCs caused premature 
differentiation of oligodendrocytes, without affecting OPC proliferation (Genoud, 
Lappe-Siefke et al. 2002). Similarly, mice heterozygous for a notch1 null mutation 
show premature myelination of brain and optic nerve, and additionally show ectopic 
myelination of incorrect axons in the cerebellum, that normally never get myelinated 
(Givogri, Costa et al. 2002).  
However, the identity of the cells that present Notch1 ligands is debatable. In the 
optic nerve, retinal ganglion cells (RGCs) express the ligand Jagged1, but so do 
oligodendrocytes. Thus, in this region, contact between mature oligodendrocytes and 
OPCs may result in an intra-lineage regulation of oligodendrocyte differentiation, as 
in vitro studies suggested previously (Zhang and Miller 1996, Yang, Lewis et al. 
2011). Additionally, an in vitro study proposed that an axonal molecule present at the 
paranodal junction, Contactin, may itself serve as a ligand for the Notch1 pathway, 
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but seemed to act in the opposite way: Contactin-mediated activation of Notch1 
promoted OPC differentiation and myelination (Hu, Ang et al. 2003). 
Thus, the role of the Notch1 signaling pathway during the differentiation of 
oligodendrocyte is not fully elucidated, and it particularly remains unclear which 
ligands bind to the Notch1 receptor in vivo, and whether they have an axonal origin.  
 
 Integrin signaling  
The laminin family of basal-lamina glycoproteins, which has been shown to promote 
survival in several cell types, can also regulate oligodendrocyte-lineage cell 
development through the signaling pathway downstream of the transmembrane 
receptor integrin. Co-culture studies using integrin-blocking antibodies (Frost, 
Buttery et al. 1999) show increased oligodendrocyte apoptosis, and a role for β1-
integrin signaling in promoting oligodendrocyte survival and myelination was 
confirmed in vivo, using integrin receptor knock-out mice (Colognato, Baron et al. 
2002, Benninger, Colognato et al. 2006, Barros, Nguyen et al. 2009) or mice 
expressing a dominant-negative β1-integrin transgene in oligodendrocytes (Lee, de 
Repentigny et al. 2006, Camara, Wang et al. 2009). In these mice, some degree of 
hypomyelination and reduction in oligodendrocyte number is found in specific CNS 
tracts, although this is variable between experimental paradigms.  
A number of molecules have been identified as ligands for integrin signaling. 
Expression studies pointed to axonal laminin-2 (Colognato, Baron et al. 2002), and in 
fact, laminin-2 deficient mice present reduced oligodendrocyte number and 
hypomyelination or dysmyelination of some CNS axonal tracts (Chun, Rasband et al. 
2003, Relucio, Tzvetanova et al. 2009), as do laminin-2 deficient human patients, 
which present alterations in CNS white matter tracts (Jones, Morgan et al. 2001). 
However, a direct interaction between axonal laminin-2 and oligodendroglial β1-
integrin has not yet been unambiguously demonstrated in vivo, and at least in vitro, 
astrocytes may also promote oligodendrocyte survival via laminin-2-β1-integrin 
interactions (Corley, Ladiwala et al. 2001). Contactin, a molecule that is expressed 
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both by neurons and oligodendrocyte-lineage cells, may also mediate 
oligodendrocyte survival and promote myelination via α6β1- integrin (Laursen, Chan 
et al. 2009).  
Additionally, integrin signaling may also be required in later aspects of 
oligodendrocyte development: laminin-2 promoted cell spreading and myelin sheath 
formation in vitro, an effect blocked by using anti-β1 integrin antibodies (Buttery and 
ffrench-Constant 1999, Relvas, Setzu et al. 2001). β1-integrin-null oligodendrocytes 
extend smaller myelin membrane sheaths when plated in vitro (Barros, Nguyen et al. 
2009). In vivo, a dominant-negative form of β1-integrin receptor decreased the 
elaboration of myelin sheaths following a demyelinating lesion (Relvas, Setzu et al. 
2001). In addition to disruption to a number of intracellular signaling cascades, these 
phenotypes may also be due to the ability of β1-integrin to directly promote local 
translation from the mbp mRNA in the processes of oligodendrocytes (Laursen, Chan 
et al. 2011). Collectively, these may explain some of the dysmyelination phenotypes 
observed in laminin-2 null mice, but the relevant oligodendroglial receptor remains 
to be determined – recently, the non-integrin receptor Dystroglycan has been found 
to mediate at least part of the laminin signaling in oligodendrocytes and promote 
myelination (Colognato, Galvin et al. 2007).  
In sum, the exact molecules and the developmental stage at which they act remain to 
be fully clarified and it is possible that combinations of factors act at multiple stages 
to exert their functions in vivo. Other extracellular matrix components, namely 
Tenascin-C, also regulate myelination: the transient developmental expression of 
Tenascin-C seems to prevent mbp expression; interestingly, it requires interaction 
with Contactin, but is thought to act via α5 integrins (Czopka, von Holst et al. 2010). 
While laminins are secreted proteins present in the extracellular matrix, Contactin is 
membrane-anchored, which would act in a juxtacrine fashion.  
Like Nrg1-ErbB signaling, integrin or dystroglycan signaling is also pleiotropic in 
oligodendrocyte development. Interestingly, the integrin signaling pathway may 
actually modulate oligodendrocyte-lineage cells’ responsiveness to Nrg1 signaling 
and switch its effect from anti-differentiation to pro-differentiation and pro-survival 





A number of observations have long suggested that neuronal electrical activity may 
influence myelination in vitro and in vivo (these have been reviewed in (Zalc and 
Fields 2000, Fields 2005, Fields 2010)). For instance, sensory and motor experience 
seem to drive myelination in vivo: myelination is accelerated with premature eye 
opening in rabbits (Tauber, Waehneldt et al. 1980); professional pianists with long-
term training have increased white matter volume in specific tracts relating to fine 
finger movements (Bengtsson, Nagy et al. 2005, Han, Yang et al. 2009). However, 
conflicting reports exist for much of this indirect evidence (Fields 2004). Direct 
testing of this hypothesis using highly specific neurotoxins in vivo also yielded 
conflicting results. Intravitreous injection of tetrodotoxin at the onset of myelination 
(postnatal day P4) in rats did not change the number of Mbp+ oligodendrocytes at 
P6, but greatly reduced the proportion of those that form myelin sheaths, and the rare 
myelin sheaths formed were loose and uncompacted. However, P5 injection had no 
effect (Demerens, Stankoff et al. 1996). Another group reported using intraocular 
injections from P0-P9; at P9, rats had normal numbers of myelinated axons in the 
optic nerve (Colello, Devey et al. 1995).  
 
The recent observation that unmyelinated axons in many regions of the CNS make 
bona-fide synapses with OPCs provided further support to this notion, as it provides 
an anatomical and cellular correlate that may underlie the seemingly activity-driven 
myelination. Such synapses are both anatomically, ultrastructurally and 
electrophysiologically similar to classical neuron-neuron synapses, though their exact 
role in myelination, if any, remains unclear (Almeida and Lyons 2013). A recent 
elaborate in vitro study proposed that glutamatergic signaling at such axon-OPC 
synapses may directly regulate local translation of mbp mRNA (Wake, Lee et al. 
2011). However, NMDA receptor-based glutamatergic signaling is dispensable for 
myelination in vivo (De Biase, Kang et al. 2011), and the exact molecular 
mechanisms underlying such synaptic communication remain unclear.  
In addition to glutamate-based synaptic vesicle release, a number of other pathways 
have been proposed to mediate the influence that electrical activity has on 
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myelination. For instance, purinergic signaling may indirectly stimulate astrocytes to 
enhance myelination (Fields and Burnstock 2006). Another study reported that 
NRG1 type I expression was shown to be dynamically regulated by electrical activity 
in axons (Liu, Bates et al. 2011); axonal overexpression of this particular isoform of 
Nrg1 caused hypermyelination (Brinkmann, Agarwal et al. 2008). As mentioned 
before, mice grown in social isolation exhibit reduced levels of Nrg1 and a 
hypomyelinating phenotype, which was phenocopied by inhibition of ErbB3 
(Makinodan, Rosen et al. 2012). Thus, the Nrg-ErbB pathway seems to be 
downstream of an experience-driven, neuronal activity-driven stimulus for 
myelination. 
Thus, the exact aspect of myelination that may be modulated by electrical activity is 
not clear, and it may be that electrical activity directly or indirectly influences 
multiple steps of oligodendrocyte development and myelination. 
 
In sum, many factors can influence the same developmental stage of myelination and 
potentially compensate for the absence of any single factor. Individual molecules can 
play multiple roles at different stages. Additionally, extrinsic factors likely exert their 
regulation over an intrinsic developmental program. Why is such complex regulation 
necessary? It may have emerged during evolution to adapt the properties of myelin to 
each specific axon, optimizing the functional output of the circuit, as mentioned 
before.  
 
 Diversity of myelinated fibers 1.5
Complex regulatory signals, including those derived from axons, may be responsible 
for generating the immense diversity of oligodendrocytes and myelinated fibers 
observed among vertebrates and within one animal’s nervous system, for which I 





Timing of oligodendrocyte differentiation and myelination 
Within the same species, the variation in the timing of oligodendrocyte 
differentiation and myelination is considerable. In the rodent CNS, analysis of the 
expression of myelin genes such as mbp revealed that the first oligodendrocytes 
appear just before birth in the ventral spinal cord, and differentiation ensues in the 
caudal direction in the following days (Foran and Peterson 1992). Myelination, as 
determined by electron microscopy, quickly follows the pattern of differentiation. 
Axonal ensheathment in the ventral spinal cord is observed in late embryonic stages 
and compact myelin is observed at birth (Bjartmar, Hildebrand et al. 1994). In the 
forebrain, differentiation of oligodendrocytes and myelination of the corpus callosum 
only occur later in the third postnatal week (Foran and Peterson 1992). The general 
pattern of myelination is replicated in other vertebrates (Remahl and Hildebrand 
1982, Hildebrand, Remahl et al. 1993). As previously mentioned, myelination 
continues to occur until adulthood, although at later stages it remains to be fully 
elucidated whether this represents de novo myelination or myelin turnover, for 
instance. 
One striking example concerns the corticospinal tract in the dorsal spinal cord. This 
tract only exhibits mature oligodendrocytes (Schwab and Schnell 1989) and compact 
myelin (Matthews and Duncan 1971) on postnatal day 11, in contrast with the 
adjacent cuneate and gracile tracts, which are myelinated on the day of birth. The late 
myelination of the rat corticopinal tract illustrates the highly local regulation of 
differentiation and myelination even in the same region of the dorsal spinal cord.  
Interestingly, some CNS regions show a different timing between oligodendrocyte 
differentiation and myelination. OPCs migrate into the rat optic nerve at late 
embryonic stages (Small, Riddle et al. 1987); the first differentiated oligodendrocytes  
(expressing myelin transcripts and proteins) are detected from P4 closer to the brain, 
and differentiation proceeds towards the retina (Colello, Devey et al. 1995). 
Surprisingly, the formation of compact myelin occurs in the opposite direction, 
starting at the retina and proceeding towards the brain. Thus, within the same animal, 
some oligodendrocytes clearly form myelin sheaths immediately upon 
differentiation, regardless of when that differentiation happens, but other 
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oligodendrocytes (such as optic nerve oligodendrocytes closer to the brain) 
experience a significant delay between the expression of myelin genes and the actual 
elaboration of myelin sheaths. This suggests that some oligodendrocytes may be 
subject to external, regional signaling that regulates the timing of their myelination. 
 
 
Figure 1.6 – 9dpf versus 6 month old zebrafish spinal cord  
(A, B) 9dpf spinal cord: neuronal somas lie in the centre, flanked by clusters of axons, some 
myelinated. The large myelinated axon in the centre of the box is the Mauthner axon.  
(C) Close up of the box in B; note it contains all myelinated axons in that hemi-spinal cord.   
(D) An area similar in size to C in an adult zebrafish contains many more myelinated axons, 
and the spinal cord is orders of magnitude larger. Scalebars: 3 µm. 
 
In the zebrafish CNS, expression of myelin genes (P0, DM20 and MBP) is first 
detected in the hindbrain at 2 days postfertilization (dpf). Oligodendrocytes rapidly 
increase in number and distribute through the midbrain and spinal cord by 4dpf 
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(Brosamle and Halpern 2002). In the optic nerve, the first oligodendrocytes only 
appear later, by 4dpf. The formation of compact myelin sheaths follows the same 
spatial pattern. Compact myelin is first detected in the ventral hindbrain and anterior 
spinal cord at 4dpf, and later in the optic nerve. After the emergence of 
oligodendrocytes and first myelinated axons, myelination proceeds at a rapid pace 
during larval development. The number of myelinated axons in the ventral spinal 
cord of adult animals is much larger compared to larvae (Figure 1.6), which indicates 
that as in mammals, myelination is an ongoing process that persists for a significant 
part of their development. Thus, the large regional variation in the timing of the onset 




The first descriptions of oligodendroglia by Pio del Rio Hortega already highlighted 
the diversity of oligodendrocyte morphologies (Río-Hortega 1928). The number of 
processes and myelin sheaths and their spatial orientation varies greatly from 
oligodendrocyte to oligodendrocyte and from CNS region to CNS region. In the 
spinal cord, some oligodendrocytes extend just one large myelin sheath (resembling 
a Schwann cell) (Remahl and Hilderbrand 1990), whereas in the cerebral cortex, 
oligodendrocytes can maintain 60 smaller-calibre sheaths (Chong, Rosenberg et al. 
2012), for instance. Hortega classified such diversity in four morphological subtypes 
(see examples in Figure 1.7). In the almost 100 years since, this morphological 
heterogeneity has been confirmed in all animal models studied, as reviewed in 
(Hildebrand, Remahl et al. 1993), and exemplified in (Almeida, Czopka et al. 2011, 





Figure 1.7 – Original silver impregnation microphotographs and illustrations by Pio 
del Rio Hortega  
(A, B) Carbonate silver impregnation of brain tissue and drawing showing a type 2 
oligodendrocyte, which extends many aligned small calibre myelin sheaths.  
(C) Type 3 oligodendrocytes extend fewer and thicker sheaths.  
(D) Type 3 (cell E at the top) and 4 (cells A-D at the bottom) oligodendrocytes; type 4 
extend just one large sheath resembling a Schwann cell. All taken from (Río-Hortega 1928) 
 
Strikingly, a particular tendency has been consistently observed amongst all this 
diversity: oligodendrocytes myelinating many axons tend to myelinate small-calibre 
axons, compared to those myelinating large axons, which extend fewer processes. 
For instance, at the onset of myelination in the rat CNS, spinal cord oligodendrocytes 
myelinate 3 axons on average, with a diameter of about 1µm, while oligodendrocytes 
in the corpus callosum myelinate 15 axons, with an average of about 0.5 µm 
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diameter; and this general pattern is confirmed  in several CNS regions by several 
studies (Bjartmar, Hildebrand et al. 1994, Berry, Ibrahim et al. 1995, Weruaga-
Prieto, Eggli et al. 1996). This relationship is also observed in the toad, chicken and 
cat, for instance (Hildebrand, Remahl et al. 1993). Interestingly, some reports 
describe a molecular correlate for this heterogeneity, whereby some antibodies 
recognize specifically either oligodendrocytes that associate with few large-diameter 
fibers (Anderson, Bjartmar et al. 1999) or oligodendrocytes that associate with many 
small diameter axons (Butt, Ibrahim et al. 1995). This indicates that the 
morphological classification is not purely artificial but indeed reflects different 
biochemical properties of subsets of oligodendrocytes. Could these different 
morphologies reflect intrinsically different subtypes of OPCs? 
 
 
Figure 1.8 – Live imaging of mosaically labelled oligodendrocytes in the developing 
zebrafish spinal cord recapitulate diversity of oligodendrocyte morphologies  
Two different oligodendrocyte morphologies, resembling a type 4 oligodendrocyte in 
Hortega’s morphological classification (top) and a type 2 oligodendrocyte (bottom). On the 
right, graph illustrating the diversity of the number of sheaths that individual 
oligodendrocytes form in the larval zebrafish spinal cord. Taken from (Almeida, Czopka et 
al. 2011)  
 
It is of particular interest to observe CNS regions such as the spinal cord, which 
contain many different axons. In our own studies of the zebrafish spinal cord, we 
have been able to directly analyze the morphology of living oligodendrocytes in vivo 
by genetically targeting the expression of fluorescent reporters such as GFP in 
individual cells (Figure 1.8). This is difficult to achieve in any other models of 
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myelination at the same single-sheath resolution. We have recapitulated the findings 
of Hortega: some oligodendrocytes extend only one, very large myelin sheath around 
the very large diameter Mauthner axon; but other oligodendrocytes can extend more 
than 20 sheaths, all on smaller axons (Almeida, Czopka et al. 2011). Interestingly, 
we also find that the vast majority of oligodendrocytes tend to fall into one of those 
categories. These oligodendrocytes coexist in very close proximity, and thus have 
access to the exact same complement of targets. What makes them choose only one 
particular type of axons?  
In sum, there is a large variation in oligodendrocyte morphologies – both between 
different regions of the CNS and within the same region. This heterogeneity is 
conserved in all individuals of the same species, and the general patterns of 
myelination are conserved across vertebrate species, which suggests that rather than 
occurring stochastically, these parameters of myelination are adapted to optimize the 
function of axons and of the emerging neuronal circuits. How do such differing 
morphologies emerge during development? It is tempting to speculate that axons 
regulate some aspects of the morphological development of oligodendrocytes, given 
that the final morphology seems adapted to the axons, and the recent evidence that 
experience-driven neuronal activity can lead to changes in white matter. However, no 
in vivo study unambiguously or convincingly demonstrated that axons directly 
regulate the morphology of oligodendrocytes, at the level of the individual cells. The 
alternative hypothesis remains possible, that distinct oligodendrocyte morphologies 
reflect inherently distinct, ‘fixed’ subtypes of oligodendrocytes. I will explore this 








My general aim in this thesis is to explore which aspects of oligodendrocyte 
development and myelination can be regulated by their target axons, and which 
aspects follow an intrinsic programme of development. This will address whether the 
diversity of oligodendrocytes observed reflects such axonal regulation, or 
intrinsically different subtypes of oligodendrocytes. Specifically, I will: 
a) Investigate the requirement of axons for early oligodendrocyte lineage cell 
development, by analysing the specification and early behaviour of OPCs in the 
absence of the initial axonal targets for myelination (Chapter 3) 
b) Address the requirement of axons for later aspects of oligodendrocyte lineage cell 
maturation, such as the timing of differentiation, the extent of myelination and the 
location of myelin sheaths, in the absence of the same axonal targets (Chapter 4) 
c) Address whether the myelinating capacity of oligodendrocyte-lineage cells is 
plastic and responsive to the axonal environment, by challenging these cells with an 


















 Fish husbandry and lines used 2.1
Zebrafish were kept and raised in the Queen’s Medical Research Institute animal 
facility under standard conditions (Nüsslein-Volhard and Dahm 2002, Westerfield 
2007) and in accordance with UK Home Office guidelines. Adult animals were kept 
at 26.5°C at a 14 hours light and 10 hours dark cycle. Embryos were kept at 28.5°C 
in embryo medium1 or conditioned aquarium water with methylene blue. Embryos 
were staged according to (Kimmel, Ballard et al. 1995). In addition to WT strains 
(WIK, AB and golden), the following transgenic or mutant lines were used: 
Line name Use Origin 
kbp
st23/+ Remove reticulospinal axons partially 
(Lyons, Naylor et al. 
2008) 
sox10:mRFP 
Visualize OPCs and oligodendrocyte 
membrane 
(Kirby, Takada et al. 
2006) 
olig2:GFP Visualize pMN progenitors and OPCs 
(Shin, Park et al. 
2003) 
mbp:EGFP Visualize oligodendrocytes 
(Almeida, Czopka et 
al. 2011) mbp:EGFP-CAAX 
Visualize oligodendrocytes and myelin 
sheaths 
sox10:KalTA4 
Sparsely label OPCs and 
oligodendrocytes 
this study 
mbp:Gal4 Sparsely label oligodendrocytes unpublished 
UAS:kaede Visualize sparsely labelled cells 
(Scott, Mason et al. 
2007) 
pax2a:GFP 
Visualize a subset of spinal 
interneurons 
(Picker, Scholpp et al. 
2002) 
glyt2:GFP 
(McLean, Fan et al. 
2007) 
 
                                                




In Figures and figure legends, ‘Tg’ before the line name means that a stable, germ-
line inserted transgenic line was used, with transgene expression in all relevant cells. 
Otherwise, a transgene name designates injection of a plasmid which results in 
sparse, mosaic expression.  
 kbp
st23 genotyping 2.2
Animals were genotyped for kbpst23 in at least one of three manners:  
a) According to (Lyons, Naylor et al. 2008): genomic DNA was extracted by 
standard protocols (Nüsslein-Volhard and Dahm 2002), from which a 250bp long 
PCR product was amplified using primers  
5′-AAAACGACCAACTGTGCCTA-3′ 
5′-ACAGTCAAACACCAGATCGAAAGTCA-3′,  
and digested with restriction enzyme MaeIII (Roche). The WT PCR product is 
cleaved into 228bp + 22bp fragments, whereas the mutant PCR product is not 
cleaved; these were visualized by routine electrophoresis on a 4% agarose gel 
containing ethidium bromide. See example in Figure 4.13C. 
b) When crossed with transgenic lines sox10:mRFP or mbp:EGFP-CAAX, myelin 
sheaths along the posterior lateral line and ventral spinal cord were easily visualized 
in a standard fluorescence microscope. The mutant phenotype was clearly identified, 
as sheaths do not extend past the urogenital opening, whereas in WT or heterozygous 
animals they extend the full length of the animal at all ages analysed. 
c) When immunostained with 3A10 antibody, axons in the posterior lateral line and 
ventral spinal cord were easily visualized in a standard fluorescence microscope. The 
mutant phenotype was clearly identified, as axons do not extend past the urogenital 
opening, whereas in WT or heterozygous animals they extend the full length of the 




  sox10:KalTA4 Plasmid construction 2.3
The middle entry vector pME-KalTA4GI was generated by PCR-amplifying the 
coding sequence for KalTA4GI, an optimized version of Gal4, from plasmid 





The PCR product was recombined with pDONR221 using BP clonase (Life 
technologies) to generate the ME element clone pME-KalTA4GI. 
A previously described Gateway plasmid containing the 7.2kbp fragment of the 
sox10 promoter, p5E_sox10 (Czopka, Ffrench-Constant et al. 2013), was recombined 
in a LR Gateway reaction with pME-KalTA4GI, and plasmids p3E-polyA and 
pDestTol2CG2 from the Tol2kit (Kwan, Fujimoto et al. 2007) using LR clonase II 
Plus (Life technologies), to generate sox10:KalTA4GI, which contains a cmlc2:egfp 
transgenesis marker for EGFP expression in the heart. 
 
 GFP-2A-KBP plasmids construction 2.4
To generate WT kbp transgenic (“rescue”) constructs, full-length kbp was initially 
amplified from complementary DNA (cDNA) of the AB strain and cloned in 
pCR2.1-Topo (Life technologies), using primers  
5’-ATGGCTGCCAACAACAGTATCGAGTGG-3’  
5’-TCACTTGGAGGAGGCCAGAGTGG-3’ 
generating pCR2.1-kbp. Subsequently, a GFP-encoding fragment was PCR-
amplified from pME-EGFP (from the Tol2kit) and a WT kbp-encoding fragment 












These primers include sequences for attaching a porcine teschovirus-1 2A (‘2A’) 
sequence, which is a short peptide that induces a strand break during messenger 
RNA translation to obtain two separate proteins from a single open reading frame. 
According to (Szymczak-Workman, Vignali et al. 2012, Szymczak-Workman, 
Vignali et al. 2012), standard recombinant PCR was then used to ligate the two 
fragments and generate GFP-2A-KBP, which was cloned into the expression vector 
pCS2+ (producing pCS2-GFP-2A-KBP) and Sanger-sequenced to verify that the 
correct sequence was generated. 
The GFP-2A-KBP sequence was then PCR-amplified from this vector using attB-





The PCR product was recombined with pDONR221 using BP clonase to generate the 
ME element clone pME-GFP-2A-KBP. 
Finally, p5E_sox10, p5E_HuC2, pME-GFP-2A-KBP, p3E-polyA and pDestTol2pA2 
from the Tol2kit were recombined in a LR Gateway reaction using LR clonase II 
Plus to generate HuC:GFP-2A-KBP and sox10:GFP-2A-KBP. 
 
 DNA microinjections 2.5
Fertilised eggs were injected with 1 nL of a solution containing 5-10 ng/µL plasmid 
DNA and 25-50 ng/µL tol2 transposase mRNA. Injected fish were analysed as 
                                                
2 unpublished, generated by Dr. T. Czopka by recombining a 3kbp HuC promoter fragment from a 
huC:Gal4 plasmid (a kind gift from Dr. M. Meyer), into a pDONRP4-P1R vector in a standard 
Gateway BP reaction. 
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mosaics or grown to adulthood to raise stable transgenic lines. For the generation of 
the stable transgenic line Tg(sox10:KalTA4), plasmid DNA encoding sox10:KalTA4 
and transposase mRNA were injected as described in 1-cell stage AB fertilized eggs. 
Successful integration of sox10:KalTA4 into the genome was detected by 
cmcl2:EGFP expression in the heart. GFP+ potential founders were individually 
outcrossed to AB wildtype, and screening for green hearts in the offspring identified 
founders with germ-line transmission of sox10:KalTA4; this F2 generation was also 
raised and screened for stable sox10:KalTA4 genome integration. 
 
 notch1a morpholino injection 2.6
Fertilized eggs (between1-8 cell stage) were injected with 500pg of a morpholino 
directed against a notch1a-specific splice junction (Ma and Jiang 2007) (Gene Tools, 
LLC) to temporarily abrogate embryonic notch1a expression.  
 
 hoxb1 mRNA injection 2.7
Fertilized eggs (between1-8 cell stage) were injected with 50pg of hoxb1b mRNA. 
The majority of hoxb1b mRNA-injected animals were morphologically normal and 
typically had two Mauthner axons on one side of the CNS and one on the 
contralateral side. A subset of hoxb1b mRNA-injected animals had morphological 
abnormalities as have been previously described (Hale, Kheirbek et al. 2004) and 
were therefore excluded from further study. 
 
 notch1a RT-PCR 2.8
To assay notch1a mRNA expression levels, total RNA was extracted from pools of 
10-20 10hpf embryos or 72hpf larvae and cDNA was synthesized using a poly-d(T) 
primer, according to standard protocols (Nüsslein-Volhard and Dahm 2002). 
Following normalization of total cDNA levels, specific notch1a cDNA levels were 




5′-CTTCTGCACTTTCTGGAGATTTAAA GAAG-3′ (Ma and Jiang 2007)  
5′-CACACGTCTGACCTGTGAAGC-3′;  





 Acridine Orange treatment 2.9
Dechorionated larvae were incubated for 30minutes in the dark in embryo medium 
containing 2µg/ml acridine orange (Sigma), followed by two quick 5-minute washes 
in embryo medium, and immediately live-imaged after. 
 
   Transmission electron microscopy 2.10
Transmission electron microscopy was performed as described in (Almeida, Czopka 
et al. 2011, Czopka and Lyons 2011). Briefly, zebrafish were terminally 
anaesthetised in tricaine (4.2mg/mL 3-amino benzoic acid ethyl ester, Sigma) and 
immersed immediately in primary fixative (4% paraformaldehyde and 2% 
Glutaraldehyde in 0.1M sodium cacodylate buffer) microwave-stimulated (using a 
Panasonic microwave with `Inverter' technology), and incubated for 2 hours at room 
temperature. Alternatively, a small number of adult animals (Figure 1.6) were 
perfused with the same primary fixative solution under the careful (and generous) 
guidance of Dr. T. Becker, and the spinal cords were dissected after primary fixation. 
Samples were transferred to a secondary fixative (2% osmium tetroxide in 0.1M 
sodium cacodylate and 0.1M imidazole buffer) at room temperature for 3 hours with 
microwave stimulation. Samples were subsequently stained en bloc with an aqueous 
saturated uranyl acetate solution (~8% w/v), and subsequently dehydrated in an 
ethanol gradient solution series (50%, 75%, 95% and 100%. Ethanol), followed by 
acetone dehydration. Samples were then pre-infiltrated with an EMbed-812 resin 
(Electron Microscopy Sciences)/acetone solution, which was then replaced by 100% 
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EMbed. The EMbed infiltrated tissue samples were then aligned in silicon moulds 
and solidified at 65°C for at least 24hours. 
Blocks were then trimmed in the shape of a trapezoid around the embedded fish, and 
the regions of interest in the spinal cord were cut into 80nm thick sections on an 
ultramicrotome (Reichert Jung Ultracut Microtome, Leica). Blocks were visualized 
under a dissection microscope to ensure sections were cut on comparable somite 
levels. Sections were chloroform-stretched, captured and allowed to dry on electron 
microscopy grids with hexagonal grid pattern (PELCO 300 Mesh Grids, Ted Pellar 
Inc.). Sections on grids were further stained with a solution of saturated uranyl 
acetate and absolute ethanol, washed, dried, and subsequently incubated in Sato lead 
stain (Czopka and Lyons 2011) for 5minutes. Grids were then washed, dried and 
stored until imaging. TEM images were taken at magnifications between 520x-6500x 
on a Phillips CM120 Biotwin transmission electron microscope at the Electron 
Microscope Facility, Daniel Rutherford Building, University of Edinburgh.  
 
   Immunohistochemistry 2.11
Whole-mount antibody labelling was carried out using standard protocols (Nüsslein-
Volhard and Dahm 2002). Briefly, zebrafish were terminally anaesthetised in tricaine 
and immersed immediately in primary fixative (2% paraformaldehyde and 1% 
Trichloroacetic acid, or alternatively 4%PFA, in PBS). Samples were then 
permeabilized (by incubation in either acetone at -20ºC or 10µg/ml proteinase K in 
PBS at room temperature), blocked in normal goat serum (‘NGS’, 10% in PBS), and 
incubated with primary antibodies over two nights at 4ºC, followed by secondary 
antibodies over one night at 4ºC. Samples were extensively washed in between steps 
(with PBS containing 1% Triton X-100). Primary antibodies used were 3A10 
antibody (1:200, Developmental Studies Hybridoma Bank), HB9 (MNR2, 1:400, 
Developmental Studies Hybridoma Bank), phosphorilated-histone 3 (PH3 Ser10, 
1:200, Cell Signalling #9701), at indicated dilutions in 5% NGS in PBS. Secondary 
antibodies were all used at 1:2000 dilution in 2%NGS in PBS, conjugated with Alexa 
fluor dyes - Al488, Al568 or Al633 (from Molecular Probes, Life Technologies). 
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Samples were then equilibrated in a graded glycerol series (30%, 50%, 70%, 95% in 
PBS). 
Antibody labelling of 5dpf dissected brains was performed as above, but after 
fixation, the tissue around the brain was carefully dissected using dissection forceps, 
and permeabilization was abbreviated, with all other steps remaining equal. 
Alternatively, some animals were immunostained in whole-mount, and dissection 
was performed after secondary antibody incubation. 
 
   Mounting for imaging 2.12
Live embryonic and larval zebrafish were embedded in 1.5% low melting point 
agarose (Sigma) in embryo medium with tricaine (168µg/mL 3-amino benzoic acid 
ethyl ester, Sigma). Animals were placed laterally on their sides and carefully 
pressed against the coverslip along the length of their trunk to ensure they were as 
flat as possible. 
For imaging of immunostained samples, samples were placed in a drop of 95% 
glycerol in PBS between a coverslip and a glass slide, in some cases with three small 
drops of vacuum grease to support the coverslip and prevent flattening and disruption 
of the tissue. 
 
   Image acquisition 2.13
Most imaging was performed with a Zeiss LSM710 confocal microscope except for 
the following: mature oligodendrocytes in 4dpf and 8dpf WT and kbp mutants 
(Figure 3.4C and Figure 4.4A); oligodendrocyte-lineage cells in 48hpf and 60hpf WT 
and kbp mutants (Figure 3.7), and acridine orange labelled apoptotic cells in 72hpf 
WT and kbp mutants (Figure 3.15). These experiments were imaged in a Zeiss 
Imager Z1 equipped with an Apotome2 structured illumination unit. 
For all imaging of WT versus kbp mutants in Chapter 3, the anterior region of the 
spinal cord was acquired in all animals by aligning the edge of the visual field in the 
eyepiece to the urogenital opening somite; and the posterior region by aligning the 
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edge of the visual field to the very last somite in the spinal cord, using a 20X 
objective (Zeiss Plan-Apochromat 20x dry, NA=0.8, Carl Zeiss Microscopy), zoom 
1x. This resulted in a 425µm long image in the Zeiss LSM710 confocal microscope 
and in a 488µm long image in the Zeiss Imager Z1. The only exception was imaging 
the posterior region of 72hpf and 96hpf oligodendrocyte-lineage cells in double 
transgenic Tg(olig2:GFP; sox10:mRFP) (Figure 3.8B), which were imaged using a 
63x objective (Zeiss C-Apochromat 63x, water immersion, NA=1.2, Carl Zeiss 
Microscopy), zoom 1x, aligning the visual field (~2 somites) to 7 somites posterior to 
the urogenital opening, and tiling two lengths of the visual field. This resulted in a 
270 µm long image in the Zeiss LSM710 confocal microscope. In all cases, Z-stacks 
were acquired of the entire depth of the spinal cord, with a Z-interval 2 µm. 
For time-lapse imaging in the Zeiss LSM710 confocal microscope, animals were 
kept in a heated stage adjusted to approximate 28.5ºC in the preparation. Z-stacks of 
the entire depth of the spinal cord were acquired every 14 minutes, with a Z-interval 
of 2.1 µm. The posterior spinal cord was imaged overnight and larvae were checked 
in the morning for circulation and general health.  
For all imaging of WT versus kbp mutants in Chapter 4, anterior and posterior spinal 
cord regions were defined as for Chapter 3. All images were acquired using a 20X 
objective, zoom 1x, Z-step of 2 µm, except for oligodendrocyte myelinating capacity 
(Figure 4.3), which were acquired using a 63x objective, and Z-step of 1.5 µm. For 
some time-coursed mosaically labelled oligodendrocyte-lineage cells (Figure 4.1), 
the posterior spinal cord of Tg(UAS:kaede animals) was illuminated briefly (~1 
minute) with an UV light immediately after 60hpf or 72hpf imaging to achieve kaede 
photoconversion and facilitate identification of individual cells in the field of view at 
later time points. 
Imaging of WT and animals with supernumerary Mauthner axons in Chapter 4 was 
as follows: 3A10 immunostained brains (Figure 4.5) were imaged using a 63X 
objective and a 1 µm Z-step; ensheathment of axons (Figure 4.6) was imaged using a 
40x objective and a 1 µm Z-step; mature oligodendrocytes (Figure 4.9) were imaged 
using a 20x objective and a 1.5 µm Z-step; single oligodendrocyte morphology 
(Figure 4.10-4.12) was imaged using a 40x or 63x objective and a 0.7-2 µm Z-step. 
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All fluorescent spinal cord images represent a lateral view, anterior to the left and 
dorsal on top. 
 
  Image processing  2.14
For most imaging, processing was kept to a minimum and included only global 
change of brightness and contrast; most processing and analysis was done in Fiji 
software (a distribution of ImageJ). Figure panels were produced using Fiji and 
Adobe Illustrator CS8. For figures, maximum-intensity projections of Z-stacks were 
made, and a representative x-y area was cropped. Some images display only one 
channel in grayscale and were inverted (dark foreground on white background) for 
ease of visualization. 
Electron micrograph tiles were aligned automatically using the automated photo-
merge tool in Adobe Photoshop CS3. 
Each time lapse movie was processed in Fiji as follows: for each time point, Z-stack 
slices encompassing the spinal cord were projected in a maximum intensity 
projection using the Image5D plugin. Projections were then registered in the x-y 
position between time points using the olig2:GFP channel as reference, using the 
‘Register virtual stack slices’ plugin; subsequently the same registration was applied 
to the sox10:mRFP channel by using the ‘Transform virtual stack slices’ plugin. 
Global brightness and contrast were adjusted. 
 
   Image analysis 2.15
Cell counts  
Oligodendrocyte number was counted in z-stacks of a lateral view of Tg(mbp:EGFP) 
larvae, in which GFP is expressed in the cytoplasm of oligodendrocytes, which 
facilitates the quantification of all oligodendrocyte cell bodies. OPC number was 
counted in z-stacks of a lateral view of Tg(olig2:GFP; sox10:mRFP) larvae, in which 
oligodendrocyte-lineage cells express both cytoplasmic GFP and membrane-tethered 
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mRFP; both channels were simultaneously visualized while counting. A grid was 
superimposed on the image and all cell bodies were counted throughout the z-stack 
using the cell counter plugin in Fiji. An approach based on unbiased stereological 
methods was used to ensure that each oligodendrocyte was only counted once 
(briefly, consecutive optical sections in the z-stacks should sample each cell body 
more than once, and each cell body was counted only in the first optical section it 
appears). 
For counts in PH3 immunostained Tg(olig2:GFP) larvae (Figure 3.5), counting was 
performed blinded to the genotype. 
 
sox10:mRFP debris analysis 
For the numbers presented in section 3.3.8 relating to Figure 3.13B, the presence of 
at least a cluster of mRFP debris (not associated with clear oligodendrocyte-lineage 
cell processes) was determined in all images from experiments that included the 
Tg(sox10:mRFP) transgenic line imaged with a 20X objective (this included images 
acquired with a Zeiss LSM710 microscope and with a Zeiss Imager Z1 microscope).  
 
Electron Micrographs 
TEM images were processed as described above. Axons in the spinal cord were 
traced using the lasso tool in Adobe Photoshop CS3. Axons were included if they 
were located in the white matter region of the spinal cord; if they were transversal to 
the section (i.e. extending longitudinally in the spinal cord) and presented a (roughly) 
circular profile; and if they contained cross sectional profiles of neurofilaments (10 
nm) and microtubules (24 nm), which are readily identifiable given their 
characteristic calibre and distribution (Czopka and Lyons 2011). The perimeter and 
area of traced axons were measured using the measuring tool in Adobe Photoshop, 
from which the diameter was calculated. Subsequently, the number and perimeter of 
all axons (for 9dpf electron micrographs) or of those above 0.5µm (for 3dpf electron 
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micrographs) in diameter was quantified. Colour code was added to the TEM images 
using the lasso and pain bucket tools in Adobe Photoshop CS3. 
 
Time-lapses 
A composite view of both GFP and mRFP channels of each time lapse was first 
analysed to detect a) the timing and number of mitotic and apoptotic events, b) the 
timing of the first dorsal migration of an olig2:GFP+ cell and c) the timing of first 
myelin sheath formation. In some time lapse movies, the specimen shifted slowly 
within the agarose in the z axis and drifted outside of the captured z-stack. 
Subsequently to this first analysis, only the subset of the movie that included the 
entire depth of  the spinal cord was considered. In all animals imaged, every mitotic 
or apoptotic event and the start of myelination occurred after the dorsal migration of 
the first OPC; therefore, only the period of each movie after the onset of dorsal 
migration was considered, for comparison purposes (in Tables 3.2 and 3.3). 
To analyse the dynamics of dorsal migration, the time at which the first dorsal OPC 
migrated above olig2:GFP+ band of neuronal somas was considered to be time point 
0 (x=0; y=1 in graph in Figure 3.9B). The time at which any further olig2:GFP+ cell 
migrated dorsally was annotated, even if the cell returned a ventral position later. The 
number of dorsally-migrated OPCs (y axis) was plotted against time (x-axis) for each 
larva using Graphpad Prism 6, and standard regression with least-squares method 
was used to fit a line to the data of each larva. This line was forced to go through 
point x=0; y=1 (point at which the first OPC migrates dorsally). R2 values varied 
between 0.82-0.98 for WT larvae and 0.78-0.97 for mutant larvae, showing that a 
straight line models this phase of the dorsal migratory dynamics well. An average 
regression line was then determined within all WT and within all mutant data, and 
used to fit those movies which already started with dorsal OPCs (Figure 3.9B).    
To analyse the migratory properties of OPCs (Figure 3.10-3.11), dorsal or ventral 
OPCs that could be reasonably distinguished within the olig2:GFP+ band (prior to, 
or retrospectively, the onset of sox10:mRFP expression) were tracked using a semi-
automated tracking Fiji plugin, Trackmate. Briefly, the annotation of each cell in 
56 
 
each frame is manual, and Trackmate automates the linking between annotated cells 
across time points. The plugin displays the tracks and provides a number of statistics 
for each tracked cell, including number of splits (i.e. mitoses), migrated distance, 
average speed and maximum speed. 
 
Single oligodendrocytes 
For analysis of single OPCs and oligodendrocytes at low magnification (Figure 4.1-
4.2), individual cells were followed at three time points (60, 72, 96hpf) and were 
identified across time points based on the morphology of the cell body, morphology 
of the processes, location in the spinal cord (in the z-axis), relative location to 
sox10+ expressing radial glial or floor plate cells, and photoconverted kaede 
fluorescence from previous time points. At each time point the presence of tubular 
structures at the end of processes (myelin sheaths) was assessed. The target axonal 
track (dorsal, medial, ventral and motor) was assessed, as well as the presence of 
ensheathed cell bodies. 
For analysis of the myelinating capacity of single mbp:EGFP-CAAX+ 
oligodendrocytes at high magnification (Figures 4.3 and 4.10-4.12) at 4, 5 or 9dpf, 
the length and number of individual internodes were measured throughout the z-stack 
using the measuring tool of either Fiji or Zen Software 2010 (Carl Zeiss 
Microscopy). 
 
   Statistical analysis 2.16
All statistical analysis was performed on Graphpad Prism 6. All data were averaged 
per biological replicate (larva), so in every case N represents number of larvae. All 
data was tested for normality using D'Agostino & Pearson omnibus test, Shapiro-
Wilk test and Kolmogorov-Smirnov test. Direct experimental comparisons of control  
and manipulated group were subjected both to a parametric, unpaired, two-tailed 
Student’s t-test, and a non-parametric Mann-Whitney test. P-values <0.05 were 
considered significant and are represented by an asterisk * in Figures. The particular 
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test displayed in individual figure legends was the t-test if the compared data passed 
at least two normality tests and the Mann-Whitney test it failed more than one 
normality test. In most cases, a significant result in a t-test was significant in the 
Mann-Whitney test, as was the case with non-significant results. For the occasional 
result which varied according to the statistical test, P-values from both tests are 
reported. Throughout the thesis and figures, error bars illustrated mean ± standard 
deviation (SD). 












3. Axons regulate proliferation and 





The sequence of events that results in the emergence of a successfully myelinated 
axon from a neural precursor and a glial precursor is extremely complex. In addition 
to the neuron’s own differentiation, oligodendrocyte precursor cells (OPCs) must be 
generated at the appropriate time and location. OPCs first emerge during 
embryogenesis from a discrete ventral domain in the spinal cord, the pMN domain 
(Rowitch 2004, Rowitch and Kriegstein 2010). This domain is established by the 
concerted action of morphogens (such as sonic hedgehog and bone morphogenetic 
proteins), which distribute in gradients along the dorsal-ventral axis of the 
developing neural tube. The particular concentrations of the morphogen cocktail in a 
domain establishes it identity. In the case of the pMN domain, morphogen signalling 
induces the downstream expression of Olig transcription factors, which are required 
for the generation of pMN progenitors and their offspring (including OPCs), and can 
be used as marker of pMN identity (Meijer, Kane et al. 2012). Olig2+ pMN 
progenitors first generate motor neurons, and later on, switch to OPC generation.  
Subsequently, OPCs must migrate and proliferate in a manner that leads to the 
population of the entire central nervous system. The number and distribution of 
OPCs and oligodendrocytes must be adequate, at each point, to ensheath and 
myelinate the required axonal targets. OPCs then extend ramified processes that 
interact with their local environment. After contacting the target axons, OPCs must 
ensheath them and kick-start a program of terminal differentiation into 
oligodendrocytes, which results in myelin biosynthesis and sheath formation. 
Notably, individual oligodendrocytes can myelinate numerous axons, and the 
thickness and length of each myelin sheath is often precisely adjusted to each axon. 
This suggests that the amount of myelin that must be synthesized at the end of each 
process varies and is locally regulated; further highlighting the complexity of the 
myelination process (I will address this in Chapter 4).  
Regulation of this sequence of events can happen at different levels: from entire cell 
populations (for instance, proliferation, migration or survival of precursors, which 
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can be modulated by secreted signals acting at a distance), to the level of single cells 
(for instance, axonogenesis, or the elaboration of myelin sheaths – more likely 
regulated by localized, contact-dependent cues). In this chapter, I will address how 
the initial stages of a complex developmental process such as oligodendrocyte 
development may be regulated by a different cell type, neurons and their axons, 
which are intimately associated with the developing myelinating cell. I will focus 
specifically on whether axons can affect aspects such as specification, migration, 
proliferation, and survival of OPCs; which must be precisely regulated to lead to the 
successful colonization of the CNS prior to actual myelin sheath formation. In the 
next chapter, I will then address whether axons can regulate the later stages of 
oligodendrocyte development and myelination. 
On the face of the complexity of developmental steps outlined above, and the sheer 
regional diversity of myelinated axons and their structure in the CNS (referred to in 
Chapter 1), axonal regulation of oligodendrocyte development would be a 
parsimonious way to explain the ontogenic and the evolutionary emergence of 
myelination. If neurons in living animals possess the signalling capabilities to 
effectively communicate and modulate oligodendrocyte development and 
myelination, then the diversity of myelinated fibers could be just a by-product of the 
axon-driven oligodendrocyte regulation. A less parsimonious alternative is that the 
diversity of myelinated fibers is also biologically encoded on the myelinating glia 
side: the location and timing of oligodendrocyte differentiation and the formation of 
every myelin sheath would also be genetically predetermined during development. It 
is possible that this alternative holds true for those particular regions of the CNS that 
exhibit a stereotyped, fixed structure in every individual. However, the first 
hypothesis, that axons regulate oligodendrocyte development and myelination, has 
gathered strong support from the study of CNS regions that exhibit experience-
dependent structural plasticity, which I will mention below. 
In humans, myelination is an ongoing process lasting well into the third decade of 
life (Fuster 2002). Recent work has revealed that myelin and oligodendrocyte-lineage 
cells in adult animals, like neurons, also respond to environmental change or an 
individual’s experience. For instance, optogenetic stimulation of the premotor cortex 
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in mouse stimulates OPC proliferation and differentiation, which seems to result in 
some degree of increased myelination in the premotor cortex and subcortical white 
matter, with accompanying motor function improvements (Gibson, Purger et al. 
2014). Similarly, stimulating the medullary pyramid in the rat brainstem promoted 
proliferation of OPCs in the corticospinal tract throughout the spinal cord (Li, Brus-
Ramer et al. 2010). Other examples are reviewed elsewhere (Fields 2008, Zatorre, 
Fields et al. 2012, Wang and Young 2014). Thus, de novo myelin formation in 
response to neuronal-driven experience during adulthood may underlie aspects of 
cognition and complex behaviours in a way never before realized. The cellular and 
molecular mechanisms that underlie this regulation in adulthood are only now 
beginning to be queried (Wang and Young 2014). Understanding the fundamental 
mechanisms of neuronal regulation of oligodendrocyte development and myelin 
formation during development may also shed light on the basis of such myelin 
plasticity in adulthood, and contribute to understanding the cellular basis of complex 
behaviours and other aspects of cognition, or their dysfunction, in adults. 
Moreover, in cases of demyelinating injury, such as in multiple sclerosis, OPCs 
remain present throughout the brain, but become surprisingly incapable of 
differentiating and remyelinating a lesioned area, leading to neuronal degeneration 
and disability progression (Franklin 2002, Franklin and Ffrench-Constant 2008). 
Why does remyelination eventually fail in this context, when de novo myelination 
can occur in other contexts in the adult CNS? Neurons and axons are present in the 
environment, but may differ substantially from their developmental stages, or from a 
healthy adult environment. The elucidation of the mechanisms that regulate 
developmental myelination and how they relate to those in a pathological context can 
provide new avenues for seeking potential therapies. 
 
3.1.1 Some aspects of oligodendrocyte development are intrinsic and 
independent of neurons 
Over thirty years ago, it was found that oligodendrocyte-lineage cells dissociated 
from brain (Abney, Bartlett et al. 1981) or optic nerve cultures (Raff, Abney et al. 
1985) had the remarkable capacity to differentiate on schedule, replicating their in 
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vivo timing of differentiation – regardless of the age at which the tissue was 
dissociated, and even in culture without neurons (Zeller, Behar et al. 1985). This 
showed that positional information was not necessarily required for the timely 
emergence of cells of the oligodendrocyte lineage; but did not address whether 
external factors (for instance, derived from astrocytes, neurons or microglia that 
might be present in these cultures) might be required for oligodendrocyte 
development. Further work demonstrated that without astrocytes or their conditioned 
media, OPCs did not proliferate, and instead differentiated prematurely (Noble and 
Murray 1984). Platelet-derived growth factor (PDGF) was identified as this 
astrocyte-secreted mitogen (Noble, Murray et al. 1988, Raff, Lillien et al. 1988, 
Richardson, Pringle et al. 1988), and PDGF’s role in promoting proliferation was 
confirmed in vivo. As long as astrocytes or PDGF were present in culture, an 
intrinsic program of development seemed to act within the OPCs that timely 
regulated their final differentiation: for instance, the offspring of an individual OPC 
divide the same number of times and differentiated simultaneously, even when two 
daughter cells were plated in separate microwells (Temple and Raff 1986). 
Purification of OPCs to homogeneity and culture in serum-free media allowed 
researchers to more specifically define the factors required for oligodendrocyte 
development: with PDGF added to the medium, purified OPCs proliferated, but did 
so indefinitely and failed to differentiate. Thyroid hormone was identified as an 
additional factor required to induce their exit from the cell cycle, and was also shown 
to be sufficient to initiate differentiation (Gao, Apperly et al. 1998), a role confirmed 
in vivo (Barres, Lazar et al. 1994, Ibarrola, Mayer-Proschel et al. 1996, Ahlgren, 
Wallace et al. 1997, Baas, Legrand et al. 2002). 
Thus, two external but non-neuronal factors were identified that regulated OPC 
proliferation and cell cycle exit in a paracrine (PDGF) or endocrine manner (thyroid 
hormone). Providing these two factors is enough for purified perinatal OPCs to 
develop in a petri dish: they are able to proliferate, and, like OPCs in vivo, 
progressively mature in morphology and antigenic phenotype (Gao and Raff 1997, 
Tang, Tokumoto et al. 2000). They timely stop proliferating and exit the cell cycle, 
and initiate a program of differentiation. Their morphology changes as they extend 
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many ramified processes (Kachar, Behar et al. 1986, Barres, Lazar et al. 1994), and 
they start expressing myelin structural proteins and glycolipids (Zeller, Behar et al. 
1985, Dubois-Dalcq, Behar et al. 1986). Eventually, the cells even produce myelin 
sheaths (Bradel and Prince 1983, Rome, Bullock et al. 1986, Szuchet, Polak et al. 
1986), either flat in the dish or around inert nano-fibers (Howe 2006, Lee, Leach et 
al. 2012, Li, Ceylan et al. 2014) or formaldehyde-fixed axons (Rosenberg, Kelland et 
al. 2008). All of these occur in the absence of neuronal influences and of live axonal 
contact, suggesting that oligodendrocyte-lineage cells have an intrinsic program of 
development, independent of the axons that these cells ensheath and myelinate.  
 
3.1.2 Axons can influence oligodendrocyte development and 
myelination, even in vitro 
Notwithstanding these observations that oligodendrocyte-lineage cells do not 
absolutely require axons for much of their developmental progression, and retain a 
certain capacity to differentiate by default, it quickly became clear that even in vitro, 
axons can drastically influence some steps of oligodendrocyte development. Under 
specific culture conditions, axons of dorsal root ganglia can promote proliferation of 
adult-isolated oligodendrocyte lineage cells (Wood and Bunge 1986). Co-culture of 
primary rat oligodendrocytes with chick spinal cord neurons is enough to raise the 
expression level of MBP and PLP mRNAs fourfold (Macklin, Weill et al. 1986). 
Additionally, oligodendrocytes will only wrap axons and not dendrites of co-cultured 
neurons, suggesting that neurons regulate oligodendrocyte adhesion or recognition of 
axonal versus non-axonal compartments (Lubetzki, Demerens et al. 1993).  
What, then, is the role of axons during developmental myelination in the context of a 
living animal? Nervous systems display immense regional variation and complexity, 
including many types of neurons, with different myelination requirements – no 
myelin at all, thin or thicker myelin, early or later myelination, all of which are 
presumably fine-tuned to optimize neural circuit function (Waxman 1997). It is 
conceivable that myelinating glia have a default intrinsic program of development, 
which does not absolutely require axons for its essential stages, but that is plastic and 
responsive to axonal influence. Individual axons could then locally modulate specific 
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aspects of oligodendrocyte-lineage development and myelination. For instance, 
regulating local synthesis of myelin proteins at the tip of the oligodendrocyte process 
may ensure the correct timing of sheath compaction, or the correct thickness of 
sheaths: this would ensure optimal functional output for each neuron, and in turn for 
the whole circuit, and would explain the regional complexity and variation that is 
observed in vivo.  
 
3.1.3 Which aspects of oligodendrocyte development and myelination 
can axons influence in vivo? 
Which precise aspects of oligodendrocyte development are modulated by axonal 
contact, axonal activity or axon-secreted signals in vivo, and which are cell-
autonomous or at least neuronal-independent? Addressing these questions requires a 
model where an identifiable subset or the totality of the axonal compartment can be 
consistently and robustly removed. What is the fate of oligodendrocyte-lineage cells 
when the axonal influence is removed? Are they generated in the first place? Can 
they successfully populate the nervous system? Can they progress through their 
differentiation program? Are they permanently arrested at a particular developmental 
stage, or is such a latent cell not sustainable for long and does it initiate a self-
destruction program? Can axonal signals be compensated for by other cells? Do 
oligodendrocyte-lineage cells proceed with their differentiation program but adapt to 
their new environment and become changed? Analysis of all the stages of 
oligodendrocyte lineage development would address these questions. 
 
3.1.4 The optic nerve as a model to assess axonal influence on glia 
The rodent optic nerve provides an excellent model for addressing the issue of axonal 
influence on developing glial cells:  
i) It has a simple composition: the sole neural component are the axons of 
retinal ganglion cells (RGCs), whose somas reside externally in the retina 
and project long axons towards the brain, relaying the entirety of visual 
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information. The only somas found within the optic nerve are those of 
astrocytes, OPCs and oligodendrocytes. 
ii) Most axons become myelinated, and myelination occurs only postnatally, 
which facilitates experimental manipulation and analysis.  
iii) The retina and RGC somas are accessible to pharmacological treatment 
(via eye injection) and to surgical manipulation: transection behind the 
retina or eye removal (enucleation) essentially removes the axonal 
component of the nerve within a few days (enucleation, for instance, 
causes a quick, drastic degradation of viable axons in the optic nerve 
within 48h).  
iv) Such manipulations can be unilateral, allowing the contralateral nerve to 
serve as an internal control.  
RGC axons develop from embryonic stages in rodents: in rats, at E17, RGCs are 
already electrically active (Galli and Maffei 1988). The number of axons peaks at 
birth and then, by developmental apoptosis of a subset of RGCs, decreases until P5 
(Sefton and Lam 1984). OPCs migrate from the brain into the optic nerve, in the 
opposite direction of axon growth, around E17 (Small, Riddle et al. 1987); 
interestingly, the specification of these OPCs depends on signaling from growing 
RGC axons in chicken embryos (Gao and Miller 2006). OPCs then proliferate, 
greatly increasing their numbers and populating the entirety of the nerve by the end 
of the first postnatal week. From P4 onwards, differentiated oligodendrocytes 
(expressing myelin transcripts and proteins) are detected, first closer to the brain, and 
differentiation proceeds towards the retina, replicating the pattern of OPC migration. 
Surprisingly, however, ensheathment and formation of compact myelin occurs in the 
opposite direction, starting at the retinal end and proceeding towards the brain 
(Colello, Devey et al. 1995). This suggests that while differentiation and production 
of myelin proteins may follow an intrinsic schedule within the OPC, actual 
myelination may require additional signaling, stronger in the region closer to the eye. 
Interestingly, RGC axons have a much larger diameter closer to the eye than the 
brain (Colello, Devey et al. 1995). While the actual molecular mechanism remains to 




Could it be that earlier aspects of oligodendrocyte development (for example, 
migration or proliferation of precursors) are autonomously determined, while later 
aspects such as sheath formation are modulated by axons? 
To address this, a number of studies used neonatal or early postnatal enucleation of 
the retina or transection of the nerve behind the retina to remove the axonal influence 
on the glial cells of the optic nerve (reviewed in Table 3.1). Interestingly, the 
influence this has on the development of oligodendrocyte-lineage cells seems to 
depend crucially on the time of the operation, as I will outline below.  
 
3.1.5 Effect of optic nerve transection on oligodendrocytes depends 
on stage of development 
 
 
Prior to myelination 
When nerves are operated early on (P0-P2, studies 1-4 in Table 3.1), prior to 
myelination, the most common finding is that appearance of differentiated 
oligodendrocyte is impaired – drastically fewer oligodendrocytes develop, and with a 
delay. No myelin sheaths are detected even at late juvenile stages. These findings 
suggest that the development of a significant proportion of OPCs or their terminal 
differentiation into oligodendrocytes requires axons. Given that a few 
oligodendrocytes do differentiate in the virtual absence of axons in some of these 
studies (studies 1, 2 and 4); and that OPCs retain some capacity for differentiation in 
the absence of axons in vitro, as mentioned previously, it seems likely that 
transecting axons affects development of normal numbers of OPCs (discussed later); 
rather than solely impede oligodendrocyte differentiation.  
 
At the onset of myelination 
Transecting nerves at the onset of oligodendrocyte differentiation allows OPCs time 
to migrate, proliferate and populate the entire nerve. Transection at P4 (study 5), 
when some OPCs are about to differentiate and produce myelin proteins, did not 
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affect the appearance or distribution of the initial MBP+ oligodendrocytes, which 
might have already entered their final program of differentiation at the time of 
transection. However, there was a significant, if transient, decrease in MBP+ 
oligodendrocyte density at P5, accompanied by a transient increase in apoptotic cells; 
both of these recovered to control levels at P6 and P7 (Ueda, Levine et al. 1999). 
Additionally, oligodendrocytes in transected nerves form no myelin, appeared more 
immature and had fewer and shorter processes. Thus, many oligodendrocytes are 
able to differentiate and produce myelin proteins without axons, as had been 
predicted before (Colello, Devey et al. 1995). The transient reduction in 
oligodendrocytes may indicate a role of neurons in providing a survival signal for a 
subset of OPCs-oligodendrocytes. Axons also seem to regulate later aspects of 
myelination such as the organization of the processes and the morphology of 
oligodendrocytes (Ueda, Levine et al. 1999).   
An earlier study appears at variance with this. In optic nerves enucleated at P5, by 
morphological identification of cells, (Valat, Fulcrand et al. 1978) similarly found 
that the first oligodendrocytes appear without delay, and, by P7, represent 20% of all 
glial cells in the nerve, as in control animals. However, they then decrease to 
represent around 5% of glial cells, unlike control nerves, in which half the cells are 
oligodendrocytes. Enucleation at any developmental stage results in a decrease in the 
total number of cells (Fulcrand and Privat 1977, Valat, Fulcrand et al. 1978), so this 
report seems to indicate a much more significant effect of axons on oligodendrocyte 
development.  
However, the two studies shouldn’t be compared directly, since (Valat, Fulcrand et 
al. 1978) presented the oligodendrocyte proportion of total cell in transversal 
sections, while (Ueda, Levine et al. 1999) presented absolute numbers of MBP+ 
oligodendrocytes in longitudinal sections. In fact, up to P7, even (Valat, Fulcrand et 
al. 1978) reported similar proportions to the control levels; only later were the results 
different, time points which (Ueda, Levine et al. 1999) did not analyse. Additionally, 
enucleation is a more severe procedure than transection, even in the hands of the 
same investigators (Ueda, Levine et al. 1999), so the results may represent real 
differences in paradigms. Finally, criteria used to identify oligodendroglia in the 
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earlier were purely morphological (Valat, Fulcrand et al. 1978), compared to the 
more recent  study, which used the more reliable immunocytochemical detection of 
MBP (Ueda, Levine et al. 1999).  
Collectively, these studies strongly suggest a role for axons in promoting survival of 
a subset of OPCs or oligodendrocytes, and in regulating the morphology of 
individual oligodendrocytes at the later stages of myelination.   
During active myelination 
Operating on nerves during active myelination confirmed a role of axons in 
promoting oligodendrocyte survival. Using immunocytochemical detection with the 
RIP antibody (which detects a phosphodiesterase, CNP, present in myelin protein 
(Watanabe, Sakurai et al. 2006)), studies 7 and 8 found that P8-transection resulted 
in a drastic reduction in oligodendrocytes at P18 compared to control nerves (>95%) 
and compared to the normal number of oligodendrocytes at the age of transection 
(90%). This indicates that the survival of already differentiated oligodendrocytes 
must be compromised. In agreement with this, more pyknotic nuclei than normal 
were detected at P16 following P12-transection, most of which were RIP+. The more 
protracted period of apoptosis detected in this study, compared to P4-transected 
nerves (study 5), may be due to the increased number of oligodendrocytes at this 
later age of transection. Thus, newly-born oligodendrocytes require axons to promote 
their survival. Interestingly, P12-transected WldS (‘Wallerian degeneration slow’) 
mice, in which axons do not degenerate immediately, exhibited no increased cell 
death – suggesting that contact with the axonal surface is sufficient to promote 
survival and that physiological activity is dispensable.  
 
After myelination 
In stark contrast, when nerves are transected in late juveniles or adult animals (P20-
onwards, studies 9-13), most oligodendrocytes persist for many weeks after 
transection, although myelin sheaths deteriorate and myelin debris abounds. This 
indicates that mature oligodendrocytes in the mature optic nerve lose their 
requirement for axons for survival. These studies will not be considered further as 
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late enucleations and consequent degeneration of already myelinated axons would 
obscure careful assessment of the developmental interactions between axons and 
OPCs.  
 
In sum, although the timing of differentiation seems to be independent of axons, the 
mature morphology of individual oligodendrocytes may be regulated by axons. 
Moreover, axons seem to provide a vital survival signal for late OPCs or newly-
differentiated oligodendrocytes; they then lose this requirement when they get older. 
The extent to which axons regulate oligodendrocyte differentiation per se remains 
unclear, since the number of OPCs may be reduced to start with, if their proliferation 
or survival is also affected. This begs the question as to precisely which aspects of 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.1.6 Does optic nerve transection affect oligodendrocyte precursor 
cell development? 
The effect that removing axons early on has in depleting the oligodendrocyte 
population could be attributed to decreased migration or proliferation of OPCs, 
decreased survival of OPCs, decreased differentiation of OPCs into 
oligodendrocytes, or decreased survival of early born oligodendrocytes. A 
combination of these is more likely – for instance, a simple defect in OPC migration 
does not explain the normal distribution of those oligodendrocytes that differentiate 
when nerves are enucleated at P0 (Ueda, Levine et al. 1999). A defect only in OPC 
proliferation does not explain the reduced survival of early-born oligodendrocytes 
following P8 or P12 transection (Barres, Jacobson et al. 1993, Ueda, Levine et al. 
1999). If there was only an impairment in differentiation when axons are removed, 
but development of OPCs was not affected, we might expect an accumulation of 
OPCs above control levels – however, that is not observed (Ueda, Levine et al. 
1999). Several of the studies in Table 1 and additional studies directly addressed the 
fate of OPCs upon operation by direct labeling of this cell population. Earlier studies 
based on morphological identification of glial cell types report a decrease in the 
proportion of ‘glioblasts’, an umbrella term that designates mitotic immature cells 
that can differentiate into astrocytes, oligodendrocytes or microglia; these will not be 
considered. The advent of immunocytochemical methods and clarification of glial 
lineages allowed reliable identification of oligodendrocyte precursors in the 
developing optic nerve, and more recent studies take advantage of this. 
 
Migration and proliferation 
(Ueda, Levine et al. 1999) showed that neonatal transection does not change the 
distribution or density of OPCs (which express the neural/glial antigen 2 proteoglican 
marker, NG2) from P1 to P4. Since their numbers normally increase over this period, 
OPCs must still have proliferated in the absence of viable axons; and indeed a pulse 
of BrdU within two days of transection labels the same proportion of OPCs as 
control nerves of the same age. These OPCs extended fewer and shorter processes in 
the absence of axons, prefiguring the altered morphology that oligodendrocytes also 
show in the same paradigm. Enucleation at the same age also did not impede 
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colonization of the nerve by OPCs. An independent study confirmed that NG2+ glia 
were still abundant 3 and 15 days after enucleation at P1 or P5 (Greenwood and Butt 
2003). Additionally, tritiated thymidine given six days after neonatal transection was 
incorporated by the same proportion of glial progenitors (as identified by 
immunoreactivity with the A2B5 antibody marker, and non-reactivity with more 
mature marker GalC and astrocytic Glial fibrilary acidic protein) as in control nerves. 
These studies suggest that OPCs can autonomously migrate and colonize the optic 
nerve, and further, that live axons or electrical activity are dispensable for OPC 
proliferation.   
However, a conflicting report indicated that P8-transection reduced the number of 
mitotic figures at P12 to 10% of control nerves (Barres and Raff 1993), but the 
authors did not determine the identity of the mitotic figures. P8 operation greatly 
increases microglial proliferation compared to earlier enucleations (Privat, Valat et 
al. 1981). Since the total number of cells is decreased in operated nerves (Valat, 
Fulcrand et al. 1978), it is unclear the extent to which the specific proliferation of 
OPCs was (proportionally) affected. Transection of P12 WldS mice, whose axons do 
not degenerate for some time, also reduced the number of mitotic figures, suggesting 
that this effect depends on physiological activity of the axons. In agreement with this, 
P15 eye-injection of tetrodotoxin, which abrogates action potentials, led to a 
significant decrease of mitotic figures two days later, although it is unclear, again, 
whether the total number of cells was changed. The authors assume these must be 
OPCs, since the decrease was specific in A2B5+ cells that incorporated BrdU one 
hour before sacrifice (however, A2B5 also labels presumptive astrocytes at this 
stage, and it is unclear whether they would be affected by ocular injection of the 
toxin).  
In this regard, recent work in P35 juvenile mice has shown that optogenetic 
stimulation of layer-V neurons in the premotor cortex at physiological rates for 30 
minutes was sufficient to induce an acute burst of OPC proliferation in the premotor 
cortex and subcortical white matter. It is unclear the extent to which the simultaneous 
proliferation of neural progenitor cells and microglia mediated the effect on OPCs 
(Gibson, Purger et al. 2014). Another recent report suggested the opposite effect: 
73 
 
sensorimotor deprivation from birth increased NG2 cell proliferation in the barrel 
cortex at P4-P6, although the effect was subtle (Mangin, Li et al. 2012). 
In sum, there is conflicting evidence on whether axons regulate proliferation of OPCs 
in vivo. It is possible that OPCs proliferate at a basal rate but additionally are 
responsive to axonal signaling that modulates their proliferative rate; and that the 




In control, wildtype mammals, many CNS regions exhibit developmental apoptosis 
of oligodendrocyte-lineage cells, including the optic nerve (Barres, Hart et al. 1992), 
brain cortex (Trapp, Nishiyama et al. 1997), and spinal cord (De Louw, Van De Berg 
et al. 2002); which are thought to be newly-generated oligodendrocytes, rather than 
OPCs. Potentially, competition for neuron-derived neurotrophic factors of these cells 
is the strategy that matches the amount of target axonal surface to the number of 
oligodendrocytes (Barres and Raff 1999). In agreement with this, no apoptotic NG2+ 
cells were detected in either control or P0-transected nerves (Ueda, Levine et al. 
1999), suggesting that OPCs, before becoming oligodendrocytes, survive 
independently of axonal influences. It is only when transection is performed at the 
onset of myelination or after that there is some detectable apoptosis of 
oligodendrocytes, as mentioned previously.  
 
One other study addressed the role of RGC axons on early oligodendrocyte-lineage 
cell development in the optic nerve by increasing their number. (Burne, Staple et al. 
1996) investigated myelination in a transgenic mouse line where the promoter 
sequence of Neuron-Specific Enolase (NSE) drives expression of the human bcl-2 
(B-cell lymphoma 2) gene, which inhibits apoptosis, in several cells, including 
RGCs. Developmental apoptosis of RGCs was reduced, and the number of axons and 
the area of optic nerves were essentially doubled. Interestingly, the supernumerary 
axons were normally myelinated, which was due to increase in oligodendrocyte 
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number. This seemed caused by increased OPC survival, as well as proliferation. 
However, oligodendrocyte-lineage cells also spuriously expressed the apoptotic 
inhibitor transgene, and their increased survival may have been artifactual and 
unrelated to the increased number of axons. Additionally, doubling RGC number 
essentially doubled the number of astrocytes in transgenic animals, which are 
thought to be the source the main OPC mitogen (PDGF) within the optic nerve, 
rather than RGC axons (Fruttiger, Calver et al. 2000); therefore, the increase in OPC 
number may have been due to an indirect effect via astrocytes.  
 
In sum, axon-derived signals may influence early OPC proliferation, but seem to 
have no major effect on migration or survival. As these cells progressively 
differentiate into oligodendrocytes, axon-derived signals promote their survival, and 
as discussed earlier, seem to regulate their morphology and the elaboration of 
processes and myelin sheaths. This would suggest that axon-derived signals are also 
necessary for the final maturation into oligodendrocytes, but such a direct 
requirement for differentiation is hard to extricate from the effects on proliferation 
and survival at this stage. 
A number of specific axonal signals have been discussed in Chapter 1 that can be 
responsible for the effects outlined above. Axonal molecules such as Notch or 
integrin ligands can play a role in regulating the final differentiation of OPCs into 
oligodendrocytes (by regulating mbp mRNA translation and the elaboration of 
myelin sheaths, for instance), a role that the optic nerve studies suggested. The 
analysis and manipulation of specific neuronal molecules, especially using 
conditional neuron-specific genetic ablation paradigms, provided definitive evidence 
for the fundamental principle that neuronal and axonal signals can regulate 
oligodendrocyte development and myelin formation to a certain extent.  
 
3.1.7 Shortcomings of axonal transection studies in the optic nerve 
Although the enucleation and transection paradigms in the optic nerve have shed 
light on the complex axonal regulation of oligodendrocyte development, they have a 
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number of shortcomings. These are fairly invasive procedures with consequences 
that may confound interpretation of the effects observed during OPC and 
oligodendrocyte development. For instance:  
a) byproducts of the degeneration of transected axons may actively influence 
behaviour of glial cell populations;  
b) enucleation or transection at any age causes a significant decrease in cross-
sectional area of the optic nerve (Valat, Fulcrand et al. 1978, Trimmer and 
Wunderlich 1990); this shrinkage could, for instance, impede OPC proliferation 
purely due to physical constraints. In fact, in vitro, OPC density and their spatial 
constraints can regulate differentiation into oligodendrocytes (Rosenberg, 
Kelland et al. 2008).  
c) whereas normally blood vessel irrigation decreases with postnatal development, 
in transected nerves vessels are much increased proportionally in the glial scar 
formed (Trimmer and Wunderlich 1990), and it has recently been shown that 
signaling from blood vessels can affect oligodendrocyte development (Yuen, 
Silbereis et al. 2014). 
d) even when performed early on, these operations cause changes not just in the 
number but also in the activation state of astrocytes, macrophages and microglia 
(Fulcrand and Privat 1977); and different functional phenotypes of microglia 
have been shown to differentially modulate OPC differentiation in vitro, and 
following remyelination in vivo (Miron, Boyd et al. 2013).  
e) neonatal transection of the optic nerve seems to cause a small transient 
degeneration of a subset of axons in the contralateral nerve, at least in albino 
rats. P4 and P5 contralateral nerves after neonatal transection are fine, and 
myelination is 1 day delayed (Sefton and Lam 1984). Another report indicates 
that following P21-transection, the intact contralateral nerve shows significantly 
increased myelin structural protein transcripts 10 days post-operation (Kidd, 
Hauer et al. 1990). 
One additional shortcoming relates to the generalization of lessons learnt from optic 
nerve oligodendrocytes: these oligodendrocytes may have specific properties not 
shared by other oligodendrocytes. For instance, purified optic nerve oligodendrocytes 
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proliferate in response to the neurotrophin NT-3 in vitro but spinal cord 
oligodendrocytes do not (Miller 2002). Xenopus optic nerve oligodendrocytes are 
permissive for neurite growth, but spinal cord oligodendrocytes are not (Lang, Rubin 
et al. 1995), highlighting the possibly different biochemical composition of their 
myelin. Additionally, in the optic nerve, oligodendrocytes face the task of 
myelinating a relatively homogenous array of axons (over 90% become myelinated), 
which may not directly translate to the analysis of oligodendrocyte behaviour in 
areas such as the brain or spinal cord, where they have to face more complex axonal 
environments. 
 
3.1.8 Another model to look at axonal regulation of myelination in vivo 
Zebrafish larvae have recently emerged as an ideal model to study myelination in 
vivo (Monk and Talbot 2009, Czopka and Lyons 2011): they are amenable to live 
imaging at single cell resolution of axons, OPCs and oligodendrocytes; myelination 
starts soon after fertilization (approximately 3 days), which allows following the 
same individual neuron from its undifferentiated state to its fully myelinated state 
with compact myelin; and a number of transgenic and genetic tools exist that allow 
us not only to visualize but also manipulate myelination, or the neuronal/axonal 
compartment (Almeida, Czopka et al. 2011, Czopka, Ffrench-Constant et al. 2013). 
Given the short time frame in which developmental myelination occurs, we can 
probe through time lapse imaging the real-time behaviour and dynamics of neurons 
and glia, and directly investigate aspects such as migration, proliferation and 
apoptosis in vivo without recourse to more indirect measures (such as the thymidine-
analogue incorporation for proliferation rate measurements, for instance). 
Like the optic nerve, zebrafish offer one additional crucial advantage – the 
manipulation of unambiguously identifiable subsets of axons fated for myelination, 
such as the axons belonging to reticulospinal neurons. The possibility, described 
below, of consistent and robust removal of a substantial number of reticulospinal 
axons from the spinal cord allows us to re-examine the effect of axons on 
myelination, in a context that circumvents many of the shortcomings of the optic 
nerve system, as I will outline now. 
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In the zebrafish CNS, reticulospinal neurons are a set of dozens of identifiable 
interneurons, most of which reside in the hindbrain and project a large-diameter axon 
along the length of the spinal cord, in one of three major spinal tracts, including the 
medial longitudinal fasciculus (mlf), which runs along the ventral spinal cord 
(Kimmel, Powell et al. 1982). Of note, one pair of such reticulospinal neurons, the 
Mauthner neurons, are among the earliest born in the zebrafish, around 10 hpf 
(Mendelson 1986). Their somas reside in the fourth rhombomere, one on each side of 
the midline, and each neuron projects a very large-diameter axon contralaterally 
(Mendelson 1986, Metcalfe, Mendelson et al. 1986). The Mauthner axons are the 
largest in the whole animal; due to their stereotyped position and caliber, several fold 
larger than the next largest axon, they are unambiguously identifiable in the zebrafish 
spinal cord (Bernhardt, Chitnis et al. 1990). Reticulospinal neurons are responsible 
for activating locomotor responses - the Mauthner axon, for instance, synapses 
directly with motor neurons (Celio, Gray et al. 1979, Fetcho and Faber 1988, Jontes, 
Buchanan et al. 2000).  
Crucially, using a fluorescent transgenic reporter for myelin, mbp:EGFP-CAAX, we 
have previously demonstrated that reticulospinal axons are the first to be myelinated 
in the zebrafish spinal cord, in an anterior to posterior gradient. The very first myelin 
sheath detected in every animal is always on one of the two Mauthner axons, around 
55 hpf (Almeida, Czopka et al. 2011).  
If the outgrowth of such axons could be specifically manipulated, either negatively or 
positively, the role of axons on myelination could be formally assessed in vivo, in a 
non-invasive manner. 
A number of zebrafish mutants have been identified where the normal development 
of a subset of neurons is affected – such is the case of the zebrafish mutant for kif1-
binding protein (kbp). The function of the KBP protein remains largely unknown. In 
humans, homozygous mutations in the KIAA1279/KBP gene cause Goldberg–
Shprintzen syndrome, a rare condition characterized by polymicrogyria, 
microcephaly, mental retardation, as well as defects to the enteric nervous system 
(Brooks, Bertoli-Avella et al. 2005). The KBP protein contains two tetratricopeptide 
repeats, which mediate protein-protein interactions (Blatch and Lassle 1999). In 
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vitro, KBP binds to the motor domain of Kinesin motor proteins, most notably Kif1 
(Wozniak, Melzer et al. 2005), and interacts with a range of proteins implicated in 
microtubule transport and dynamics, such as the Stathmin family of proteins (Alves, 
Burzynski et al. 2010). More recently, it has also been shown to interact with 
filamentous actin (Drevillon, Megarbane et al. 2013). Interestingly, in a 
neuroblastoma-cell line, KBP knockdown reduced the length of dendritic spines as 
well as neurite length, whereas overexpression of KBP increased both (Drevillon, 
Megarbane et al. 2013), suggesting that a role of KBP in neuronal development may 
underlie the defects observed in Goldberg–Shprintzen patients. 
In fact, in zebrafish where the kbp gene contains a splice-disrupting mutation, some 
neurons show destabilized and disorganized microtubules along their axons, as well 
as mislocalized mitochondria. These axons grow at reduced speeds, and many 
degenerate (Lyons, Naylor et al. 2008). This culminates in an axon outgrowth defect 
that does not affect all neurons similarly in the global kbp knockout mutant: in the 
CNS, reticulospinal axons are most affected and fail to extend along the entire spinal 
cord. In transversal electron micrographs, the number of large-diameter axons in the 
ventral spinal cord, mostly reticulospinal axons, is greatly reduced, but other tracts in 
the spinal cord, such as the dorsal tract, seem relatively unaffected by the loss of kbp, 
and the distribution and number of neuronal cell bodies is also unaffected (Lyons, 
Naylor et al. 2008). As no single-cell resolution expression studies are available, it 
remains unclear whether the specificity of this phenotype in a global knockout 
reflects variegated expression from the kbp gene, which could normally be absent 
from other subpopulations of neurons. Alternatively, it could reflect a differential 
requirement of this protein in neurons containing very long axons, such as the 
reticulospinal neurons (however, other tracts containing very long axons seem 
unaffected, such as the dorsal tract). Since wildtype reticulospinal neurons 
transplanted into kbp mutants grow their axons normally, the role of kbp in 
promoting and maintaining axon outgrowth is neuron-autonomous, and is not due to 
the influence of other cell types.  
Thus, this mutant provides us with a posterior region of the spinal cord (roughly a 
third to a half of its length) where the majority of the axons that are the first targets 
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for myelination are absent. In spite of a localized degeneration within one or two 
somites of kbp mutant axon growth cones, for the remainder of the spinal cord, 
reticulospinal axons simply never grow into this region. This is in contrast to the 
optic nerve transection studies where axons were potentially in contact with OPCs 
before subsequently degenerating, possibly triggering confounding effects. 
Additionally, this axon outgrowth failure allows study of even earlier events of OPC 
development, which are not so easy to address in the optic nerve, as such events 
occur prenatally. I will be able to examine whether reticulospinal axons are required 
for OPC specification. If OPCs are generated, they will exist in a drastically altered 
axonal environment, in the virtual absence of their first target axons, for the 
remainder of their development. Moreover, both the general morphology and the 
spinal cord structure of kbp mutants are similar to wildtype larvae, so there are no 
confounding effects of a drastic reduction in size. Finally, the initial period of 
axonogenesis occurs normally in kbp mutants; and the more rostral region of the 
spinal cord does contain reticulospinal axons. This should provide, in the same 
animal, an anterior region that could serve as an internal control for any effect 
observed in the region where axons are absent. This is especially important since this 
is a global kbp knockout mutant.  
Therefore, once characterized in more detail, this system should allow me not only to 
determine the influence that growing axons have on oligodendrocyte-lineage 
development in zebrafish, but additionally will do so in a manner that overcomes 






My aim is to determine whether the axonal targets for myelination can regulate early 
aspects of oligodendrocyte development and myelination. I address this in the 
zebrafish spinal cord, by chronologically analysing oligodendrocyte-lineage cell 
progression into myelination in larvae which lack reticulospinal axons, the very first 
axons that become myelinated. 
  
Specifically, I aim to further characterize the axonal outgrowth phenotype of kbp 
mutants, which should provide both a region where an identifiable subset of axons is 
absent, and an internal control region with a normal complement of axons. This 
should overcome many shortcomings of the optic nerve model, as mentioned above. 
Since reticulospinal axons are the first major initial targets for myelination, I expect 
that their absence represents a drastic alteration in the axonal environment. In this 
chapter, I will investigate whether specification, migration, proliferation, and 
survival of oligodendrocyte-lineage cells are affected. In the next chapter, I will 
address how later aspects of the development of oligodendrocyte-lineage cells, such 
as the timing of oligodendrocyte differentiation and the formation of myelin sheaths, 






3.3.1 Reticulospinal axon outgrowth is specifically disrupted in kbpst23 
mutant zebrafish 
 
I sought to better characterize the timing of the axonal outgrowth defect in kbp 
mutants along the anterior-posterior axis of the spinal cord. The onset of myelination 
occurs in an anterior to posterior gradient in the spinal cord, having reached the 
posterior end of the spinal cord by 4dpf. I performed whole-mount 
immunohistochemistry on larvae with 3A10 antibody, which recognizes a 
neurofilament-associated epitope and labels most large-caliber, neurofilament-
bearing axons, from 36 hpf until 4 dpf. In the majority of WT larvae at 36 hpf, and in 
their entirety at 48hpf (Figure 3.1 B), growing reticulospinal axons (most 
prominently, the Mauthner axons) have reached the caudal end of the spinal cord. In 
the same posterior region (about somites 20-24), in the kbp mutant, reticulospinal 
axons failed to do so, and are clearly absent from the ventral spinal cord (Figure 3.1 
B). Other axons, including dorsal axons, those of Rohon-Beard neurons, medial 
axons and motor axons all remain present in the mutant in this region. In contrast, in 
an anterior region of the spinal cord (about somites 9-13), all axonal tracts are similar 
between wildtype and mutant (Figure 3.1 B), including the ventral tract where 
reticulospinal axons grow. This specific absence of reticulospinal axons in the 
posterior region of the kbp mutant spinal cord persisted at least through to 4dpf, 
when myelination is underway (Figure 3.1 C).  
I confirmed these results in electron micrographs of transversal sections of the 
posterior spinal cord of 3 dpf larvae. At this stage, neuron somas occupy the central 
region of the spinal cord (grey matter), and lateral regions contain clusters of 
longitudinal axons (white matter), which will later form tracts such as the mlf in the 
ventral region (Figure 3.2 A). Similar numbers of large-diameter axons (with a 
diameter larger than 0.5 µm) are present in the dorsal region of the white matter of 
both WT and mutant spinal cords, but fewer large-diameter axons are present in the 
ventral region of mutant larvae (Figure 3.2 B-C). The perimeter of these cross-
sectional axonal profiles reflects the axonal surface available for potential 
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interactions with oligodendrocyte-lineage cells. The combined perimeter of all large-
diameter axons is specifically reduced in the ventral spinal cord: 34±16 µm/half-
spinal cord in WT vs 7±4 µm in mutants (100 axons from N=5 WT larvae; 30 axons 
from N=5 mutants; p=0.0074 in t-test). In the dorsal spinal cord, the total perimeter 
is similar between WT and mutant animals: 31±7 µm in WT vs 26±5 µm in mutants 
(109 axons from N=5 WT larvae; 103 axons from N=5 mutants; p=0.2740 in t-test) 
Thus, within the same mutant animal, the anterior region contains an apparently 
normal complement of axons, serving as an internal control for analysis of the 
posterior region, where the initial target axons for myelination are absent from an 
early age. In this region, the total axonal surface is greatly decreased (to ~ 20%) in 











Figure 3.1 – kbp
st23
 mutants specifically lack the first axonal targets for myelination, 
only in the posterior spinal cord. 
(A) Lateral view of a 4 days post fertilization (dpf) zebrafish larvae. Green and magenta 
boxes indicate anterior and posterior regions, respectively. In all figures, anterior is left and 
posterior is right; dorsal is up and ventral is down. 
(B) Lateral views of 48 hpf larvae immunostained with 3A10 antibody. In kbpst23 mutant 
larvae (bottom), the ventral axonal tract (mostly reticulospinal axons) is absent in the 
posterior region. Brackets indicate dorsal and ventral tracts. Scalebar: 25 µm. 
(C) Lateral views of 4dpf larvae immunostained with 3A10 antibody. Brackets indicate 
dorsal and ventral tracts; asterisks point to examples of ventral roots, where motor axons exit 
the spinal cord in each somite. Scalebar: 25 µm.  






Figure 3.2 – kbp
st23
 mutants lack the first myelinated axons in the posterior spinal cord. 
(A) Diagram of the zebrafish spinal cord. Neuron somas occupy the centre (blue circles), 
flanked by clusters of longitudinal axons (pink circles). Double blue line is the pia mater, 
which delimits the spinal cord. Boxes indicate regions captured in (B). (B) Representative 
dorsal and ventral regions showing longitudinal axons (pink); pia mater is shaded in blue. 
Scalebar: 2 µm. (C) Average number (±standard deviation) of large-diameter (>0.5 µm) 
axons in the posterior spinal cord.  
Dorsal: 12±3 (N=5 WT) vs 10±1 axons (N=5 mutants), p=0.5159 in Mann-Whitney test 
Ventral: 12±6 (N=5 WT) vs 3±2 axons (N=5 mutants), p=0.0079 in Mann-Whitney test 
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3.3.2 Reticulospinal myelin sheaths are specifically absent in the 
posterior spinal cord of mutants 
 
I then examined myelin sheaths in kbpst23 mutants by live-imaging of a 
Tg(mbp:EGFP-CAAX) reporter, where membrane-tethered GFP is expressed in 
myelinating oligodendrocytes (Almeida, Czopka et al. 2011). At 4 dpf the onset of 
myelination has reached the posterior region of the spinal cord. In WTs, the 
reticulospinal axons possess myelin sheaths easily identifiable in the ventral tract of 
the spinal cord (Figure 3.3 A, brackets); and some medial, dorsal and motor myelin 
sheaths have also formed. In the mutant, I observed a drastic reduction of ventral 
myelin sheaths ensheathing reticulospinal axons, but other medial, motor and dorsal 
sheaths formed normally. No obvious difference in myelination was evident in the 
anterior region between WT and mutants (Figure 3.3 A). Thus, the pattern of 
myelination is partially disrupted, and specifically so in the region corresponding to 
the absence of reticulospinal axonal targets.  
 
 
Figure 3.3 – kbp
st23
 mutants specifically lack reticulospinal myelin sheaths, only in the 
posterior spinal cord. 
(A) Lateral view of live Tg(mbp:EGFP-CAAX) larvae at 4dpf. Myelin sheaths in the 
anterior region (left) are identical in WT and mutant larvae. In the posterior region (right), 
reticulospinal myelin sheaths are specifically absent in the ventral spinal cord (brackets). 
Myelin in the dorsal, medial and ventral (non-reticulospinal) tracts of the spinal cord, and on 




3.3.3 Absence of RS axons correlates with reduced number of ventral 
oligodendrocytes 
 
I wondered whether this disruption in myelination represented a reduction in the 
myelinating capacity of oligodendrocytes, or simply a reduction in the number of 
oligodendrocytes. To address this, I imaged the transgenic line mbp:EGFP, in which 
cytoplasmic GFP expressed in mature oligodendrocytes labels their somas (Figure 
3.4A), enabling counting and analysis of their dorsal-ventral distribution (Figure 
3.4B). At 4 dpf, in the anterior spinal cord, where reticulospinal axons are present, 
there is no difference in the total number of mbp:EGFP+ oligodendrocytes, or in the 
ventral subset. In the posterior region, where reticulospinal axons are absent, the total 
number of oligodendrocytes is significantly reduced (30±6 oligodendrocytes in WT 
vs 22±5 in mutants, p=0.0004 in t-test). The reduction is especially significant in the 
subset of ventral oligodendrocytes (grey bars in Figure 3.4B, 21±4 oligodendrocytes 
in WT vs 16±3 in mutants, p<0.0001 in Mann-Whitney test).  
In an independent experiment, I imaged the double transgenic line mbp:EGFP; 
mbp:EGFP-CAAX in a slightly more caudal region of the spinal cord. The reduction 
in oligodendrocyte number in the posterior spinal cord was confirmed:  22±4 
oligodendrocytes in WT vs 11±4 in mutants (N=10 WT, 11 mutants; p<0.0001 in t-
test); whereas the number of anterior oligodendrocytes remained similar between WT 
and mutant (49±4 oligodendrocytes in WT vs 48±4 in mutants, N=11 for both, 
p=0.54 in t-test). Additionally, at 8 dpf, the number of ventral oligodendrocytes 
remains significantly reduced in the posterior spinal cord of mutants: 26±5 
oligodendrocytes in WT vs 14±2 in mutants (N=10 WT, 11 mutants; p<0.0001 in t-
test). At the caudal end of the spinal cord, the presence of oligodendrocytes along the 
anterior-posterior axis terminates earlier in mutants compared to WTs (Figure 3.4C, 
note arrowheads). This second experiment may have overestimated the decrease in 
oligodendrocyte density in mutants by including this more caudal region that is 
devoid of oligodendrocytes.  
The oligodendrocyte number phenotype in the posterior spinal cord was somewhat 
variable between individual mutant larvae. Such variability may exist in the 
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underlying axonal phenotype, which may reflect the nature of the kbpst23 genetic 
lesion. Rather than a complete loss of function, kbpst23 disrupts a splice donor site 
which generates a number of spurious transcripts that coexist in mutant cells – at 
least one of which is described to encode an in frame insertion that retains wildtype 
kbp function (Lyons, Naylor et al. 2008). The severity of the loss of kbp function 
may vary according to relative level of transcripts at any time in each neuron. While 
my analysis indicated a consistent and drastic axonal phenotype in reticulospinal 
neurons, there may be subtler and variable outgrowth defects in other axons of the 
spinal cord (including the anterior region) that escaped my analysis. It would require 
an exhaustive cataloguing of all neuronal subtypes to completely elucidate the extent 
and variability of the kbp (axonal) phenotype.  
However, in the absence of ventral reticulospinal axons, there is consistently a 
correlating reduction in the number of mature ventral oligodendrocytes. This 
reduction strongly suggests a disruption in the developmental progression of 
oligodendrocyte-lineage cells – potentially affecting only those oligodendrocytes that 
normally myelinate reticulospinal axons. I therefore proceeded to investigate which 







Figure 3.4 – kbp
st23
 mutants have a reduced number of mature oligodendrocytes in the 
posterior spinal cord 
(A) Lateral views of the spinal cord of 4dpf Tg(mbp:EGFP) larvae. oligodendrocyte somas 
are visible in the spinal cord; some ventral oligodendrocytes associate with the Mauthner 
myelin sheaths (brackets), except in the posterior region of mutants, which also has fewer 
oligodendrocytes. Scalebar: 25 µm. 
(B) Quantification of mbp:EGFP+ cell number per 425 µm length of tissue (~5 somites), in 
4dpf larvae. Grey bars (ventral subset of oligodendrocytes) in posterior region are displayed 
to the side for ease of visualization. Error bars represent standard deviation. 
Anterior: 
Total oligodendrocytes: 71±7 (N=11 WT) vs 73±8 oligodendrocytes (N=10 mutants), 
p=0.5097 in t-test 
Ventral oligodendrocytes: 44±4 (N=11 WT) vs 44±4 oligodendrocytes (N=10 mutants), 
p=0.9443 in t-test  
Posterior: 
Total oligodendrocytes: 30±6 (N=20 WT) vs 22±5 oligodendrocytes (N=14 mutants), 
p=0.0004 in t-test 
Ventral: 21±4 (N=20 WT) vs 16±3 oligodendrocytes (N=14 mutants), p<0.0001 in Mann-
Whitney test 
(C) Lateral views of a more posterior region of the spinal cord of 4dpf Tg(mbp:EGFP; 
mbp:EGFP-CAAX) larvae. Brackets indicate the ventral tract where the Mauthner axons are 
located. Mutants have fewer oligodendrocytes in the same region, and oligodendrocytes 




3.3.4 Absence of reticulospinal axons does not affect the balance of 
motor neuron – OPC production from the pMN domain  
 
Oligodendrocyte-lineage cells arise from the pMN domain, a population of 
proliferative Olig2+ precursor cells that initially generates motor neurons (until 
~55hpf) and later switches to production of OPCs. A recent study showed that 
dopamine release from the axons of non-reticulospinal, diencephalic projection 
neurons can promote the proliferation of pMN precursors and generation of motor 
neurons from the pMN domain (Reimer, Norris et al. 2013). This study sets a 
precedent for projection neurons from the brain and their axons regulating spinal 
cord neurogenesis. Therefore, I wondered if the absence of reticulospinal axons 
could alter the balance of motor neuron and OPC production from the pMN domain. 
I first investigated the number of mitotic olig2+ pMN precursors immunoreactive for 
phosphorylated histone 3 (PH3). At 36hpf (when reticulospinal axons have just 
extended along the entire spinal cord in most WT larvae), and later at 48-50hpf, I 
found a similar number of olig2:GFP+ PH3+ cells in both the anterior and posterior 
regions of WT and mutant larvae (Figure 3.5). Furthermore, the number of total 
PH3+ mitotic cells in the spinal cord also did not reach statistically significant 
differences at either time point. 
I then investigated the number of HB9+ motor neurons produced in the absence of 
reticulospinal axons. At 48 hpf, when most motor neurons have been born, there was 
no difference in the number of HB9+ motor neurons between WT and mutant larvae 








 Figure 3.5 – Mitotic pMN precursor number is not altered in kbp
st23 
mutants. 
(A) Lateral view of the posterior region of 36hpf and 48-50 hpf Tg(olig2:GFP) larvae 
immunostained for anti-GFP (green), 3A10 (grey, inset) and PH3 (magenta), a marker of 
mitosis. The dotted box indicates the region displayed under each panel, in the 3A10 
channel. Note the absence of ventral Mauthner axons already at 36hpf. Panels denote the 
same individual larvae at the anterior and posterior region. Scalebar: 25 µm. 
(B) Quantification of total PH3+ and olig2:GFP+ PH3+ subset  of cells per 425 µm length of 
tissue (~5 somites). Error bars represent standard deviation. 
36 hpf, Anterior: 
Total PH3+ cells: 49±9 (N=27 WT) vs 55±8 cells (N=9 mutant), p=0.0786 in t-test 
GFP+ PH3+ cells: 12±4 (N=27 WT) vs 13±6 cells in (N=9 mutant), p=0.2698 in t-test 
36 hpf, Posterior: 
Total PH3+ cells: 60±10 (N=27 WT) vs 61±10 cells (N=9 mutant), p=0.8968 in t-test 
GFP+ PH3+ cells: 15±4 (N=27 WT) vs 16±3 cells in (N=9 mutant), p=0.5603 in t-test 
48-50 hpf, Anterior: 
Total PH3+ cells: 29±17 (N=15 WT) vs 20±11 cells (N=10 mutant), p=0.1528 in t-test 
GFP+ PH3+ cells: 6±5 (N=27 WT) vs 4±2 cells in (N=9 mutant), p=0.3240 in t-test 
48-50hpf, Posterior: 
Total PH3+ cells: 39±12 (N=15 WT) vs 36±10 cells (N=10 mutant), p=0.5839 in t-test 






Figure 3.6 – Number of mature motor neurons is not altered in kbp
st23
 mutants. 
(A) Lateral view of 48 hpf larvae immunostained for HB9, a marker of post-mitotic motor 
neurons. Scalebar: 25 µm. 
(B) Quantification of HB9+ cells per 150 µm length of tissue (2 somites). Error bars are 
standard deviation.  
Anterior: 137±8 (N=13 WT) vs 137±10 cells (N=9 mutants), p=0.8454 in t-test;  






Finally, to investigate the specification of OPCs, I imaged the double transgenic line 
olig2:GFP; sox10:mRFP at 48hpf. Either transgene alone labels several 
subpopulations of cell types in the spinal cord: olig2 is expressed by pMN 
precursors, motor neurons and oligodendrocyte-lineage cells, and sox10 is expressed 
by oligodendrocyte-lineage cells and also a population of dorsal olig2- neurons. 
However, the combination of both transgenes specifically marks only 
oligodendrocyte-lineage cells in the spinal cord (Figure 3.7A).  
The number of initial OPCs at 48hpf, although variable, is not significantly different 
between WT and mutant larvae in either the anterior or posterior spinal cord (Figure 
3.7B). At 60 hpf, more OPCs have been specified, and a subset of OPCs starts to 
migrate dorsally in the posterior spinal cord (Figure 3.7A, right, dorsal arrowheads). 
The number of OPCs also did not reach a statistically significant difference, although 
a non-significant trend towards a decrease in OPCs in mutant animals was observed. 
Note that the variability of total OPC number at this time point is large, which 
severely reduced the power of this particular analysis (about 50% power to detect the 
difference between observed means). As discussed earlier, this variability may reflect 
the nature of the kbp genetic lesion. It would require a very large number of animals 
to make it a highly powered analysis to observe that difference (for instance, about 
40 animals per group to reach 80% power). 
Thus, I cannot exclude the possibility that the absence of reticulospinal axons affects 
the number of oligodendrocyte-lineage cells soon after their generation; but the 
appearance of the very first OPCs does not seem to be affected. Therefore, the 
reduced number of mature oligodendrocytes later on is most likely due to an effect 








Figure 3.7 – The initial number of OPCs is not altered in kbp
st23
 mutants.  
(A) Lateral view of the posterior region of 48-60hpf Tg(olig2:GFP; sox10:mRFP) larvae 
(arrowheads point to double-labelled cells, OPCs). No difference in OPC number is apparent 
at either time point. Scalebar: 25 µm. (B) Quantification of olig2:GFP+ sox10:mRFP+ cells 
per 448 µm length of tissue (6 somites). Error bars are standard deviation:  
48hpf, anterior:  
Total OPCs: 66±6 (N=10 WT) vs 60±7 cells (N=9 mutants), p=0.0965 in t-test  
Dorsal OPCs: 24±6 (N=10 WT) vs 20±8 cells (N=9 mutants), p=0.2079 in t-test  
48hpf, posterior:  
Total OPCs: 8±4 (N=18 WT) vs 6±4 cells (N=20 mutants), p=0.2092 in t-test  
Dorsal OPCs: 0±0 (N=18 WT) vs 0±0 cells (N=20 mutants), p=0.1071 in Mann-Whitney test 
60hpf, posterior:  
Total OPCs: 28±8 (N=10 WT) vs 22±5 cells (N=9 mutants), p=0.1157 in t-test  




3.3.5 Dorsal distribution of OPCs is normal in the absence of target 
axons 
 
A subset of OPCs starts migrating dorsally at 60 hpf in a stereotyped anterior to 
posterior gradient. By 72hpf, several OPCs have accumulated in the dorsal spinal 
cord, above the olig2:GFP band where motor neurons reside (delimited by red dotted 
line in Figure 3.8A). Since reticulospinal axons run along the ventral spinal cord, I 
wondered whether more OPCs might migrate dorsally in mutants when reticulospinal 
axons are absent, perhaps in search of other targets for myelination. As I have just 
shown, at 60hpf, the number of the very first dorsal OPCs is similar in the posterior 
spinal cord of WT and mutants (Figure 3.7B, grey bars). I investigated the number of 
dorsal olig:GFP+ sox10:mRFP+ OPCs later, at 72and 96 hpf. At these time points, a 
subset of GFP+ mRFP+ cells has matured into oligodendrocytes but retains 
expression of both markers; therefore I will refer to them as ‘oligodendrocyte-lineage 
cells’, rather than ‘OPCs’.  
At 72hpf and 96hpf, the total number of oligodendrocyte-lineage cells is already 
reduced in the posterior spinal cord of mutant larvae (Figure 3.8 B). However, the 
number of dorsal cells is not significantly different between WT and mutant. This 
suggests that the subset of OPCs that migrate dorsally in the spinal cord does so 
independently of the presence of reticulospinal axons. Additionally, it suggests that 
the disruption to (ventral) oligodendrocyte-lineage cell development must start 







Figure 3.8 – The dorsal distribution of a subset of oligodendrocyte-lineage cells is not 
affected in kbp
st23
 mutants.  
(A) 72hpf posterior spinal cord of Tg(olig2:GFP) larvae, which labels oligodendrocyte-
lineage cells, motor neurons and pMN progenitors. Cells above dotted line are dorsally 
migrated OPCs. Scalebar: 25 µm.  
(B) Quantification of oligodendrocyte-lineage cells in the posterior region of the spinal cord.  
72hpf, posterior:  
Total cells: 28±6 (N=21 WT) vs 23±7 cells (N=17 mutants), p=0.0170 in t-test  
Dorsal cells: 10±3 (N=18 WT) vs 8±5 cells (N=17 mutants), p=0.0947 in Mann-Whitney test 
96hpf, posterior:  
Total cells: 31±7 (N=17 WT) vs 26±8 cells (N=17 mutants), p=0.0499 in t-test  
Dorsal cells: 12±3 (N=17 WT) vs 10±4 cells (N=17 mutants), p=0.2073 in t-test 
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I additionally performed time lapse-imaging of the posterior spinal cord of the same 
reporter line starting approximately at 60 hpf, imaging the entire depth of the spinal 
cord every 14 minutes. OPCs move towards the dorsal spinal cord frequently in both 
WT and mutant larvae, starting a few hours after the emergence of the first 
olig2:GFP+, sox10:mRFP+ cells in each somite (Figure 3.10A, arrowheads). OPCs 
kept accumulating dorsally for the duration of the imaging period (longest time lapse 
is 17 hours long), occasionally dividing (Figure 3.10A, asterisk). To analyze the 
dynamics of the dorsal migration, I normalized the time in all movies by setting time 
point 0 when the first olig2:GFP+ OPC migrated above the olig2:GFP+ band (Figure 
3.10B). I found a relatively large range of migration dynamics within the WT larvae, 
with OPCs accumulating dorsally at rates ranging from 0.5 to 3 OPCs per hour per 
animal; this, however, was not significantly different from mutant larvae (mean ± 
standard deviation: 1.164 ±0.73 OPCs/hour in N=17 WT larvae versus 1.077±0.48 
OPCs/hour in N=19 mutant larvae). 
Collectively, these results indicate that the distribution of a subset of 
oligodendrocyte-lineage cells to the dorsal spinal cord is a feature independent of 
ventral, reticulospinal axons, and suggests that these OPCs are not “searching” for 






Figure 3.9 – Dorsal OPCs migrate at a similar rate in WT and kbp
st23
 mutants. 
(A) Time-lapse movies of Tg(olig2:GFP; sox10:mRFP) larvae. A subset of OPCs migrates 
dorsally in both WT and mutants (arrowheads), occasionally dividing (asterisk), over a 
protracted period of time that overlaps with the onset of myelination (note myelin sheaths on 
last panels). Scalebar: 25 µm.  
(B) Dorsal migration dynamics of OPCs. The number of accumulated dorsal OPCs is plotted 
against time (minutes); x=0 is the point at which the first OPC migrates dorsally. Blue traces, 
WT; Pink traces, mutant.  
(C) Number of OPCs that migrated dorsally divided by the duration of the imaging period, 
per larvae. Each dot represents one larva. Error bars are standard deviation: 1.164±0.731 
(N=17 WT) vs 1.077±0.484 OPCs/hour (N=19 mutants), p=0.6670 in Mann-Whitney test. 
100 
 
3.3.6 OPC migration is subtly affected in the absence of axon targets 
 
I then wondered if the migratory capacity of OPCs is affected by the lack of 
reticulospinal axons. OPCs express several receptors that could respond to a number 
of secreted or adhesion molecules expressed on the surface of axons (Tsai and Miller 
2002, de Castro and Zalc 2013). Migration of OPCs seems directed and not an 
random in the zebrafish spinal cord (Kirby, Takada et al. 2006, Mathews, Mawdsley 
et al. 2014), in the chicken or rodent brain, or during remyelination (de Castro and 
Zalc 2013). In vitro, the motility of OPCs seems responsive to factors such as the 
neurotransmitter glutamate (Gudz, Komuro et al. 2006) or to extracellular matrix 
molecules (Milner, Edwards et al. 1996), suggesting that specific signaling from 
axons, or at least the physical environment in which they exist, may regulate OPC 
migration. Although optic nerve OPCs still seemed to distribute throughout the nerve 
following nerve transection (Ueda, Levine et al. 1999), this broad analysis may not 
have uncovered subtler defects in the migratory properties of OPCs. To address this, 
I tracked individual OPCs in my time lapses in WT and mutant larvae; parsing out 
between dorsal OPCs and those that remain in the ventral spinal cord. 
 
Dorsal OPCs 
I tracked 172 dorsal OPCs from 17 WT larvae and 215 dorsal OPCs from 19 mutant 
larvae, varying from 1-18 hours per cell, and 5-23 cells per larvae. My “dorsal” 
analysis refers to all OPCs that rose above the olig2:GFP band at any point during 
the imaging period. As previously described (Kirby, Takada et al. 2006, Lee, 
Padmanabhan et al. 2010), OPCs move intermittently and frequently change their 
trajectories, and some OPCs returned to more ventral positions after migrating 
dorsally. Examples of dorsal OPC trajectories (of those OPCs with the largest 
tracked distances) are represented in Figure 3.11 A (WT) and B (mutant). 
In agreement with previous studies (Kirby, Takada et al. 2006), the total distance 
covered by each OPC varied greatly, with a range of 6-216 µm in WT and 9-191 µm 
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in mutant larvae. Representative examples of OPC distances tracked in three WT and 
three mutant larvae are shown in Figure 3.11C. The average distance tracked per 
OPC per animal is not significantly different between WT and mutants (Figure 3.11 
D).  
The average speed at which OPCs migrated also varied greatly. Interestingly, the 
average OPC speed per larvae is slightly reduced in kbp mutants (Figure 3.11 E). A 
histogram of the frequency distribution of speeds of all OPCs tracked further 
suggested that a larger proportion of mutant OPCs migrate at slower rates (<6 
µm/hour) than WTs (Figure 3.11 F). Since OPCs frequently pause in their 
trajectories, a decreased average speed may mean that OPCs paused more often 
while migrating, or that OPCs migrate at an actual lower velocity. The maximum 
speed that dorsal OPCs attained between individual time points was not significantly 
different between WT and mutants (Figure 3.11G), therefore, mutant dorsal OPCs 
may simply have paused more.  
As I exemplified in Figure 3.11 C, the variability in these parameters in-between 
OPCs and between each individual larvae is high. This somewhat reduced the power 
of my statistical analysis to detect the small differences in the observed means, 
despite the high number of cells and animals imaged. However, it is very hard to 
determine the biological relevance of the slight reductions in the average values of 
these parameters. Considering that the range of speeds and distances covered is 
similar between WT and mutant, as is the maximum speed attained, the migratory 
parameters of mutant dorsal OPCs are mostly similar to WT dorsal OPCs. This 








Figure 3.10 – Migratory parameters of dorsal OPCs are mostly unaffected in the 
posterior spinal cord of kbp
st23
 mutants. 
(A, B) Tracing of the migratory paths of seven WT (A) and seven mutant (B) dorsal OPCs 
which covered the largest distances. All traces are oriented so that anterior is left and dorsal 
is up. Note that some paths finish ventrally. Dashed lines delineate direction of spinal cord. 
Scalebar: 25 µm. 
(C) Examples of distances covered for all tracked dorsal OPCs in three representative WT 
and mutant larvae. Each dot represents the distance covered by one OPC. 
(D) Quantification of the average dorsal OPC distance covered per larvae. Bars represent 
standard deviation: 47±15 (N=17 WT) vs 41±10 µm/cell (N=19 mutants), p=0.3764 in 
Mann-Whitney test 
(E) Quantification of the average dorsal OPC speed per larvae. Bars represent standard 
deviation: 5.95±1.75 (N=17 WT) vs 4.50±1.61 µm/hour (N=19 mutants), p=0.0142 in t-test 
(F) Histogram of the frequency of speeds of all dorsal OPCs tracked (172 WT OPCs and 215 
mutant OPCs). Speeds are split into 3 µm/hour bins, and the percentage of all OPCs tracked 
in each bin is plotted on the y axis. More mutant OPCs are present in the lower-speed bins 
(arrowheads): 12% WT OPCs vs 26% mutant OPCs average 0-3 µm/hour; 42% WT OPCs 
vs 51% mutant OPCs average 3-6 µm/hour. 
(G) Quantification of the maximum dorsal OPC speed per larvae. Bars represent standard 






The combination of transgenes that I used permitted me to similarly analyse the 
migratory parameters of ventral OPCs, that is, of OPCs that never migrate above the 
olig2:GFP band. These include those OPCs that will myelinate reticulospinal axons, 
and are thus more likely to be affected by their absence.  
I tracked 213 ventral OPCs from 18 WT larvae and 241 ventral OPCs from 19 
mutant larvae, varying from 3-18 hours per cell, and 7-19 cells per larvae. As 
expected, the trajectories of ventral OPCs are more aligned along the anterior-
posterior axis, rather than presenting a net dorsal movement as dorsal OPCs do. 
Examples of ventral OPC trajectories (of those OPCs with the largest tracked 
distances) are represented in Figure 3.12 A (WT) and B (mutant). 
The total distance covered by each OPC varied from 5-142 µm in WT and 0-94 µm 
in mutant larvae. This reduced maximal distance covered by mutant OPCs was in 
fact accompanied by a significant reduction in the average distance tracked per OPC 
per larva in mutants (Figure 3.12 C). Additionally, the average OPC speed per larvae 
is significantly reduced in kbp mutants (Figure 3.12 D). A histogram of the frequency 
distribution of speeds of all OPCs tracked confirmed that a larger proportion of 
mutant OPCs migrate at slower rates (<2 µm/hour) than WTs (Figure 3.12 E). 
Furthermore, the maximal speed that ventral OPCs attained between individual time 
points was also significantly reduced in mutants (Figure 3.12F).  
Thus, in the absence of reticulospinal axons, ventral OPCs seem to migrate less than 
WT OPCs, and at slower speeds. This is in contrast with dorsal OPCs, which seem 
comparatively less affected. It is important to remember that especially these ventral 
OPCs migrate in a drastically altered axonal environment, which makes is very hard 












(A, B) Tracing of the migratory paths of five WT (A) and five mutant (B) ventral OPCs 
which covered the largest distances. All traces are oriented so that anterior is left and dorsal 
is up. Dashed lines delineate direction of spinal cord. Scalebar: 25 µm. 
(C) Quantification of the average ventral OPC distance covered per larvae. Bars represent 
standard deviation: 33±10 (N=18 WT) vs 27±7 µm/cell (N=19 mutants), p=0.0404 in t-test 
(D) Quantification of the average ventral OPC speed per larvae. Bars represent standard 
deviation: 3.06±0.70 (N=18 WT) vs 2.42±0.59 µm/hour (N=19 mutants), p=0.0047 in t-test 
(E) Histogram of the frequency of speeds of all ventral OPCs tracked (213 WT OPCs and 
241 mutant OPCs). Speeds are split into 2 µm/hour bins, and the percentage of all OPCs 
tracked in each bin is plotted on the y axis. More mutant OPCs are present in the lower-speed 
bins (arrowhead): 33% WT OPCs vs 49% mutant OPCs average 0-2 µm/hour. 
(F) Quantification of the maximum ventral OPC speed per larvae. Bars represent standard 





3.3.7 OPCs divide fewer times in the posterior spinal cord of mutants 
 
A reduction in oligodendrocyte-lineage cell number is already evident by 72hpf 
(Figure 3.8). My time-lapse imaging of OPCs in the posterior spinal cord starting 
from 60hpf allowed me to monitor the period during which this disruption to the 
development of oligodendrocyte-lineage cells starts occurring. After specification 
from pMN progenitors (whose mitotic rate was not affected by the absence of 
reticulospinal axons, Figure 3.5), OPCs are committed to the oligodendrocyte 
lineage, but still proliferate. I wondered if a reduction in OPC proliferation could 
contribute to the reduction in mature oligodendrocyte numbers later.  
I found that my time-lapses allowed me to directly visualize OPC mitotic events. 
Occasionally, the mRFP+ processes of an OPC seemed to partially retract. mRFP+ 
membrane accumulated in the center of the cell, resembling a cleavage furrow, 
which split in two, followed by separation of GFP+ cytoplasm in two portions 
(within 14-42 min; see example in Figure 3.9 A, asterisk). Table 3.2 summarizes the 
total number of mitotic events I observed in dorsal and in ventral OPCs in all animals 
imaged. The total number OPC mitotic events observed in all mutant larvae is halved 
compared to WTs, even though more cells were tracked, more animals were imaged, 
and for a longer total amount of time.  
 
 
Table 3.2 – Total OPC mitoses in the posterior spinal cord (60-72hpf) 
 




dorsal ventral total dorsal ventral total 
WT 10 9 19 172 213 385 176 18 
mutant 4 6 10 215 241 456 218 21 
* Does not include OPCs already dorsal when imaging starts and OPCs that migrated away or into the 
field of view (including in the z-axis). However, mitotic events were counted in some of these subsets. 
** Includes only the length of time after the onset of dorsal migration (See Chapter 2)  
 
In individual larvae, between the 60-72hpf periods, OPC mitoses were not frequent 
in the 425 µm-stretch of posterior spinal cord imaged. No OPC mitoses were 
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observed in 9/18 WT larvae and in 13/21 mutant larvae. In one WT larva (the longest 
imaged), 4 mitotic events occurred; but in most animals only one mitosis occurred.  
Based on my previous imaging of the same reporter line (Figures 3.7 and 3.8), the 
number of oligodendrocyte-lineage cells should rise from about 27 at 60hpf to 44 at 
72hpf in WT larvae in the length of tissue imaged in my time-lapses. In mutants, it 
should rise from 21 to 36 cells at 96hpf. Therefore, one or two mitoses per larvae in 
this region may represent up to about 5% of all oligodendrocyte-lineage cells. This is 
roughly similar to the global analysis of total mitotic events: 19/385 cells underwent 
mitosis in WT (5%) versus 10/456 in mutants (2%). 
The majority of mitotic events I observed occurred in the second half of the imaging 
period, suggesting that the rate of mitosis is just starting to increase. If this mitotic 
rate persists or increases for the next 24 hours of development, then an apparent 
halving of total mitotic events in the absence of reticulospinal axons may contribute 
significantly towards the reduced number of mature oligodendrocytes observed at 
96hpf.  
Interestingly, both dorsal and ventral OPC mitoses were affected in the mutants, 
despite the fact that target axonal surface is only reduced in the ventral spinal cord. 
This suggests that the signals underlying this effect on OPC proliferation act at a 





3.3.8 Axons regulate survival of OPCs 
 
When imaging the reporter line sox10:mRFP, I noticed the presence of mRFP+ 
debris in the posterior region of mutant larvae (Figure 3.13A). Since RFP is 
membrane-tethered in this line, this suggests that there is loss or shedding of the 
processes of sox10+ cells, or even loss of cellular integrity and death. I rarely 
observed this in WT larvae, where all mRFP fluorescence belongs to OPC processes 
and to oligodendrocyte myelin sheaths. The extent of debris present was variable 
between individual larvae. I quantified the number of animals that presented at least 
a cluster of mRFP+ debris not associated with a clear OPC process or 
oligodendrocyte myelin sheath (Figure 3.13B). At 48hpf, debris was rare: 1/19 WT 
and 1/20 mutants presented debris in the anterior region and 1/19 WT and 2/20 
mutants had debris in the posterior region. At 60hpf, 0/22 WT and 2/18 mutants 
presented debris anterior and 1/22 WT and 1/17 mutants had debris in the posterior 
region. From then on, many more mutant animals presented debris than WTs. At 
72hpf, 6/44 WT and 11/36 mutants presented debris anterior compared to 3/54 WT 
and 37/47 mutants in the posterior spinal cord. Finally, at 96hpf, 0/11 WT and 0/8 
mutants presented debris anterior, and 6/28 WT and 21/25 mutants presented debris 
in the posterior spinal cord.  
These results showed that loss of cellular integrity of oligodendrocyte-lineage cells 
starts potentially from 60hpf. My time-lapse analysis of olig2:GFP; sox10:mRFP 
larvae at 60hpf showed that in mutant animals, starting between 6-14 hours after the 
onset of dorsal migration, a subset of ventral oligodendrocyte-lineage cells undergoes 
cell death: mRFP+ membrane disintegrates, resulting in disappearance of cellular 
processes and soma membrane and appearance of mRFP+ debris. Additionally, cell 
death is also inferred by the disappearance of olig2:GFP+ cytoplasm. On one 
occasion, an oligodendrocyte-lineage cell very transiently (~2 hours) formed a 
myelin sheath before it died (Figure 3.14A), but in the majority of cell death events 
no such structures were observed. Neighbouring OPCs in the same region of a dying 
cell behave normally, differentiating and forming myelin sheaths (Figure 3.14). The 




Figure 3.13 –sox10:mRFP+ debris in the posterior spinal cord of kbp
st23
 mutants. 
(A) High-magnification view of the posterior region of 72hpf Tg(sox10:mRFP) larvae. In 
WT, mRFP labels OPC processes (asterisks), and myelin sheaths (brackets). In mutants, 
mRFP+ debris is readily apparent (arrowheads). Scalebar: 10 µm.  
(B) Percentage of larvae with mRFP+ debris in the anterior (A) and posterior (P) spinal cord. 
From 60hpf onwards, debris was ubiquitous in mutant posterior spinal cord (see text for 
details).   
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Table 3.3 – Total OPC cell death events in the posterior spinal cord (60-72hpf) 
 
# cell death events 
Length of time imaged  
 (hours; all larvae combined) 
# larvae 
dorsal ventral total 
WT 0 0 0 176 18 
mutant 1 12 13 218 21 
 
I never observed oligodendrocyte-lineage cells undergoing cell death in WT larvae, 
whereas cell death events occurred in 11/21 mutant larvae imaged at similar stages of 
development. Typically, I observed only one such event in each individual larva; 
only two mutant larva displayed two cell death events. Like the mitotic rate of OPCs 
in the previous section, in the context of a single animal, this represent the death of a 
small (<5%) subset of cells in the region analyzed; but this effect may accumulate at 
even higher rates during the next 24 hours of development and contribute 
significantly towards the decrease in mature oligodendrocyte number in mutants at 
96hpf.   
These results indicate that developmental apoptosis of OPCs does not occur early on 
in the spinal cord of WT larvae, and suggest that in the absence of reticulospinal 
axons, a subset of ventral oligodendrocyte-lineage cells undergoes cell death. Since 
such events occurred only ventrally and in a restricted number of cells, the 
underlying signal that would usually promote survival probably does so in a contact-













(A) Lateral view of the posterior region of a mutant Tg(olig2:GFP; sox10:mRFP) larva, 
imaged from 60 hpf. Timing indicates minutes. A single visible OPC differentiates and 
forms a myelin sheath at 336’ (arrowheads). At 364’ the myelin sheath is degraded into 
RFP+ debris, and other processes are gone by 420’; by 588’ the cell has died, resulting in a 





Finally, I further confirmed that I was observing cell death by treating sox10:mRFP 
animals with Acridine Orange (AO). AO is a fluorescent, cationic, vital dye that 
intercalates DNA and facilitates visualization of dying cells (with compromised 
nuclear integrity and fragmented DNA), and which has been used to label dying cells 
in zebrafish larvae (Hammerschmidt, Pelegri et al. 1996, Paquet, Bhat et al. 2009). A 
30-minute treatment was enough to brightly label some foci in the posterior region of 
72hpf larvae. These AO+ foci were readily apparent in mutants, often in the ventral 
region and surrounded by mRFP+ debris (Figure 3.15A). Quantification of total AO+ 
foci showed that mutant larvae have significantly more AO+ foci in the posterior 
region of the spinal cord, whereas the number of these foci in the anterior region was 
just borderline significantly different between WT and mutant larvae, according to 
the statistical test used (see Figure 3.15B legend for details).  
Additionally, the number of AO+ foci specifically surrounded by mRFP+ debris is 
significantly increased only in the posterior region of mutants (Figure 3.15B), but not 
in the anterior region. Moreover, in an alternative, independent binning of the same 
data, the number of AO+ foci specifically localized in the ventral spinal cord is also 
significantly increased only in the posterior region of mutants, but not in the anterior 
region (Figure 3.15 C).  
 
Collectively, my results indicate that the absence of reticulospinal axons and the 
severe reduction in target axonal surface correlate a) with a drastic ~50% reduction 
in the proliferation rate of all spinal cord OPCs, and b) with the cell death of a subset 
of ventral oligodendrocyte-lineage cells. The absence of these target axons did not 
affect the initial number of OPCs specified or their migration pattern and dorsal 
distribution. At a later stage, the number of mature oligodendrocytes is also reduced, 
especially in the ventral spinal cord. These data strongly suggest that the initial target 
axons for myelination promote proliferation and survival of oligodendrocyte lineage 








Figure 3.15 – A subset of ventral oligodendrocyte-lineage cells dies in the posterior 
spinal cord of kbp
st23
 mutants. 
(A) Lateral view of the posterior region of Tg(sox10:mRFP) larvae at 72hpf, incubated for 
30 minutes with the vital dye Acridine Orange (AO), which stains apoptotic cells in green. In 
mutants, green apoptotic foci are apparent (arrowhead), often in the ventral region and 
surrounded by mRFP+ debris. Scalebar: 20 µm. 
(B) Quantification of total AO+ foci and AO+ foci surrounded by mRFP+ debris (grey bars). 
Error bars represent standard deviation. 
Anterior: 
Total AO+ foci: 1.75±1.45 (N=20 WT) vs 2.7±1.45 foci (N=17 mutant), p=0.0530 in t-test, 
p=0.0441 in Mann-Whitney test 
AO+ mRFP+ foci: 0.8±1.06 (N=20 WT) vs 1.18±1.02 foci in (N=17 mutant), p=0.1762 in 
Mann-Whitney test 
Posterior: 
Total AO+ foci: 0.85±0.81 (N=20 WT) vs 2.35±1.32 foci (N=17 mutant), p=0.0002 in 
Mann-Whitney test 
AO+ mRFP+ foci: 0.10±0.31 (N=20 WT) vs 1.59±1.06 foci in (N=17 mutant), p<0.0001 in 
Mann-Whitney test 
 (C) Quantification of total AO+ foci and AO+ foci specifically localized in the ventral 
spinal cord (grey bars). Independent binning of same dataset in (B), see (B) for total AO+ 
foci descriptive statistics. Error bars represent standard deviation. 
Anterior, ventral AO+ foci:  
0.60±0.94 (N=20 WT) vs 1.12±0.93 foci in (N=17 mutant), p=0.0687 in Mann-Whitney test 
Posterior, ventral AO+ foci:  






My analysis of the kbp mutant provided insight into the development of 
oligodendrocyte-lineage cells in the absence of their first major axonal targets, and 
therefore into their requirement for OPC and oligodendrocyte development. My main 
finding was that early developmental aspects such as OPC specification and 
population of the spinal cord were not drastically affected in the absence of axons; 
however, later aspects were affected: proliferation was reduced and survival 
impaired. These effects were observed by non-invasive time lapse imaging, which 
provides the most unambiguous, direct measure of proliferation and cell death in 
vivo.  
Crucially, these were all determined in a physiological milieu, without recourse to an 
invasive manipulation to remove axons, and therefore are less likely to represent 
confounding effects of such manipulations, as indicated in the introduction to this 
chapter. 
This indicates that axons promote the proliferation and survival of oligodendrocyte-
lineage cells, in vivo, in what may represent a mechanism to match the numbers of 
oligodendrocyte lineage cells to the axonal surface competent for myelination. 
 
3.4.1 OPC Specification 
I found that the emergence of the very first OPCs is similar in control animals and in 
animals lacking reticulospinal axons (Figure 3.7). This indicates that the 
specification of OPCs in the spinal cord is independent of contact with axons. As 
mentioned previously, Shh induces the generation of the pMN domain. In the spinal 
cord, sonic hedgehog is secreted by the notochord and floor plate cells, both of which 
are unaffected in the kbp mutant; it is unsurprising then that OPCs formed normally. 
Interestingly, in apparent contrast, in the chicken optic nerve, RGC axons seem in 
fact indispensable for inducing OPC specification at the base of the optic nerve. 
However, RGC axons themselves deliver sonic hedgehog, as well as neuregulin 
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signalling (Gao and Miller 2006), highlighting the role of the sonic hedgehog 
pathway in OPC specification throughout the CNS. It would be interesting to 
determine whether the outgrowth of RGC axons is affected in the kbp mutant, and 
whether this impacts OPC development in that region of the CNS.  
A recent study implicated diencephalic dopaminergic neurons, which project their 
axons from the brain to the ventral spinal cord, in the specification of motor neurons 
from the pMN progenitor domain. (Reimer, Norris et al. 2013) showed that during 
zebrafish embryonic development, dopamine release from these axons stimulates the 
sonic hedgehog pathway in pMN progenitors, promoting their proliferation. 
Dopamine gain-of-function manipulations significantly expand the pMN progenitor 
population and the number of motor neurons formed during development and 
regeneration. This study sets a precedent for projection neurons and their axons 
regulating spinal cord neurogenesis. The target spinal cord neural progenitors happen 
to be pMN progenitors, which subsequently specify OPCs, so it is conceivable that 
later, gliogenesis from the same domain may also be modulated by disruption of 
projection axons. The authors did not determine whether the OPC population was 
increased, as was the motor neuron population, following dopamine gain-of-function. 
In kbp mutants, the number of mitotic olig2+ pMN progenitors and of HB9+ motor 
neurons in the posterior spinal cord was similar to WT (Figure 3.5 and 3.6), so it is 
unlikely that axon outgrowth of dopaminergic projection neurons is disrupted as is 
the outgrowth of reticulospinal axons. Additionally, commitment to the 
oligodendrocyte lineage may be regulated by distinct mechanisms that would 
compensate for an increase in the number of pMN progenitors. 
 
3.4.2 OPC migration and distribution 
After specification, OPCs migrate away to colonize the entire CNS. In the zebrafish 
embryonic spinal cord, a subset of OPCs migrates dorsally. (Kirby, Takada et al. 
2006) previously time-lapse imaged these dorsal OPCs and showed that they often 
associate with axons running along a dorsal tract, the dlf, whose axons I have 
observed to become myelinated typically by dorsal oligodendrocytes (see Chapter 4). 
OPCs in the dorsal spinal cord extend numerous filopodia-like processes; when they 
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contact neighbouring OPC processes, they retract and often migrate away. Ablation 
of single OPCs is often followed by colonization of that space by neighbouring 
OPCs. These OPC process interactions may thus ensure their uniform distribution 
during embryonic spinal cord development in zebrafish, in preparation for 
myelination. Additionally, a similar repulsive behaviour was observed between 
OPCs residing in adult rodent brain (Hughes, Kang et al. 2013), implying that this 
mechanism is retained throughout life. The molecular mechanisms underlying these 
repulsive interactions remain unknown, but analogies with dendrite outgrowth and 
axon-dendrite targeting may be drawn, and families of molecules such as DSCAM  
and protocadherins could be a potential avenue for starting that investigation 
(Almeida and Lyons 2013). Neither the study on embryonic zebrafish spinal cord, 
nor the study on adult rodent brain addressed whether neurons or axons played any 
role in regulating this behaviour. 
If the migratory capacity of OPCs really serves to distribute them through the 
nervous system to adequately myelinate axons, axons may actively regulate OPC 
motility or, at a population level, the pattern of migration of many OPCs. For 
instance, immature axons not ready for myelination could promote OPC migration, 
whereas axons competent for myelination could provide a stop signal and arrest it, to 
increase the probability of the OPC differentiating locally and myelinating it. One 
might have predicted that in the absence of a subset of those target axons, OPCs 
would keep migrating for longer, or specifically migrate elsewhere, attracted by other 
myelination targets. 
However, I showed that the absence of the ventral reticulospinal axons does not 
affect the number of dorsal OPCs (Figure 3.7 and 3.8), or the rate of migration of a 
subset of OPCs that migrates towards the dorsal spinal cord (Figure 3.9). This 
strongly indicates that the induction of a subset of OPCs to migrate dorsally is 
independent of ventral axonal influences. The molecular mechanisms underlying this 
induction of dorsal migration are entirely unknown. Interestingly, mutant zebrafish 
where the pMN domain generates an excess of OPCs have increased numbers of 
dorsal OPCs (Fbxw7 mutant) (Snyder, Kearns et al. 2012), whereas mutants where 
the pMN domain generates fewer total OPCs have fewer dorsal OPCs (pescadillo 
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mutant (Simmons and Appel 2012), or swap70 morphants (Takada and Appel 
2011)). This suggests that such induction of dorsal migration is purely due to the size 
of the initial OPC population, possibly by a ventral density-dependent mechanism. 
This further suggests that mechanisms regulating dorsal migration are OPC-
autonomous and axon-independent. 
After a subset of OPC in induced to migrate dorsally, how do they recognize their 
targets and stop migrating? Dorsal axons in the dlf are suitably located to provide a 
stop signal and limit the extent of dorsal OPC migration, but this remains unverified. 
A recent study showed that isoprenylation activity was required within OPCs to 
recognize whatever their dorsal targets may be and arrest migration: (Mathews, 
Mawdsley et al. 2014) found that OPCs often ectopically migrated dorsally too much 
in a mutant in the isoprenoid and cholesterol biosynthetic pathway, hmgcs1. The 
authors suggest that the target for this isoprenylation may be a G-protein γ subunit of 
Cxcr2, a GPCR that binds the ligand Cxcl1, and whose disruption in rodents causes a 
similar migratory OPC phenotype. The origin of Cxcl1, even if it is the relevant 
ligand, remains speculative, although it is known to be secreted by astrocytes. In fact, 
most previous studies have identified factors capable of regulating OPC migration 
that are not produced by axons – these include, for instance, PDGF (Frost, Zhou et al. 
2009), the floor-plate derived Netrin-1 (Jarjour, Manitt et al. 2003), and secreted 
ECM components acting partly through the α5β1 integrin pathway (Frost, Kiernan et 
al. 1996, Milner, Edwards et al. 1996). It will be interesting to determine if any of 
these signals plays a role in limiting dorsal migration in zebrafish, and if so, what 
their origin is; interestingly, classical astrocytes are not present in zebrafish.    
Unlike (Kirby, Takada et al. 2006), who used a particular transgenic reporter line that 
prevented clear OPC visualization of the ventral spinal cord, I was also able to 
monitor the migration of ventral OPCs, which myelinate most reticulospinal axons in 
WT larvae. I found that in the absence of reticulospinal axons, a number of migratory 
parameters of ventral OPCs are slightly reduced – average distance covered and 
average speed; and dorsal OPCs were comparatively even less affected (Figure 3.10 
and 3.11). It remains possible that this effect is due to the lack of kbp function in 
OPCs, which may itself be required for transducing migratory signals. Imaging the 
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anterior spinal cord, where reticulospinal axons are present but kbp function is not, 
will help answer this question. If this phenotype really is specific to the posterior 
spinal cord of mutants, it remains to be determined what the biological relevance of 
these subtle reductions may be. It is hard to determine whether they are due to the 
lack of specific reticulospinal-derived axonal signalling, or instead due to the altered 
environment. The dying oligodendrocyte-lineage cells present in the mutant could be 
releasing molecules to the milieu which perturb these migratory parameters. 
Additionally, in a normal situation, axons may subtly facilitate migration purely by 
providing a physical substrate for OPCs, even if their signals don’t play a major role 
in regulating OPC migration. 
Collectively, my results provide the first direct demonstration in a living organism 
that the general directedness and motility of many OPCs is mostly normal in the 
absence of a substantial number of their axonal targets. This supports the idea that 
the distribution and tiling of OPCs is independent of axons.  
 
3.4.3 OPC proliferation 
I showed that the number of mitotic pMN olig2+ progenitors was unchanged in the 
absence of reticulospinal axons through the onset of OPC specification (Figure 3.5). 
This indicates that reticulospinal axons do not regulate the proliferation of pMN 
progenitors, unlike dopaminergic axons, which do regulate proliferation of pMN 
progenitors at similar stages. Later on, OPCs specified from these progenitors are 
committed to the oligodendrocyte lineage, but are still proliferative, and are 
identifiable by the sox10:mRFP marker in my time-lapse imaging of double 
transgenic larvae Tg(olig2:EGFP; sox10:mRFP). This allowed me to directly count 
the number of mitoses in the posterior spinal cord (Figure 3.9 and Table 3.2). The 
total number of mitotic events was halved in the mutants, an effect that became 
apparent when the absolute frequencies for all larvae were combined. Strikingly, 
both ventral mitoses and dorsal mitoses are reduced in the absence of (ventral) 
reticulospinal axons. This suggests that the missing signal can act at some distance, 
and thus may more likely be a secreted mitogen, rather than a contact-dependent cue. 
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If it were a contact-dependent signal, many other axons in the dorsal spinal cord 
could presumably provide such a signal. 
What might this mitogenic signal be? Neuronal activity has recently been 
demonstrated to regulate OPC proliferation in vivo (Mangin, Li et al. 2012, Gibson, 
Purger et al. 2014), as had been predicted before (Barres and Raff 1993). It remains 
to be determined if this regulation occurs directly between axons and OPCs, for 
instance, mediated by axonal factors secreted in an activity-dependent manner, such 
as neurotransmitters. Axonal neurotransmitters could communicate with OPCs at 
axon-OPC synapses, which occur ubiquitously in vivo (Almeida and Lyons 2013), or 
be secreted into the milieu along the axon. OPCs express many neurotransmitter 
receptors (Karadottir and Attwell 2007), but the end result of the activation of these 
receptors, in vivo, remains obscure. Alternatively, it remains possible that the 
observed effect on OPC proliferation upon neuronal stimulation may be indirect, via 
neural precursor or microglial activation, since these cells were also affected by the 
stimulus (Gibson, Purger et al. 2014). 
More traditionally, some secreted, long-range acting signals are thought to regulate 
OPC proliferation. Known mitogens for OPCs include integrin ligands (Blaschuk, 
Frost et al. 2000), neurotrophin-3 (Barres, Raff et al. 1994), or the main mitogen 
PDGF (see Introduction). It is interesting to note that the source of these molecules in 
mammals is thought to be astrocytic. Directly analogous cells with stellate astrocyte 
morphology are notably absent from zebrafish, although GFAP+ radial glia exist in 
the spinal cord and share many of the roles of astrocytes (Lyons and Talbot 2014, in 
press). To date, no studies exist on the expression or role of PDGF and its receptor in 
the development of the zebrafish spinal cord. Is it expressed in the appropriate time 
and place to serve as a mitogen for OPCs? Do radial glial cells produce it, if there are 
no astrocytes? A comparative study showed that the zebrafish orthologue of PDGF-A 
diverges extensively from the mouse and human orthologues in the signal peptide 
region and C-terminus of the mature peptide (Liu, Korzh et al. 2002). Does it serve 
the exact same function as in mammals, given its divergence? Could it be that 
zebrafish PDGF is not mitogenic for OPCs? Are zebrafish OPCs responsive to 
PDGF, i.e., do they express the relevant receptor? Are there other mitogens specific 
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to the zebrafish spinal cord? It is noteworthy that at the stages included in my time-
lapse analysis, I did not observe extensive OPC proliferation. Although it cannot be 
excluded that OPC proliferation ramps up later on, it is possible that extensive OPC 
proliferation simply does not occur in zebrafish. Could this relate to the absence of 
astrocytes, and possibly of PDGF, in the zebrafish spinal cord? In the mammal spinal 
cord, OPCs must populate and myelinate an immensely larger volume, several orders 
of magnitude larger than the zebrafish embryonic spinal cord. It is thought that the 
evolution of the larger volume of the mammal spinal cord required, or led to the 
evolutionary emergence of a secondary, dorsal source of OPCs (Richardson, Kessaris 
et al. 2006). In contrast, during embryonic and larval development, a single 
oligodendrocyte can extend processes that span the entire height of the zebrafish 
spinal cord. 
In sum, my results suggest that axons promote OPC proliferation. To formally rule 
out a role of kbp itself in proliferation, I would need to investigate the anterior spinal 
cord of kbp mutants, where reticulospinal axons are present, and where OPC 
proliferation should not be affected. Still, my results suggest that axons provide a 
long-range acting mitotic signal during OPC development in vivo, contributing to the 
regulation of mature oligodendrocyte number later on.  
 
3.4.4 OPC/oligodendrocyte survival 
I also found that the survival of a subset of OPCs was impaired in the absence of 
reticulospinal axons. My live imaging indicates that several hours after the onset of 
dorsal migration, a small subset of ventral OPCs dies in the posterior spinal cord 
(Figure 3.13 and 3.14). My time-lapse analyses were focused on the 60hpf-72hpf 
hour period, and all cell death events occurred towards the end of this period, 
implying that whatever triggered cell death had just started its effect, and suggesting 
that the rate of cell death for the next 24 hour period may increase further.  
What was the stage of development of the dying cells? Both olig2 and sox10 
endogenous expression, and GFP and mRFP protein levels, persist in zebrafish OPCs 
when they terminally differentiate into oligodendrocytes. This means that the dying 
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double labelled cells could be an OPC or an oligodendrocyte. Since mRFP is 
membrane bound, I could visualise the morphology of these cells at a moderate 
resolution. During terminal differentiation, OPCs retract many of their ramified 
processes and elaborate myelin sheaths with a characteristic tubular profile. Using 
this morphological criterion, I could identify one cell that formed a clear myelin 
sheath and maintained it for approximately 2 hours, before undergoing cell death 
(Figure 3.14). Although this one cell could be defined as an ‘early’ oligodendrocyte 
when it died, the majority of dying cells do not clearly form myelin sheaths prior to 
the sudden appearance of mRFP+ debris. However, the onset of the terminal 
differentiation may occur slightly before the morphological specialization that the 
formation of a myelin sheath represents, so the cells might already have been 
oligodendrocytes. Similarly, the point of no return in terminal differentiation may 
occur slightly before endogenous expression of mbp and of the reporter transgene 
mbp:EGFP-CAAX (which labels the membrane of oligodendrocytes). Thus, 
although no GFP-CAAX+ debris is apparent in the posterior spinal cord of kbp 
mutants, reporter protein might simply not have accumulated to detectable levels 
before death ensues.  
Therefore, as such cells may have already entered a terminal differentiation program 
when they died, the requirement for an axonal-derived survival signal in the 
zebrafish spinal cord may also be only from the oligodendrocyte stage, as previous 
studies would suggest (Ueda, Levine et al. 1999).  
Time-lapse analyses at a higher spatial and temporal resolution would allow me to 
investigate the fine morphology and dynamics of oligodendrocyte-lineage cell 
processes prior to their death in the absence of reticulospinal axons. This would 
provide a better indication as to the stage of morphological development of these 
cells. I would also be able to better assess whether the dying cells ever manage to 
ensheath any axons. Interestingly, in zebrafish larvae where Sox10 (a transcription 
factor required to induce myelin gene expression in OPCs(Li, Lu et al. 2007)) is 
genetically disrupted, OPCs are generated normally and clearly ensheath axons, 
forming what resembles a myelin sheath like the one I observed in one mutant cell 
(Figure 3.14). They then undergo apoptosis (Takada, Kucenas et al. 2010). Sox10 
124 
 
could be promoting survival of oligodendrocytes downstream of a pro-survival 
pathway induced by an axonal signal; it would be interesting to determine if this 
could be the same survival signal that is missing when reticulospinal axons are 
absent. Sox10 mutant oligodendrocytes may be surviving slightly longer since the 
required axonal signal is not disrupted, and they have a bit more time to elaborate 
myelin sheaths before the apoptotic program is triggered; whereas in the posterior 
spinal cord of kbp mutants, the absence of an upstream reticulospinal axon-derived 
signal triggers cell death earlier. In this scenario, most oligodendrocytes would not 
even have time to form myelin sheaths before disintegrating. It would be interesting 
to determine if the activity of Sox10 or expression of its target genes is altered in the 
dying OPCs. However, it would be hard to assess this at single cell resolution, which 
would be required given that only a small subset of oligodendrocyte-lineage cells die 
in my experiments.  
What determines whether a particular cell dies or survives in the absence of 
reticulospinal axons? In other contexts, precociously-differentiated oligodendrocytes 
in the conditional Notch1 mutant (Genoud, Lappe-Siefke et al. 2002), or ectopically-
located oligodendrocytes in the grey matter of animals overexpressing PDGF 
(Calver, Hall et al. 1998), also could not survive in the long-term and resulted in 
increased apoptosis. In these cases, it is thought that oligodendrocytes died because 
they missed out on the right time or place for survival cues. In kbp mutants, dying 
cells were in their normal locations within the spinal cord and in close vicinity 
(within the same one somite) to cells that survived. Some of these were already 
producing myelin sheaths at the time of cell death, suggesting that the dying cells 
were not differentiating prematurely. Thus, rather than the wrong place or time, the 
dying cells might have be lacking the right amount of signal. In WT larvae, there 
may normally be a limiting amount of survival signals; just enough to prevent an 
inherent apoptosis program in the majority of oligodendrocyte-lineage cells. 
Possibly, when the axonal environment is disrupted, a localized, transient oscillation 
on the combined level of pro-survival signals may be enough to tip the cell over the 
edge and trigger an irrevocable programme of apoptosis.  
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Given that OPC cell death in the absence of reticulospinal axons occurred only in the 
ventral spinal cord, in a localized and sparse manner, I would expect that this signal 
acts in a contact-dependent manner. This could potentially include physiological 
activity-derived cues, such as synaptic and extra-synaptic vesicle release along 
axons, or signals exposed on the surface of axons such as classical juxtacrine 
signalling pathways - for instance, NRG1. Although shown to promote survival in 
vitro, an absolute requirement of NRG1 for CNS myelination in vivo was not found 
(Brinkmann, Agarwal et al. 2008, Perlin, Lush et al. 2011). This could be due to 
redundancy with other pathways, which could compensate for its absence, so I 
cannot exclude that NRG1 exposed on the surface of axons promotes 
oligodendrocyte survival in vivo. 
It is remarkable that I observed little or no OPC developmental apoptosis in the 
spinal cord of WT, control animals. As mentioned previously, most CNS regions in 
mammals exhibit a significant proportion of dying OPCs, including up to 50% of all 
oligodendrocytes in the optic nerve (Barres, Hart et al. 1992). This species-difference 
is not limited to OPCs: developmental cell death of motor neurons also does not 
occur naturally in zebrafish (Lewis and Eisen 2003). In the case of OPCs, it could be 
related to the aforementioned observation that widespread OPC proliferation may 
simply not occur in zebrafish. Zebrafish OPCs may proliferate at a low, basal rate 
which may be enough to populate the zebrafish spinal cord. Thus, in WTs, there is no 
large excess of OPCs that needs to be trimmed down to match the available axonal 
area, and no significant apoptosis ensues. A survival cue from axons is still needed 
for the number of oligodendrocytes that do mature; a requirement which may simply 
be a feature of oligodendrocytes in all species.  
 
3.4.5 Multiple mechanisms match OPC population size to available 
axonal surface 
 
In an individual WT larva, I determined that over 12 hours, from 60-72hpf, 1-2 OPCs 
divide in 425µm of the posterior spinal cord of WT (corresponding to ~5% of all 
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OPCs in that region). If this rate persists through the next 24h, and based only on the 
72hpf absolute numbers, I would expect that by 96hpf, ~6 OPCs are generated 
through OPC divisions. In mutants, OPC proliferation is roughly halved. Thus, by 
96hpf, I would expect this proliferation defect to contribute with a reduction in ~3 
OPCs compared to WT numbers. 
I additionally observed that a subset of ventral oligodendrocyte-lineage cells die in 
the mutants, whereas developmental apoptosis was never observed in WTs. In an 
individual larva, I mostly observed only one such event over the same 12-hour 
period. If this rate persists for the next 24h, I would expect 3 OPCs to have died due 
to a missing survival signal at 96hpf. 
Adding both effects, I would expect a reduction in ~6 oligodendrocyte-lineage cells 
in mutants compared to WT in a 425µm stretch of the posterior spinal cord. In fact, 
this is roughly the reduction I found when counting mature oligodendrocytes at 
96hpf in a similar stretch of the spinal cord (Figure 3.4): I counted 30±6 total 
oligodendrocytes in WT versus 22±5 in mutant; and 21±4 ventral oligodendrocytes 
in WT versus 16±3 in mutants. Thus, the combination of both factors accounts for 
the reduction of mature oligodendrocyte number. This suggests that axons can 
regulate both OPC proliferation and survival to a certain extent, in what may be a 
mechanism to attempt to match OPCs to the existing axonal surface.  
It remains formally possible that axons only actually regulate one of these aspects, 
and the second effect is a consequence of the first. For instance, it could be that 
reticulospinal axons only provide a survival signal, and not a mitogenic signal. When 
these axons are absent, a subset of oligodendrocyte-lineage cells dies, and the debris 
and cell death byproducts that are released into the milieu are inhibitory to the 
proliferation of other OPCs, which could occur autonomously. In the future, to 
address this possibility, it will be interesting to attempt to specifically block the 
apoptosis of oligodendrocyte-lineage cells in the kbp mutant. For instance, caspase-
inhibiting peptides or p53 morpholinos (antisense oligonucleotides that interfere with 
expression of the target gene) have both been used in zebrafish to prevent the 
apoptotic signaling cascade (Williams, Barrios et al. 2000, Robu, Larson et al. 2007). 
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This would allow me to dissociate the proliferation phenotype from the survival 
phenotype. 
Interestingly, in other contexts, when excessive numbers of OPC are generated in a 
cell-autonomous manner (for instance, in the spinal cord of PDGF-overexpressing 
mice (Calver, Hall et al. 1998), and of Neurofibromatosis type-1 mutant zebrafish 
(Lee, Padmanabhan et al. 2010, Shin, Padmanabhan et al. 2012)), the final number of 
mature oligodendrocytes is normal, as the number of OPCs is trimmed down through 
apoptosis. These findings support the fundamental model that axons can regulate the 
size the OPC population that matures into oligodendrocytes. It would be interesting 
to determine if the trimming down of numbers in these contexts is also due to 
competition for limited amounts of proliferative and survival signals derived from 
axons. If this is the case, then a prediction is that artificially increasing the axonal 
surface and axon-derived signals in these animals (for instance, in NF1 mutant 
zebrafish), would rescue some of apoptosis observed. In the next chapter, I will 
describe a strategy for increasing the axonal surface in zebrafish, which could be 
used to test this prediction. 
It remains to be determined whether the reduced oligodendrocyte number in kbp 
mutants is actually matched to the remaining axonal surface. Note that specification 
of OPCs was not drastically affected, and in fact I observed in my time-lapse analysis 
that the emergence of most olig2+ sox10+ OPCs is due to de novo specification from 
olig2+ pMN progenitors, rather than proliferation of OPCs. Therefore, a core number 
of OPCs might still develop, but does their differentiation into oligodendrocytes 
occur normally, and is their myelination perfectly adequate to the axonal surface that 
remains? There was a drastic 80% reduction in the ventral axonal surface that is the 
initial target for myelination. Yet, at 4dpf, oligodendrocytes were reduced only in 
~25%. Are they actually matched? If there is still a surplus of oligodendrocyte-
lineage cells, how is their differentiation affected, if at all?  I will address these 




In sum, my aim was to address whether previous in vitro and indirect in vivo 
findings that axon-derived signals can regulate aspects of oligodendrocyte-lineage 
development held true in the context of a living animal, in a physiological context 
that could be attributable to a direct effect of axons on OPCs. I demonstrated that 
reticulospinal axons do not regulate the proliferation of pMN progenitors, the 
generation of motor neurons, the specification of oligodendrocyte-lineage cells or 
their early migration patterns. Therefore these aspects of oligodendrocyte 
development are likely to follow an axon-independent programme. I then 
demonstrated that both proliferation and survival of OPCs are regulated by 
reticulospinal axons, the very first targets for myelination. They may represent both 
sides of the same coin in a mechanism that matches the size of the OPC population to 
the amount of axonal surface to be myelinated.   
My work also highlighted some species differences to oligodendrocyte-lineage 
development in mammals. I did not observe widespread OPC proliferation or 
apoptosis in control, WT animals; whereas both of these occur extensively in several 
regions of the mammal CNS. It may be that the emergence of larger CNSs required, 
or followed, the evolution of mechanisms for expansion of the OPC population (such 
as PDGF-dependent proliferation, and secondary sources of OPCs), concomitantly 
with a mechanism for trimming down excess OPCs (based on competition for limited 
axonal signals that suppress an endogenous apoptotic programme). The primordial, 
primitive features of this mechanism may already be present in the teleost lineage 
that includes zebrafish, and may simply have been scaled up by evolution. Such 
scaling may even have been driven by axons – which could secrete novel factors or 
express more signals in mammals.  
 
What happens subsequently? Can axons also regulate later aspects of 
oligodendrocyte development, such as the actual formation of myelin sheaths, or 
their maintenance, in vivo? Many oligodendrocyte-lineage cells survive in the 
posterior spinal cord of kbp mutants and differentiate into oligodendrocytes. They do 
so in an altered axonal environment. Can they form their myelin sheaths normally in 
this environment? In the next chapter, I will address these questions by determining 
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the fate of the surviving oligodendrocytes, and investigate whether their myelinating 
capacity is affected. I will also address these questions by adopting a “gain-of-
function” strategy in which I will increase the axonal surface that is the initial target 














4. Axons regulate the myelinating capacity 





The sequence of events that results in the emergence of a successfully myelinated 
axon from a neural precursor and a glial precursor is extremely complex. In Chapter 
3, I demonstrated that the emergence of the first OPCs and their initial migration 
occur independently of axons, but that soon after, axons regulate proliferation and 
survival of oligodendrocyte-lineage cells in vivo. This likely constitutes a mechanism 
that contributes to match the size of the OPC population to the amount of axonal 
surface that will require ensheathment and myelination. This matching and migration 
into their target areas leads to population of the entire CNS by OPCs, a prerequisite 
for actual myelination. As each OPC ceases migrating and reaches its target area, it 
must sustain a programme of very dynamic extension and retraction of cellular 
processes (Fox, Afshari et al. 2006), presumably to sample potential targets and other 
structures not destined for myelination; such remodelling must be responsive to local 
signalling derived from contact with its milieu. The cell also likely centrally 
regulates its core level of process arborisation. As myelination approaches, 
oligodendrocyte-lineage cells remodel their plasma membrane, become less ramified, 
and maintain only those processes along which they will generate myelin sheaths 
(Hardy and Friedrich 1996). To start elaborating myelin sheaths, the cell must 
coordinate synthesis and delivery of many different structural components to the end 
of each process, and each component must be delivered at the appropriate time, 
rather than all simultaneously (Aggarwal, Yurlova et al. 2011). It shuttles specific 
proteins along those processes, but also specific messenger RNAs. Myelin basic 
protein, for instance, which is required for membrane compaction, is locally 
translated where myelin sheaths are being formed (Colman, Kreibich et al. 1982, 
Ainger, Avossa et al. 1993, Snaidero and Simons 2014). When myelination ensues, 
the cell must regulate the timing of synthesis and transport of each structural protein, 
but also regulate the timing and level of translation from those mRNAs localized to 
myelinating processes. This is in addition to the vast amounts of the specialized 
cellular membrane that it must synthesize – one rough estimation puts it at 1000 
times the area of the soma membrane (Brady 2012). Another estimation is that 
during active myelination, the myelin surface area in each cell expands between 
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5000-50000 µm2 each day, compared with the soma’s surface area of about 300 µm2 
(Baron and Hoekstra 2010, Snaidero and Simons 2014). Individual oligodendrocytes 
can form up to 60 myelin internodes in adult mice, ranging from 20-200µm in length 
(Chong, Rosenberg et al. 2012). How does a single cell coordinate the complex 
events outlined above in all of its processes? Does every process belonging to the 
same oligodendrocyte receive the same myelin synthesis toolkit, and make identical 
myelin sheaths, as per the cell’s central commands? If so, one would expect a single 
oligodendrocyte to make similar amounts of myelin and similar sheaths at the tip of 
all of its processes. Alternatively, the amount of myelin that is synthesized at the end 
of each process of an individual oligodendrocyte could be locally regulated by 
interaction with its target axon. Contact-dependent cues would regulate the 
extension, thickness and longitudinal growth of each particular sheath, and each 
oligodendrocyte should be able to generate different myelin sheaths on vastly 
different axons. In line with this, in global ultrastructural analyses of myelination in 
many CNS regions, the thickness and length of each myelin sheath is often precisely 
adjusted to each axon, suggesting local regulation. However, local regulation of 
myelin biogenesis in a process-specific manner remains to be unambiguously 
demonstrated in vivo. To address which hypothesis represents the fundamental mode 
of myelin formation, one must carefully observe an individual oligodendrocytes’ 
formation of its full complement of myelin sheaths. 
Since Pio del Rio Hortega’s original descriptions of oligodendroglia almost 100 
years ago (Río-Hortega 1928), the same types of oligodendrocyte morphologies are 
repeatedly found: oligodendrocytes tend to either elaborate many myelin sheaths on 
small-caliber axons or very few sheaths on large-calibre axons (Remahl and 
Hilderbrand 1990, Bjartmar, Hildebrand et al. 1994). Reports have described a 
molecular correlate of this heterogeneity – for instance, carbonic anhydrase II 
staining labels only those oligodendrocytes making many small-caliber myelin 
sheaths (Butt, Ibrahim et al. 1995).  
This would suggest that each cell centrally controls the delivery of myelin 
components and every process produces the same amount of myelin. Different 
oligodendrocyte morphologies would then represent different specialized subtypes of 
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oligodendrocytes, each subtype fixed to myelinate a particular calibre, i.e., make a 
particular amount of myelin at the end of every process. In this scenario, the 
myelinating potential of oligodendrocytes is a fixed, intrinsic property of each cell, 
that could be specified prior to myelination, and be consequence of each individual 
oligodendrocyte’s inherent program of development. In a complex environment with 
many types of axons (such as the spinal cord), a “small-calibre axon”-
oligodendrocyte, upon contacting and sampling the axonal environment, would only 
specifically recognize or stabilize contacts with small calibre axons, promoting 
subsequent ensheathment and myelin formation, and would ignore or actively retract 
processes that contact large-calibre axons. A slightly different hypothesis is that 
every OPC/oligodendrocyte is potentially capable of myelinating any competent 
axon, but upon contacting its first axonal target, the whole cell becomes committed 
to those types of axons and the myelinating potential of that cell becomes fixed 
thereafter. Whichever molecular mechanisms would underlie the emergence of such 
subtypes, whether cell-autonomous or dependent on initial axonal interactions, 
remain completely unknown in the CNS. 
However, an alternative explanation for the different types of oligodendrocyte 
morphology remains, which does not require central control of myelin biosynthesis. 
Communication with the target axon could locally regulate each oligodendrocyte 
process to produce a specific amount of myelin. The complement of myelin sheaths 
of each cell would then reflect only the influence and constraint of the axons it 
contacts. The observed tendency of oligodendrocytes to myelinate either large or 
small diameter axons may simply reflect different timings of axonal development, 
with different cohorts of the same axons becoming competent for myelination at 
different times. For instance, the whole cohort of large-diameter axons in a tract may 
become competent for myelination initially, and tracts containing small diameter 
axons become competent later with little overlap between the two periods, which has 
been inferred to happen in mammals (Matthews and Duncan 1971, Butt and Berry 
2000).  
Thus, the extent to which axons are capable of locally regulating the formation of 
myelin sheaths in vivo remains unclear. Despite the observed classes of 
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oligodendrocyte morphologies, oligodendrocyte-lineage cells may still be plastic and 
able to myelinate any axon that is competent for myelination, irrespective of its 
caliber, location, neurotransmitter phenotype or other characteristics. The studies 
describing the heterogeneity of oligodendrocyte morphology and its possible relation 
with timing of differentiation or axonal calibre are purely correlational; few studies 
to date address causality. In addition to being able to carefully observe the 
morphology of individual oligodendrocytes, one must be able to manipulate their 
axonal targets. If axons locally regulate myelin sheath formation, and 
oligodendrocytes are plastic in relation to the axons they myelinate, then when 
artificially challenged with an axonal environment different from what they are 
normally exposed to during development, they should be able to adapt and myelinate 
them. For instance, if transplanted into a different region of the CNS, 
oligodendrocytes should be able to myelinate their new targets; if, alternatively, they 
represent a fixed subtype of oligodendrocytes, they won’t be able to myelinate them.  
A hint as to the plasticity of oligodendrocytes and the nature of myelin sheath 
formation comes from the study of demyelinating diseases such as multiple sclerosis. 
Following a demyelinating lesion, latent, adult OPCs are capable of differentiating 
and forming myelin (Franklin and Ffrench-Constant 2008) in what must perforce be 
an axonal environment drastically different from the developmental situation. 
Demyelinated axons are much larger and mature than their developmental 
counterparts were upon initial myelination, and have a distinct state of physiological 
activity. Adult OPCs can form myelin around them, suggesting that these cells are 
plastic and can myelinate any axon; however, it could be argued that such adult 
OPCs represent a specialized, fundamentally different subtype than developmental 
OPCs, and that this does not represent the general mode of myelin sheath formation. 
Additionally, remyelinated axons have shorter and thinner myelin sheaths (Franklin 
and Ffrench-Constant 2008), suggesting that even if these are bona-fide OPCs, the 
plasticity they show is limited, or the lesioned milieu and demyelinated axons are not 
capable of recapitulating their developmental signaling.  
In a transplantation study in rat, (Fanarraga, Griffiths et al. 1998) isolated optic nerve 
oligodendrocyte-lineage cells and transplanted them into the spinal cords of myelin-
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deficient rats, which are deficient for Proteolipid protein and never show any normal 
compact myelin. The optic nerve is constituted by fairly homogenous small-diameter 
axons, and optic nerve oligodendrocytes are therefore only typically exposed that 
narrow range of small axonal calibres. On the other hand, the spinal cord contains a 
variety of axons of different caliber, including some of the largest axons in the CNS 
(Hildebrand, Remahl et al. 1993). 10-14 days after transplantation, compact myelin 
was evident in transversal sections of the spinal cord of the receiving mutant mice, 
which could not be made by endogenous oligodendrocytes. This indicates that the 
transplanted cells integrated, differentiated and were able to make myelin sheaths in 
a vastly different environment from what they usually encounter. The transplanted 
cells myelinated axons of a very large caliber that they would never encounter in the 
optic nerve – strongly suggesting that these cells are indeed plastic, and not 
predetermined to myelinate a subset of axons of a specific caliber. This study, 
however, could not exclude the hypothesis that already at the OPC stage there may 
be inherently different subtypes only able to myelinate certain calibers; these may 
remain undifferentiated in the optic nerve but upon transplantation would contribute 
to the myelination of very large spinal cord axons. Indeed, around 45% of total 
transplanted cells had the antigenic phenotype of OPCs. It also remains possible in 
this paradigm that all OPCs initially have the potential to myelinate any axon, but 
during contact with its first target, the oligodendrocyte becomes committed to similar 
axons thereafter.  
Although this study challenged oligodendrocyte-lineage cells with a different set of 
target axons, its readout (transversal sections of the spinal cord) did not allow 
assessment of the array of myelin sheaths each individual oligodendrocyte made and 
the size of each sheath, as is the case for the majority of in vivo myelination studies. 
Essentially, the question remains as to whether the generation, maintenance and 
growth of myelin sheaths are intrinsically determined in oligodendrocytes, or can be 
regulated by axons. Recent observations that myelination may be influenced by 
experience strongly support the latter. For instance, in socially isolated mice, myelin 
structure and oligodendrocyte transcription (Liu, Dietz et al. 2012), and 
oligodendrocyte morphology (Makinodan, Rosen et al. 2012) are altered compared to 
control. Conversely, housing rats in an enriched environment increased the number 
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of myelinated fibers in the corpus callosum, in parallel with improved performance 
in a spatial learning task (Zhao, Shi et al. 2012). Training rats in a limb-reaching 
motor task induced an alteration in the relevant white matter tract associated with the 
sensorimotor cortex, concomitantly with increased myelin staining (Sampaio-
Baptista, Khrapitchev et al. 2013). In humans, piano practice (Bengtsson, Nagy et al. 
2005), or juggling (Scholz, Klein et al. 2009), induce microalterations in the relevant 
white matter tracts that are compatible with changes in myelination. In general, 
however, it remains to be determined which particular aspect of myelination is 
influenced, as some of these changes could be explained by de novo myelination, 
myelin remodelling, changes in the calibre of myelinated fibers, or oligodendrocyte 
turnover. 
In this chapter, I describe strategies in which I challenge the oligodendrocyte-lineage 
cells with different axonal environments and analyze individual oligodendrocyte 
morphology in vivo to begin to address two fundamental aspects about the mode of 
myelin sheath formation:  
First, what determines the myelinating capacity (the amount of myelin) of 
oligodendrocyte-lineage cells? In the rat anterior medullary vellum, oligodendrocytes 
that myelinate many small axons are estimated to maintain a volume of myelin of 
around ~600 µm3, while oligodendrocytes that myelinate few large axons can 
maintain up to ~30000 µm3 (Butt, Ibrahim et al. 1998). Is there a maximum, and do 
oligodendrocytes normally myelinate at full capacity? Can axons regulate that 
capacity, by modulating the number, length or thickness of the myelin sheaths that 
each oligodendrocyte makes? Alternatively, is the amount of myelin that each 
oligodendrocyte makes an inherent property of each cell, specified early on? In the 
long-term, determining the signaling pathways that regulate the myelinating capacity 
of oligodendrocytes will contribute, for instance, to the search for repair strategies 
following demyelinating lesions. Why are myelin sheaths in remyelinated axons 
thinner and shorter? Do they adequately restore long-term function? In later stages of 
multiple sclerosis, endogenous remyelination eventually fails, despite the presence of 
OPCs in the lesions. Can we target developmental signals that regulate the 
myelinating capacity of oligodendrocyte-lineage cells to maximize remyelination? 
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Second, do oligodendrocyte-lineage cells centrally coordinate the formation of 
myelin sheaths and distribute the same myelin synthesis toolkit to the tip of every 
process? That is, are all myelin sheaths made by an individual oligodendrocyte 
similar? Occasionally oligodendrocytes myelinate both small and large-calibre 
axons, but these seem to be a very small minority. Could they be a particular, more 
plastic subtype of oligodendrocytes? Alternatively, can axons locally control the 
formation of myelin sheaths in each oligodendrocyte process? That is, can individual 
oligodendrocytes form myelin sheaths of different size, and myelinate small and 
large-calibre axons in parallel? If so, the rarity of oligodendrocytes that myelinate 
large and small axons could simply be due to a very narrow time window in which 
different types of axons could be simultaneously competent for myelination, as well 
as be in close proximity. 
What is the relevance of finding the answer to these questions? Myelin and white 
matter alterations have recently been associated with a range of neuropsychiatric 
disorders, but also with learning and memory in several motor and cognitive tasks 
(Fields 2008, Zatorre, Fields et al. 2012). In principle, myelin sheath formation and 
myelinating capacity may be a crucial parameter regulated throughout life and 
underlying these alterations (Wang and Young 2014). Its dysregulation may directly 
contribute to a range of disorders. For instance, ErbB4 has been linked to 
susceptibility to schizophrenia and bipolar disorder. Mice where ErbB4 function is 
inactivated in oligodendrocytes (Roy, Murtie et al. 2007), and mice raised in social 
isolation (Makinodan, Rosen et al. 2012) have oligodendrocytes that form fewer and 
thinner myelin sheaths, leading to a hypomyelinating phenotype and reduced nerve 
conduction velocity. These mice also exhibit dopaminergic alterations and 
behavioural changes consistent with a schizophrenic-like phenotype. Elucidating the 
mechanisms underlying the regulation of sheath formation and oligodendrocyte 
morphology may help us understand the basis of behavioural and cognitive changes 







My general aim is to address whether the myelinating capacity of individual 
oligodendrocytes in the zebrafish spinal cord can be influenced by their target axons 
or whether it is a restricted property that is intrinsically determined in 
oligodendrocytes. To address this, I examined the morphology of individual 
oligodendrocytes challenged with a different set of target axons to myelinate than 
they usually encounter: in animals with substantially fewer axonal targets and in 
animals with supernumerary axonal targets. 
In the posterior spinal cord of kbp mutants, the number of the initial axonal targets, 
the reticulospinal axons (including the large-calibre Mauthner axons), is decreased, 
leading to a drastic 80% reduction in axonal surface available for contact-dependent 
interactions with oligodendrocyte-lineage cells (see Chapter 3). Interestingly, the 
number of oligodendrocyte-lineage cells is concomitantly decreased, but only by 
~25%. Thus, a potential excess of oligodendrocyte-lineage cells exist in the posterior 
spinal cord of kbp mutants in relation to the amount of target axonal surface. I aimed 
to determine if this axonal environment could affect the differentiation and 
morphology of the remaining oligodendrocyte-lineage cells.  
I also sought to independently manipulate the axonal environment in the opposite 
direction, and challenge oligodendrocyte-lineage cells with increased axonal surface 
to myelinate. I aimed to characterize oligodendrocyte-lineage cells in animals in 
which the number of initial target axons (reticulospinal axons, and in particular the 
readily identifiable Mauthner axon) is substantially increased.  
These non-invasive manipulations will offer the added advantage over 








In the posterior spinal cord of kbp mutants, many OPCs differentiate into 
mbp:EGFP+ myelinating oligodendrocytes by 4dpf, but they do so in an environment 
with a drastic reduction in the amount of target axonal surface. To be able to examine 
single oligodendrocyte-lineage cells from their OPC stage through to maturation into 
oligodendrocytes, I generated the transgenic line sox10:KalTA4, where the 
transcription factor KalTA4 (an optimized version of Gal4 (Distel, Wullimann et al. 
2009)) is expressed in oligodendrocyte-lineage cells. By crossing it with the reporter 
UAS:kaede, the fluorescent protein kaede is expressed in a variegated, mosaic 
fashion in the cytoplasm of some sox10+ cells. In the spinal cord, in addition to 
oligodendrocyte-lineage cells, the sox10:KalTA4 line labels a subset of dorsal 
neurons, radial glia and floor plate cells, which are readily identifiable by 
morphology and location and were excluded from the analysis. Cells were identified 
as OPCs if they expressed the fluorescent reporter kaede, resided in their 
characteristic locations in the spinal cord and if they had multiple branched processes 
(Figure 4.1 A). If those processes became less branched and terminated in tubular 
structures (myelin sheaths), I considered those cells as having matured into 
oligodendrocytes (Figure 4.1 A). 
 
4.3.1 Surviving OPCs don’t wait to differentiate 
 
I first wondered whether axons can regulate the timing of differentiation: OPCs 
could take longer to differentiate in the absence of their reticulospinal axonal targets. 
As described in Chapter 3, a subset of oligodendrocyte-lineage cells undergoes 
apoptosis in kbp mutant; I excluded that subset from this analysis.  
I identified 66 OPCs in 16 WT larvae and 48 OPCs in 10 mutant larvae at 60hpf or 
72hpf, and assessed whether they had matured into oligodendrocytes by 96hpf. A 
similar proportion of all cells identified in WT and mutants transitioned into mature, 
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myelinating oligodendrocytes by 96hpf – 62/66 WT cells and 46/48 mutant cells 
(Figure 4.1).  
These results indicate that in the absence of a significant number of target axons, 
surviving OPCs differentiated on time. This suggests that either the exact timing of 
OPC differentiation is an intrinsically determined feature of each cell, or that the 
remaining axons are sufficient to provide a timely differentiation cue for the 
surviving OPCs. In any case, OPCs do not require an exact complement of specific 
individual axons to differentiate, as the axonal complement is drastically altered in 

















Figure 4.1 – In the posterior spinal cord of kbp
st23
 mutants, surviving OPCs do not wait 
to differentiate  
(A) Individual oligodendrocyte-lineage cells of Tg(UAS:kaede) larvae at 72-96hpf 
microinjected with sox10:KalTA4 plasmid at the one-cell stage. Sparse expression of 
KalTA4 from the plasmid trans-activates expression of the cytoplasmic fluorescent reporter 
protein kaede in a subset of sox10+ cells. Both in WT (top) and in mutant larvae (bottom), 
OPCs are readily morphologically distinct from mature oligodendrocytes at 96hpf, which 
present myelin sheaths. Scalebar: 10 µm. 
(B) List of all cells identified as OPCs in WT or mutant larvae at either 60hpf or 72hpf and 
monitored through to 96hpf. Each row represents a cell; a magenta box indicates an OPC 
morphology (no myelin sheath profiles, ramified processes) and a green box indicates a 
mature oligodendrocyte morphology (myelin sheath profiles). In both WT and mutant larvae, 




4.3.2 Surplus OPCs don’t myelinate incorrect axons 
 
Given the potential excess of surviving oligodendrocyte-lineage cells, I then 
wondered if the remaining axons could regulate the myelinating capacity of 
oligodendrocytes as an additional way of matching to the available axonal surface. In 
the absence of a substantial proportion of their normal axonal targets, OPCs could 
make less myelin, or alternatively could incorrectly or prematurely myelinate other 
axons, in different territories than what they usually do in WTs. 
I first investigated whether surviving oligodendrocyte-lineage cells in the posterior 
spinal cord of kbp mutants would myelinate their normal targets by 96hpf. To 
address this, I compared mutant oligodendrocyte morphology with the morphology 
of oligodendrocytes in WT larvae. I mosaically labeled oligodendrocytes by crossing 
mbp:Gal4 animals with a Tg(UAS:kaede) reporter. Double transgenic animals 
express Gal4 in many myelinating oligodendrocytes, which in turn activates 
expression of the cytoplasmic fluorescent protein kaede in a random subset of mbp+ 
cells. I imaged sparsely labelled oligodendrocytes at 96hpf (Figure 4.2). 
Combined with the previous data set at 96hpf (from Figure 4.1), I assessed the 
axonal targets of a total of 223 oligodendrocytes from 29 WT larvae and 131 
oligodendrocytes from 16 mutant larvae. 
In WTs, 114/ 223 oligodendrocytes associated only with Mauthner myelin sheaths. 
These oligodendrocytes had a very stereotyped location just ventral to the Mauthner 
axon, and mostly extended just one long and large sheath on the Mauthner axon 
(example is cell e in Figure 4.2). In contrast, in mutant animals, which lack Mauthner 
axons in the posterior spinal cord, I never observed oligodendrocytes with such 
morphology (0/ 131)  
In WT animals, the remaining ventral oligodendrocytes (71 cells) tended to 
myelinate numerous small caliber axons in the ventral or medial spinal cord (Figure 
4.2, cells a, b and c). Some ventral oligodendrocytes (17/71 ventral cells, 24%) also 
ensheathed motor axons as they exit the spinal cord in the ventral roots (Figure 4.2, 
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cell b, red arrowhead). Occasionally, ventral oligodendrocytes ensheathed axons in 
the dorsal tract of the spinal cord (Figure 4.2, cell b, 4/71 ventral oligodendrocytes). 
In mutant animals, ventral oligodendrocytes mostly myelinated ventral and medial 
axons (Figure 4.2, cells f, g and h), and the proportion ensheathing motor axons 
(Figure 4.2, cell g) is similar to WT: 27/88 ventral cells (31%). Ventral 
oligodendrocytes in mutant larvae also occasionally ensheathed more dorsal axons 
(4/88 ventral cells, Figure 4.2, cell f).  
Dorsal oligodendrocytes typically ensheathed dorsal or medial axons in WTs (Figure 
3.17, cell d) and in mutant animals. 
Thus, there is no drastic alteration in the types of axons that are ensheathed by 
oligodendrocyte-lineage cells when reticulospinal axons are absent. Specifically, in 
the ventral spinal cord where reticulospinal axons are absent, oligodendrocytes do 
not prematurely or incorrectly myelinate other axons, such as motor axons, or axons 
in the more distant dorsal tract. I therefore wondered if oligodendrocyte-lineage cells 






Figure 4.2 – In the posterior spinal cord of kbp
st23
 mutants, surviving OPCs do not 
myelinate incorrect axons or axonal tracts  
(A) Individual mbp:KalTA4+ mature oligodendrocytes in 4dpf Tg(UAS:kaede) larvae. The 
dashed line indicates the ventralmost limit of the spinal cord. Red arrowheads point to 
examples of oligodendrocyte-ensheathed motor axons outwith the spinal cord. Blue 
arrowheads point to examples of circular profiles resembling ensheathed somas. See text for 






4.3.3 Extent of oligodendrocyte myelination is decreased in kbp 
mutants 
 
To investigate whether the extent of myelination of individual oligodendrocytes was 
affected in the absence of reticulospinal axons, I imaged individual mbp:EGFP-
CAAX+ oligodendrocytes at high-resolution (Figure 4.3 A). Injection of mbp:EGFP-
CAAX plasmid DNA in newly fertilized eggs results in sparse, stochastic, mosaic 
expression of the transgene, rather than in all cells of the relevant type. I focused on 
the morphology of ventral oligodendrocytes, since my target analysis indicated that 
these are most likely to ensheath reticulospinal axons in WT (Figure 4.2). 
I first determined the number of myelin sheaths made by each oligodendrocyte. In 
the anterior spinal cord, the number of myelin sheaths was variable, and did not 
reach a statistically significant difference between WT and mutant ventral 
oligodendrocytes. In the posterior spinal cord, mutant ventral oligodendrocytes made 
on average 3 myelin sheaths less than WT ventral oligodendrocytes (Figure 4.3 B). 
This result indicates that oligodendrocytes adapt to the reduced axonal surface by 
reducing the number of myelin sheaths they make, and suggests that axons can 
regulate the formation of myelinating processes. Interestingly, when I combined the 
data for all oligodendrocytes in the spinal cord (ventral and dorsal, indicated in the 
legend of Figure 4.3), the difference in the posterior region became non-significant 
statistically, although the trend remained. This may be due to the high variability of 
sheath number observed per oligodendrocyte (otherwise already well documented 
(Almeida, Czopka et al. 2011, Chong, Rosenberg et al. 2012)), and a reduced power 
of this analysis.  Alternatively, it may hint that dorsal oligodendrocytes are not quite 
as affected as ventral oligodendrocytes, highlighting the potential contact-
dependence of this regulation, as reticulospinal axons are missing specifically from 
the ventral spinal cord. 
I additionally determined the average length of each myelin sheath made by ventral 
oligodendrocytes (Figure 4.3 C), as well as the combined total length of myelin 
sheaths per ventral oligodendrocyte (Figure 4.3 D). Both parameters were 
significantly reduced in the posterior spinal cord of mutants. This suggests that 
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oligodendrocytes also adapt to the reduced axonal surface by reducing the length of 
the myelin sheaths they make, and that axons can locally regulate the growth of 
myelin sheaths. Surprisingly, however, both parameters were also significantly 
reduced in the anterior spinal cord. When I combined the data for ventral and dorsal 
oligodendrocytes (indicated in the legend of Figure 4.3), these differences remained 
strikingly significant, in both the anterior and posterior spinal cord, indicating that all 
oligodendrocytes are affected. 
This suggests that kbp itself, which is globally knocked out, may regulate the growth 
of myelin sheaths. It is less likely that this phenotype is due to the specific absence of 
reticulospinal axons, which only affects the posterior region (see Discussion). It will 
be very interesting to determine whether this reduction in the size of myelin sheaths 








Figure 4.3 – Oligodendrocyte myelinating capacity is reduced in kbp
st23
 mutants  
(A) Single mbp:GFP-CAAX+ oligodendrocytes in the posterior region of 4dpf WT and kbp 
mutant larvae. Note fewer and shorter sheaths in mutant oligodendrocyte. Scalebars: 10 µm. 
(B) Quantification of myelin sheath number per ventral oligodendrocyte. Error bars represent 
standard deviation. 
Ventral oligodendrocytes: 
Anterior: 13±5 (N=10 WT) vs 10±2 sheaths (N=6 mutant), p=0.4063 in t-test 
Posterior: 13±3 (N=6 WT) vs 10±3 sheaths (N=15 mutant), p=0.0304 in t-test 
All oligodendrocytes (ventral and dorsal): 
Anterior: 14±5 (N=18 WT) vs 13±5 sheaths (N=11 mutant), p=0.7517 in t-test 
Posterior: 14±3 (N=10 WT) vs 12±4 sheaths (N=17 mutant), p=0.1997 in t-test 
(C) Quantification of average myelin sheath length per ventral oligodendrocyte. Error bars 
represent standard deviation. 
Ventral oligodendrocytes: 
Anterior: 34±8 (N=10 WT) vs 20±4 µm (N=6 mutant), p=0.0013 in t-test 
Posterior: 28±7 (N=6 WT) vs 16±4 µm (N=15 mutant), p=0.0002 in t-test 
All oligodendrocytes (ventral and dorsal): 
Anterior: 32±8 (N=18 WT) vs 20±5 µm (N=11 mutant), p=0.0002 in t-test 
Posterior: 28±6 (N=10 WT) vs 16±4 µm (N=17 mutant), p<0.0001 in t-test 
 (D) Quantification of total, combined myelin sheath length per ventral oligodendrocyte. 
Error bars represent standard deviation. 
Ventral oligodendrocytes: 
Anterior: 408±80 (N=10 WT) vs 200±59 µm (N=6 mutant), p<0.0001 in t-test 
Posterior: 357±96 (N=6 WT) vs 159±43 µm (N=15 mutant), p=0.0007 in Mann-Whitney 
test 
All oligodendrocytes (ventral and dorsal): 
Anterior: 406±82 (N=18 WT) vs 261±100 µm (N=11 mutant), p=0.0002 in t-test 






4.3.4 Oligodendrocytes incorrectly myelinate neuronal somas in kbp 
mutants 
 
Surprisingly, although I didn’t observe incorrectly myelinated axons in the mutant 
posterior spinal cord, I frequently observed unusual circular profiles at the end of 
processes of mutant oligodendrocytes (Figure 4.4, blue arrowheads). These circular 
profiles occurred in addition to normal, tubular looking myelin sheaths. The number 
of such profiles was variable between cells, sometimes occurring in clusters (Figure 
4.4, cell g), or isolated (Figure 4.4, cell h). In my mosaic analysis of mature 
oligodendrocytes at 96hpf, I observed such profiles in 19/66 oligodendrocytes in 
mutant larvae (29%), and only in 1/38 oligodendrocytes in WT larvae (3%).  
I also identified such profiles in the previous data set of time-coursed mosaic 
oligodendrocyte-lineage cells (sox10:KalTA4; UAS:kaede). Interestingly, at 72hpf, 
5/72 WT oligodendrocytes possessed such profiles, but 3 of these retracted them, as 
they were not present at 96hpf, totaling 2/72 oligodendrocytes at this time point 
(3%). In comparison, 9/66 mutant oligodendrocytes exhibited such profiles (14%) at 
96hpf, with no cases of retraction.  
This suggests that the formation of such unusual profiles occurs at a low level in WT 
larvae, and is corrected as oligodendrocyte-lineage cells develop; in kbp mutants, 
such profiles are maybe formed more often, or not corrected. 
The location and shape of these circular profiles is consistent with the hypothesis that 
they are cell somas. To exclude the possibility that they were oligodendrocyte somas 
that aberrantly expressed the reporter fluorescent protein, I analyzed the double 
transgenic line mbp:EGFP-CAAX; mbp:EGFP, in which both membrane-tethered 
and cytoplasmic GFP are expressed in all myelinating oligodendrocytes. In this line 
both the processes and myelin sheaths of every oligodendrocyte are labelled, as well 
as the cell somas of actual oligodendrocytes (with cytoplasmic GFP). I also readily 
observed many such profiles in this line (Figure 4.4A), indicating that they represent 
ensheathments of non-oligodendrocyte lineage cell somas. Both dorsal (Figure 4.4 A, 
cell a) and ventral oligodendrocytes (Figure 4.4 A, cells b, c and d) bore such circular 
profiles. These profiles could be made close to the oligodendrocyte cell body (Figure 
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4.4 A, cell a) or at a distance (Figure 4.4 A, cell b), and were present both in the 
ventral spinal cord (Figure 4.4 A, cell c) and in more dorsal regions (Figure 4.4 A, 
cells a and b). Additionally, I occasionally observed incomplete circular profiles, 
resembling partially ensheathed somas (Figure 4.4 A, cell d).  
I quantified the number of such profiles in the anterior and posterior region of WT 
and mutant spinal cords (Figure 4.4 B). At 4dpf, mutant larvae had significantly 
more circular profiles than WT in the posterior region. Strikingly, mutant larvae also 
had more aberrant profiles in the anterior region. This was not a transient 
phenomenon, as the number of circular profiles remained increased in mutants in the 
posterior region at 8dpf. 
I confirmed the identity of the cells ensheathed in these profiles by analyzing double 
transgenic lines Tg(glyt2:GFP; sox10:mRFP) and Tg(pax2:GFP; sox10:mRFP). In 
these lines, cytoplasmic GFP is expressed in a subset of interneurons in the spinal 
cord (either glycinergic, or expressing the transcription factor pax2), and membrane-
tethered RFP labels the membrane of oligodendrocyte-lineage cells. At 3dpf, I 
readily observed GFP+ neurons partially or totally covered by oligodendrocyte 
mRFP+ membrane (Figure 4.4 C).  
Thus, in kbp mutants, oligodendrocyte-lineage cells aberrantly ensheath neuronal 
somas. The mechanistic basis for this phenotype is likely to relate to the global lack 
of kbp function, in either axons or oligodendrocytes, since it also occurs in the 





Figure 4.4 – In kbp
st23
 mutants, OPCs aberrantly wrap neuron somas. 
(A) Representative mutant mbp:GFP+ oligodendrocytes (dark cells, labelled with letters) 
bearing mbp:GFP-CAAX+ circular profiles (blue arrowheads) in the posterior region of 4dpf 
Tg(mbp:EGFP; mbp:EGFP-CAAX). Scalebars: 20 µm.  
(B) Number of circular profiles in a 448 µm length of tissue. All p values are from Mann-
Whitney tests: 
4dpf, anterior: 0.5±0.7 (N=11 WT) vs 3.3±3.4 profiles (N=11 mutant), p=0.0257  
4dpf, posterior: 0.2±0.4 (N=11 WT) vs 3.7±3.8 profiles (N=11 mutant), p=0.0022  
8dpf, posterior: 0.3±0.7 (N=10 WT) vs 6.7±5.0 profiles (N=11 mutant), p<0.0001 
(C) Example of Glyt2:GFP+ (left) and Pax2:GFP+ (right) neurons wrapped by 
sox10:mRFP+ oligodendrocyte membrane in double transgenic larvae Tg(glyt2:GFP; 
sox10:mRFP) or Tg(pax2a:GFP; sox10:mRFP), at 72hpf. Scalebars: 5 µm  
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In sum, of the oligodendrocytes that survive and differentiate in the kbp mutant, there 
are variable alterations in morphology in comparison to WT oligodendrocytes. 
Some of these alterations occur specifically in the posterior spinal cord where the 
reticulospinal axons are absent: for instance, ventral oligodendrocytes in that region 
extend fewer myelin sheaths, suggesting that axons regulate the extension of new 
myelin sheaths. Ventral oligodendrocytes may be more affected than dorsal 
oligodendrocytes, which could hint that this regulation occurs locally and requires 
contact. 
Other alterations include the observation that myelin sheaths were shorter, and the 
combined length of all the sheaths that an individual oligodendrocyte extends is also 
smaller. This difference occurred both in ventral and dorsal oligodendrocytes. 
Additionally, I also observed that oligodendrocytes extend myelin sheaths aberrantly 
around neuronal somas. Strikingly, however, these alterations also occur in the 
anterior spinal cord, where reticulospinal axons are present. Therefore, these 
alterations may be due to the global lack of kbp. It will be very interesting to 
determine whether kbp functions in oligodendrocytes to promote the growth of 
myelin sheaths, for instance, or in neurons to prevent the ensheathment of neuronal 
somas (see Discussion).  
The potential role of kbp itself in causing these phenotypes precluded concluding 
whether axons are able to regulate oligodendrocyte myelinating capacity. If axons do 
directly regulate the growth or localization of myelin sheaths, then a prediction is 
that providing additional axonal signals might increase oligodendrocyte myelinating 
capacity, in the opposite direction of the kbp manipulation. I therefore sought an 





4.3.5 Generation of zebrafish with supernumerary Mauthner axons 
 
I sought to provide a “gain-of-function” approach to address whether axons can 
regulate myelination. I generated animals in which supernumerary Mauthner axons 
are formed in the spinal cord, in two genetic independent manipulations: temporary 
knockdown of notch1a function and transient overexpression of hoxb1 genes. 
Loss of Notch1a receptor function has been previously described to result in a fairly 
specific neurogenic phenotype, whereby multiple Mauthner neurons are specified, 
instead of the typical two (Gray, Moens et al. 2001, Liu, Gray et al. 2003). I sought 
to temporarily abrogate early Notch1a function by microinjecting an antisense 
morpholino oligonucleotide into newly fertilized eggs. I found that 500pg of a 
previously described splice-disrupting Notch1a morpholino (Ma and Jiang 2007) was 
sufficient to generate larvae with supernumerary Mauthner neurons (Figure 4.5A, 
“notch1a MO”). I found that the majority of larvae contained supernumerary 
Mauthner neurons at least on one side of the hindbrain, ranging from 2-7. These 
supernumerary Mauthner neurons projected very-large diameter axons, similar to the 
WT larvae, which crossed the midline and grew caudally, throughout the ventral 
spinal cord.  
Importantly, Notch1 function has been implicated in oligodendrocyte development 
and myelination later during embryonic development (see Chapter 1). Morpholinos 
interfere with target gene expression only during the first 1-2 days of development, 
and they become increasingly diluted with each cell division; eventually their effect 
wears off. I showed that correct notch1a transcript is reduced compared to controls at 
10hpf, around the time Mauthner neurons are born, but at 72 hpf, when myelination 
begins, they are already restored to WT levels (Figure 4.5B). Therefore, this 
manipulation should only transiently abrogate Notch1a function, which precludes 
any direct effects of the loss of Notch1a function on oligodendrocyte development. 
To unambiguously exclude this possibility, I sought an additional independent way 
to increase the number of Mauthner neurons.  
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Overexpression of hoxb1 genes, which are important regulators of boundary 
formation and patterning of the hindbrain (McClintock, Kheirbek et al. 2002, 
Tumpel, Wiedemann et al. 2009), has previously been described to generate ectopic 
Mauthner neurons (McClintock, Carlson et al. 2001). When overexpressed 
ubiquitously in the early embryo, these genes disrupt the identities of the hindbrain in 
such a way that structures belonging to the 4th hindbrain segment, such as Mauthner 
neurons, are additionally established elsewhere in the hindbrain (for instance, in the 
more rostral 2nd segment). I found that injecting 50ng of hoxb1b mRNA in newly 
fertilized eggs generated larvae with ectopic Mauthner neurons that also projected 
their large-diameter axons contra-laterally in the ventral spinal cord (Figure 4.5A, 
“hoxb1b mRNA”). Typically, these larvae had one Mauthner neuron on one side of 
the midline and 2-3 Mauthner neurons on the other side. A subset of larvae with 
gross morphological abnormalities, as previously described (McClintock, Carlson et 














Figure 4.5 – Generation of larvae with supernumerary Mauthner axons 
(A) Ventral view of the hindbrain of 5dpf 3A10-immunostained larvae. Anterior is top and 
posterior is towards the bottom. In WT, the two prominently labelled cells are the Mauthner 
neurons, which project large diameter axons caudally (arrowheads). Larvae injected with 
notch1a MO or hoxb1b mRNA have several Mauthner neurons and axons.  
(B) RT-PCR detecting the correctly spliced form of the notch1a WT transcript (notch1a) and 
ef1α, a housekeeping control gene. In notch1a MO-injected larvae, the amount of correctly 
spliced form is decreased at 10hpf compared with control WT. At 72hpf, the level of 





4.3.6 Supernumerary axons are normally ensheathed 
 
I next wondered whether the supernumerary Mauthner axons could be recognized by 
OPCs, and whether OPCs would be able to contact and ensheath them. I injected 
either notch1a morpholino or hoxb1b mRNA in newly fertilized eggs of the 
fluorescent reporter line sox10:mRFP. At 3dpf, the OPC membrane ensheathing the 
Mauthner axons allowed me to unambiguously identify these axons. Mauthner axons 
have a stereotyped location in the ventral spinal cord; their axon is several-fold larger 
than the next largest-diameter axons; additionally, they are continuously ensheathed 
along their length, without any gaps corresponding to nodes of Ranvier, which is 
unique in the zebrafish CNS.  
In a projection of a lateral view of one half of the spinal cord, only one such 
Mauthner-surrounding membrane was observed in WT animals (Figure 4.6). In 
either notch1a MO or hoxb1b mRNA -injected animals, however, several Mauthner-
surrounding membranes were clearly visible, indicating that OPCs recognize and 
ensheath at least some of the supernumerary Mauthner axons. I repeated the 
injections in newly fertilized eggs of the reporter line mbp:EGFP-CAAX. At 5dpf, 
similarly, only one continuous Mauthner myelin sheath was visible in each half 
spinal cord of WT animals, whereas notch1a MO and hoxb1b mRNA-injected 
animals exhibited several Mauthner-myelin sheaths (Figure 4.6). 
These data indicate that at least some supernumerary Mauthner axons are being 
recognized by OPCs, which are capable of ensheathing them, while undergoing 
differentiation into mbp:EGFP-CAAX+ oligodendrocytes.  This suggests that the 
supernumerary Mauthner axons likely present the same recognition and adhesion 








Figure 4.6 - Supernumerary Mauthner axons are ensheathed by myelinating glia 
(A) Lateral view of one half of the spinal cord of 3dpf Tg(sox10:mRFP) larvae, and of 5dpf 
Tg(mbp:EGFP-CAAX) larvae. In WT, one Mauthner axon per larvae ensheathed 
(arrowhead); in larvae with supernumerary Mauthner neurons, additional Mauthner axons 




4.3.7 Supernumerary Mauthner axons are robustly myelinated 
 
Subsequently to recognition and adhesion between OPCs and oligodendrocytes, 
different regulatory mechanisms regulate the differentiation into myelinating 
oligodendrocytes and the formation of myelin sheaths. In the optic nerve, for 
instance, myelin sheath formation is uncoupled from the expression of myelin genes 
which mark the onset of differentiation (Colello, Devey et al. 1995). To address 
whether bona-fide compact, multilamellar myelin was being formed around the 
supernumerary axons, rather than simply ensheathments by oligodendrocyte-derived 
membrane, I examined these animals by electron microscopy. In transversal sections 
of the spinal cord, the Mauthner axon and its lipid and electron-dense myelin sheath 
are readily identifiable. Only one myelinated Mauthner axon is ever visible on each 
side of the spinal cord in 9dpf WT animals, whereas many myelinated Mauthner 
axons are present in notch1a MO and hoxb1b mRNA injected animals (Figure 4.7 A 
“M”). In all animals examined, I never found very large-diameter axons in the 
ventral spinal cord that were not myelinated. This indicates that oligodendrocytes do 
recognize, ensheath and myelinate all of the supernumerary Mauthner axons, which 
my previous live imaging was unable to unambiguously address, given that the axons 
themselves were not labelled. 
In higher magnification views (Figure 4.7B), the Mauthner myelin sheaths in animals 
with supernumerary Mauthner axons appear to be bona-fide, compact multi-lamellar 
sheaths, of comparable thickness to WT Mauthner myelin. In the lower 
magnification views in Figure 4.7A, the Mauthner myelin sheaths do not always 
present as compact sheaths apposed to the axon in the entirety of its cross-sectional 
profile, and at points seems to defasciculate and enlarge or vacuolate. This can be 
due to sub-optimal fixation, dehydration or embedding during sample processing for 
electron microscopy (zebrafish are fairly impermeable to liquids, including electron-
microscopy fixatives); unfortunately, larvae of such small size are impossible to 
perfuse. This precluded me from confidently assessing Mauthner axon thickness by 
determining the number of myelin lamellae or g-ratios (that is, the quotient between 
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axon diameter and axon+myelin diameter), which is why I don’t present these two 
parameters that are more traditionally used in analyses of myelination. 
I next wondered whether the supernumerary Mauthner axons were of a similar cross-
sectional size to WT Mauthner axons, and what the net effect of these manipulations 
was in increasing the total axonal surface. Since axons (including the Mauthner) are 
of an irregular shape and not circular in cross-sectional profiles in these electron 
micrographs, I quantified the perimeter of these axons (excluding the myelin 
sheaths), as this parameter better reflects the axonal surface that is available for 
potential contact-dependent interactions with OPCs or oligodendrocytes. I found that 
in animals with up to three Mauthner axons on one side of the spinal cord, the 
perimeter of each Mauthner axon was not significantly different from WT animals 
with a single Mauthner axon on one side of the spinal cord (Figure 4.7 C, top graph). 
This meant that in animals with 2 Mauthner axons on one side of the spinal cord, the 
total Mauthner axonal surface had essentially doubled, and in animals with three 
Mauthner axons had essentially tripled (Figure 4.7 C, bottom graph). In animals with 
4 or more Mauthner axons, some of the axons were slightly smaller, a reduction that 
although statistically significant, represents only an average perimeter reduction from 
12 to 9 µm. In these animals, the total Mauthner circumference is still significantly 
increased further than animals with 3 Mauthner axons (p=0.0384, t-test), just not 
quite 4-fold when compared to WT animals with one Mauthner axon.  
These results indicate that supernumerary Mauthner axons, which are not normally 
present in WTs, were capable of providing both the correct adhesion signals and of 
inducing myelination by oligodendrocytes, which seem to be a plastic population. 
Interestingly, in the optic nerve, the onset of myelination correlates with the presence 
of large-diameter axons, even though oligodendrocytes differentiate first in regions 
with small-diameter axons (Colello, Devey et al. 1995). Similarly, in the zebrafish 
spinal cord, the large Mauthner axon is the first myelinated. Could supernumerary 
Mauthner axons be diverting the myelinating capacity of oligodendrocytes from 










Figure 4.7 - Supernumerary Mauthner axons are robustly myelinated. 
(A) Electron micrographs of transversal sections of the spinal cord of 9 dpf larvae, focusing 
on the ventral area. One Mauthner axon (M) is readily identifiable in WT animals, 
surrounded by black electron-dense myelin. In animals with supernumerary Mauthner 
neurons, additional Mauthner axons are present in each side of the spinal cord, all of them 
surrounded by electron-dense myelin.  
(B) Higher magnification view of the myelin sheath surrounding Mauthner axons (M), in 
two independent larvae in each condition, showing an apparently similar thickness. notch1a 
MO examples had 3 and 4 Mauthner axons on that side of the spinal cord. hoxb1b mRNA 
examples had 2 Mauthner axons on each side of the spinal cord.  
(C) Quantification of the average perimeter of each individual Mauthner (M-) axon 
(excluding myelin sheath) in 9 dpf larvae. 1 M-axon category includes only WT M-axons. 
Error bars represent standard deviation. 
1 M-axon: 13.54±0.65 µm (N=6 WT larvae);  
2 M-axons: 12.74±1.66 µm (N=9 larvae); p=0.3265 in Mann-Whitney test 
3 M-axon: 11.57±1.78 µm (N=3 larvae); p=0.0952 in Mann-Whitney test 
4+ M-axon: 9.53±0.98 µm (N=4 larvae); p=0.0095 in Mann-Whitney test 
(D) Quantification of the total Mauthner perimeter per half spinal cord, according to the 
number of Mauthner axons per half spinal cord. 1 M-axon category includes only WT M-
axons. Error bars represent standard deviation. 
1 M-axon: 13.54±0.65 µm (N=6 WT larvae);  
2 M-axons: 25.49±3.33 µm (N=9 larvae); p=0.0004 in Mann-Whitney test 
3 M-axon: 34.70±5.34 µm (N=3 larvae); p=0.0238 in Mann-Whitney test 






4.3.8 Other ventral large-diameter axons are myelinated normally 
 
To determine if supernumerary Mauthner axons were myelinated at the expense of 
adjacent axons of smaller diameter, I analyzed the neighbouring ventral spinal cord 
and counted the number of myelinated axons present (Figure 4.8A), which are 
mostly other reticulospinal axons. I found that in animals with up to 3 Mauthner 
axons on each side of the spinal cord, the number of additional myelinated axons was 
not significantly different from WTs, but that this number decreased slightly in 
animals with 4 or more Mauthner axons (according to the statistical test used, Figure 
4.8 B). I also wondered whether these neighbouring myelinated axons could be of a 
smaller size in animals with supernumerary Mauthner axons than in WT animals. 
This could mean that the oligodendrocytes were selecting a smaller cohort of 
additional ventral axons that would require less myelin. However, the average 
perimeter of these axons in WT animals was not different from animals with 
supernumerary Mauthner axons, including those with 4 or more Mauthner axons 
(according to the statistical test used, Figure 4.8 C). Since their ventral location was 
also not changed, this indicates that the same cohort of nearby axons also becomes 
myelinated in animals with supernumerary Mauthner axons. Altogether, these data 
indicates that in the zebrafish spinal cord, even when tripling the amount of axonal 
surface that is the initial target for myelination, the oligodendrocyte population will 
recognize it, adapt to it and myelinate it robustly, without detriment to the 
myelination of other axons. The ability of the oligodendrocyte population to respond 
to the challenge in the axonal environment hints that this cell type is very plastic. As 
I describe in Chapter 3, axons can regulate the size of the oligodendrocyte-lineage 
population by regulating its proliferation and survival. Therefore, in animals with 
supernumerary Mauthner axons, the oligodendrocyte population could simply be 
more numerous. Alternatively, or in addition, supernumerary axons could also 
regulate the amount of myelin, or number of sheaths, that each individual 
oligodendrocyte makes. I thus sought to address which of these possibilities underlie 




Figure 4.8 - Supernumerary Mauthner axons are not myelinated at the expense of 
other axons 
(A) Electron micrographs of transverse sections of the ventral spinal cord of 9dpf larvae. 
Large myelinated axons other than the Mauthner axon (M) are evident.  
(B) Quantification of the number of myelinated axons adjacent to the Mauthner axon in the 
ventral spinal cord. 1 M-axon category includes only WT M-axons. Error bars represent 
standard deviation. 
1 M-axon: 24±4 axons (N=5 WT larvae);  
2 M-axons: 23±4 axons (N=8 larvae); p=0.5470 in Mann-Whitney test 
3 M-axon: 22±3 axons (N=3 larvae); p=0.3393 in Mann-Whitney test 
4+ M-axon: 17±1 axons (N=2 larvae); p=0.0952 in Mann-Whitney test, p=0.0359 in t-test 
(C) Quantification of the perimeter of additional myelinated axons adjacent to the Mauthner 
axon(s). 1 M-axon category includes only WT M-axons. Error bars represent standard 
deviation. 
1 M-axon: 3.22±0.14 µm (240 axons from N=5 WT larvae);  
2 M-axons: 3.11±0.14 µm (238 axons from N=8 larvae); p=0.222 in Mann-Whitney test 
3 M-axon: 3.52±0.26 µm (69 axons from N=3 larvae); p=0.2500 in Mann-Whitney test 
4+ M-axon: 3.55±0.03 µm (66 axons from N=2 larvae); p=0.0952 in Mann-Whitney test, 
p=0.0284 in t-test  
165 
 
4.3.9 Supernumerary axons do not regulate oligodendrocyte number 
 
I wanted to determine whether an increased number of oligodendrocytes could 
contribute to the myelination of supernumerary Mauthner axons. I injected notch1a 
MO and hoxb1b mRNA into newly fertilized eggs of the transgenic fluorescent 
reporter line mbp:EGFP, where cytoplasmic EGFP is expressed in mature 
oligodendrocytes, which enables counting of oligodendrocyte number (Figure 4.9 A). 
At 5dpf, over the length of ~5 somites (425µm of the spinal cord), the total number 
of oligodendrocytes wasn’t different between WT animals and animals with 
supernumerary Mauthner axons (Figure 4.9 B). The size of the dorsal population of 
oligodendrocytes specifically was also not different from WT, which indicates that in 
addition to the total number of oligodendrocytes, their dorsal-ventral distribution is 
not altered, despite the increased number of the ventrally-localized Mauthner axons.  
These data indicate that the large-caliber reticulospinal Mauthner axons do not 
regulate oligodendrocyte distribution or number, in apparent contrast with the results 
described in Chapter 3. However, this could be a comparatively smaller 
manipulation, and a small effect on OPC proliferation, which may have occurred at 
earlier time points, might have gone undetected (see more in Discussion). 
In any case, given that the number of oligodendrocytes remains unchanged, to 
account for the adaptation of oligodendrocytes to the extra axonal surface, it is likely 








Figure 4.9 – Presence of supernumerary Mauthner axons does not affect 
oligodendrocyte number or distribution. 
(A) Lateral view of 5 dpf transgenic Tg(mbp:EGFP) larvae. Similar numbers of 
oligodendrocytes are apparent in WT larvae and larvae with supernumerary Mauthner axons. 
Arrowheads point to examples of dorsally located oligodendrocytes which extend processes 
ventrally to myelinate ventral axons (including Mauthner axons, see Figure 4.12).  
(B) Quantification of oligodendrocytes per 425µm length of tissue in the midtrunk region of 
the spinal cord. Error bars represent standard deviation. 
Total:  
WT: 66±6 oligodendrocytes (N=6); notch1a MO: 67±5 oligodendrocytes (N=10), p=0.7495 
in t-test; hoxb1b mRNA: 63±8 oligodendrocytes (N=9), p=0.3658 in t-test 
Dorsal:  
WT: 25±3 oligodendrocytes (N=6); notch1a MO: 24±4 oligodendrocytes (N=10), p=0.4797 




4.3.10 Axons regulate the myelinating potential of individual 
oligodendrocytes 
 
To investigate whether regulating the number of myelin sheaths and/or their length 
was the mechanism by which oligodendrocytes adapted to the extra axons, I labeled 
individual oligodendrocytes in WT larvae or in larvae with supernumerary Mauthner 
axons by microinjecting a plasmid encoding the transgene mbp:EGFP-CAAX in 
newly fertilized eggs. This allowed me to identify single EGFP+ oligodendrocytes 
myelinating the Mauthner axon(s), isolated in a field of view, and analyze their 
morphology.  
In WT animals at 5 dpf, the majority (26/35) of oligodendrocytes that myelinate the 
Mauthner axons have a very stereotyped position just ventral to the axon and extend 
only a single large myelin sheath, reminiscent of the association between Schwann 
cells and peripheral axons (Figure 4.10 A, B). This type of association corresponds to 
Pio del Rio Hortega’s description of “type IV oligodendrocytes”. Most of the 
remainder (7/35) extend just two myelin sheaths, ensheathing one segment of one 
Mauthner on one side of cord and one segment on the other Mauthner. Very rarely, a 
WT oligodendrocyte may also ensheath a smaller axon in addition to Mauthner, as 
discussed previously. Each WT oligodendrocyte that myelinates Mauthner axons 
covers 151±49 µm of Mauthner axon length. 
In larvae with supernumerary Mauthner axons, the majority of oligodendrocytes 
elaborated 2 or more myelin sheaths, and in contrast to WT oligodendrocytes, those 
oligodendrocytes myelinating just one segment of Mauthner axons were a minority 
(Figure 4.10 A, B). In one instance, for example, I observed one oligodendrocyte 
myelinating seven distinct segments on the supernumerary Mauthner axons (Figure 
4.10 A, “notch1a MO”). Additionally, in these larvae, on average, each individual 
oligodendrocyte covered a significantly longer total length of Mauthner axons in 
some animals (Figure 4.10 C, 256±67 µm in notch1a MO animals and 185±88 µm in 




Figure 4.10 – Individual oligodendrocytes myelinate multiple supernumerary 
Mauthner axons at 5 dpf. 
(A) Lateral view of single mbp:GFP-CAAX+ oligodendrocytes myelinating Mauthner 
neurons in 5 dpf larvae. In WT, Mauthner-dedicated oligodendrocytes form one long myelin 
sheath and lie ventral to the axon. In animals with supernumerary Mauthner axons, 
Mauthner-associated oligodendrocytes have more than one myelin sheath associated with 
Mauthner axons. Brackets and numbers label each myelin sheath; MIP = Maximum intensity 
projection; bottom left corner indicates the depth of each slice in the z-stack.   
(B) Quantification of the diversity of morphologies of oligodendrocytes that myelinate 
Mauthner axons, at 5dpf. In WT larvae, the majority of Mauthner-dedicated 
oligodendrocytes forms one long myelin sheath. In larvae with supernumerary Mauthner 
neurons, the vast majority of oligodendrocytes myelinating the Mauthner now form 2 or 
more myelin sheaths. See text for details. 
(C) Quantification of the total length of myelin sheaths formed along Mauthner axons per 
oligodendrocyte. Error bars represent standard deviation. 
WT: 150.8±48.5 µm (N=31 cells); notch1a MO: 256.4±66.5 µm (N=10), p<0.0001 in t-test; 
hoxb1b mRNA: 185.3±87.6 µm (N=14), p=0.0958 in t-test 
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To investigate whether this was a stable association, I repeated this experiment at 9 
dpf, when I had observed normal myelination of extra Mauthner axons by electron 
microscopy. At this stage, the number of WT oligodendrocytes associated with a 
single Mauthner myelin sheath was even greater than 5dpf (17/19). In animals with 
supernumerary Mauthner axons, the number of oligodendrocytes making several 
myelin sheaths was higher than 5dpf (13/13 in notch1a MO, 4/6 in hoxb1b mRNA-
injected larvae, Figure 4.11B). Therefore, this was not a transient phenotype, and 
each individual oligodendrocyte maintains more myelin sheaths in the presence of 
supernumerary axons.  
Additionally, each oligodendrocyte that myelinates Mauthner axons covers 
essentially twice as much axonal length in notch1a MO versus WT animals, with a 
(non-significant) trend towards a longer length in hoxb1b mRNA-injected animals 
(Figure 4.11 C). 
I have shown that the total perimeter of Mauthner axons in notch1a MO and hoxb1b 
mRNA-injected animals is greatly elevated when compared to WT Mauthner axons. 
Additionally, the thickness of their myelin sheaths is roughly similar, and other 
axons are normally myelinated. Collectively, these data indicate that in the presence 
of supernumerary Mauthner axons, each individual oligodendrocyte makes an 
increased amount of total myelin.  
The individual oligodendrocytes analyzed here presented the stereotyped 
morphology of Mauthner-dedicated oligodendrocytes described previously in WTs. 
Mauthner axons have unusual anatomical features: their prominently large axonal 
calibre, for instance, but also the fact that they are continuously myelinated along 
their length, without the unmyelinated gaps that are nodes of Ranvier. We never 
observed these features in any other axons in the zebrafish spinal cord. I therefore 
considered the hypothesis that these ventral oligodendrocytes represent a specific 
subtype of Mauthner-dedicated oligodendrocytes. I wondered if other 
oligodendrocytes in the spinal cord could also be affected by the presence of 




Figure 4.11 - Individual oligodendrocyte myelinating capacity at 9 dpf. 
(A) Single mbp:EGFP-CAAX+ oligodendrocytes myelinating Mauthner axons in 9 dpf 
larvae present similar morphologies to 5dpf  
(B) Quantification of the diversity of morphologies of oligodendrocytes that myelinate 
Mauthner axons, at 9dpf. 5dpf difference is maintained. See text for details.  
(C) Total length of myelin sheaths formed along Mauthner axons per oligodendrocyte, at 
9dpf. Error bars represent standard deviation. 
WT: 193.9±55.7 µm (N=16 cells); notch1a MO: 418.8±95.0 µm (N=13), p<0.0001 in t-test; 
hoxb1b mRNA: 249.4±107.2 µm (N=6), p=0.3289 in Mann-Whitney test.  
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4.3.11 Axons regulate the localization of oligodendrocyte myelin 
sheaths 
 
I next investigated whether the myelinating capacity of oligodendrocytes can be 
regulated only by their normal target axons, or alternatively, whether all 
oligodendrocytes are plastic and responsive to axonal cues. In other words, can axons 
regulate the myelinating capacity of any oligodendrocyte? To address this I 
examined the morphology of other oligodendrocytes in the spinal cord of zebrafish 
with supernumerary Mauthner axons. 
 In these animals, I readily observed some dorsal oligodendrocytes that extended 
processes ventrally and ensheathed large segments of the Mauthner axons, in 
addition to smaller-diameter axons. In contrast, in WTs, dorsal oligodendrocytes 
typically myelinate only smaller-diameter dorsal or medial axons (Figure 4.12, and 
cell d in Figure 4.2). Furthermore, I readily observed ventral oligodendrocytes that 
myelinated the supernumerary Mauthner axons in addition to other small diameter 
axons (Figure 4.12, arrow). This happened only rarely in WTs. These features were 
observed at both 5 and 9 dpf, which indicates that this was not a transient 
phenomenon.  
These results indicate that axons are capable of regulating not only the myelinating 
capacity of those oligodendrocytes that typically associate with them, but can also 
influence the localization and extension of sheaths belonging to oligodendrocytes 
located more distally in the spinal cord.  
Together, my data suggests that oligodendrocytes are highly plastic in the sense that 
each individual cell is not destined to myelinate only one particular subtype of axon. 
When the axonal environment is drastically challenged, they can recognize many 







Figure 4.12 - Individual oligodendrocytes readily myelinate supernumerary Mauthner 
axons and smaller calibre axons. 
(A) Lateral view of single mbp:EGFP-CAAX+ oligodendrocytes located in the dorsal spinal 
cord, in 5dpf larvae. In WT, these tend to myelinate smaller diameter axons located in the 
dorsal spinal cord. In larvae with supernumerary Mauthner axons, many dorsal 
oligodendrocytes extend processes ventrally to myelinate large segments of the additional 
Mauthner axons (brackets). Often, this occurs concomitantly with myelination of other 






In this Chapter, I investigated whether later stages of the development of 
oligodendrocyte-lineage cells, such as the timing of terminal differentiation and the 
extent of myelination could be regulated by axons. I addressed this issue by two 
approaches, an axonal “loss-of-function”, whereby target axonal surface was 
reduced, and an axonal “gain-of-function”, whereby the target axonal surface was 
increased. 
 
4.4.1 Decreased axonal surface 
Following a slight decrease in proliferation and survival of oligodendrocyte-lineage 
cells, the posterior spinal cord of kbp mutants presents with about 75% of the normal 
number of oligodendrocytes. Strikingly, however, the axonal surface in the ventral 
spinal cord is reduced to 20% of WT levels. This suggested that oligodendrocyte-
lineage cells might exist in excess of their target axonal surface in the posterior 
spinal cord of mutants, and I proceeded to analyse if this altered axonal environment 
could affect myelination by those cells. 
I first resorted to a mosaic label for OPCs that allowed me to track individual cells as 
they transition into differentiation (Figure 4.1). A priori, one could expect that in the 
absence of reticulospinal axons, OPCs could simply remain latent, waiting until other 
axons became competent for myelination. I found that despite the drastically altered 
axonal environment, OPCs differentiated on schedule, supporting previous in vitro 
studies of an intrinsic mechanism within OPCs that regulates the number of their 
divisions and their timing of differentiation (Gao, Apperly et al. 1998, Durand and 
Raff 2000). 
I subsequently determined that oligodendrocyte-lineage cells in the mutant associated 
with their normal axonal targets (Figure 4.2). Since a large proportion of ventral 
axonal surface is missing, one could have expected that ventral oligodendrocytes 
would divert their processes and myelin sheaths towards more distal tracts, such as 
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the dorsal tract, or towards motor axons. However, the proportion of 
oligodendrocytes that did this in the mutant was not drastically different from WT.  
Given the observations above, if there truly is an excess of oligodendrocyte-lineage 
cells, then each cell must make less myelin to adapt to the reduced axonal surface. In 
principle, they could do this in two manners: by elaborating fewer sheaths and/or by 
making shorter sheaths.  
I determined that the number of sheaths made by individual oligodendrocytes was 
not significantly different in the anterior spinal cords. In the posterior spinal cord, I 
observed a trend towards fewer sheaths. This was a significant difference in ventral 
oligodendrocytes in particular (Figure 4.3). Therefore, a small reduction in the 
number of sheaths contributes to the adaptation of excess oligodendrocytes towards a 
reduced axonal surface. A small reduction of 3 sheaths on average per 
oligodendrocyte might be a relevant contribution towards that adaptation, if it occurs 
in every oligodendrocyte in the region. 
In addition, strikingly, I observed that the average length of each myelin sheath was 
significantly reduced in the posterior spinal cord, as well as the combined length of 
myelin sheaths per oligodendrocyte. This would imply that a reduced axonal surface 
could present fewer signals that promote extension of myelin sheaths, thereby 
regulating the amount of myelin each oligodendrocyte makes. However, even if this 
is occurring in the posterior spinal cord, it is not the only cause of this phenotype, 
because I also observed a reduction in sheath length in the anterior region of the 
spinal cord, where reticulospinal axons are present. There are a number of possible 
explanations for a reduction in myelin sheath length in the anterior spinal cord: 
a) There may be a smaller number of neurons that project potentially smaller axons 
along the anterior spinal cord, whose outgrowth is also affected by the genetic 
ablation of kbp. Disruption to these axons might have escaped the relatively low-
resolution immunohistochemical analysis presented in Figure 3.1 in Chapter 3, but 
could still contribute to a reduction in target axonal area. A careful high-resolution 
analysis of electron micrographs of transversal sections of the anterior spinal cord 
will be essential to investigate this possibility. 
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b) Alternatively, it is possible that kbp function is required in axons for sheath 
growth. For instance, every axon, including those in the anterior spinal cord, may 
have actively stopped growing due to the global lack of kbp. In addition to its 
obvious role in reticulospinal axon outgrowth, KBP may generally be required in 
every axon to promote its basal growth as the animal itself grows. Such an effect 
would be less obvious than the clear reticulospinal axon disruption. If 
oligodendrocyte myelin sheaths require signalling from actively growing axons to 
elongate, then sheaths everywhere in the kbp mutant spinal cord would not grow, and 
remain smaller. Alternatively, KBP could be responsible for transporting a sheath-
growth promoting factor along the axon. Testing these hypotheses would require 
restoring wildtype KBP function solely to axons, which would rescue the phenotype 
in the anterior region. 
c) A third alternative hypothesis is that kbp is required in oligodendrocytes for 
myelin sheath elongation. For instance, KBP could normally promote the transport of 
components of the growing myelin sheaths along oligodendrocyte processes. kbp is 
disrupted in every cell in mutant larvae, including oligodendrocyte-lineage cells. 
Therefore, myelin sheaths in the anterior as well as posterior spinal cord would not 
grow as much as in WT. Testing this hypothesis would require restoring wildtype 
kbp function solely to oligodendrocyte-lineage cells, which would rescue the 
phenotype in the anterior region. 
I will later outline a strategy to address these hypotheses. 
I further made the remarkable observation that neuronal somas were ensheathed by 
oligodendrocyte membrane in the spinal cord of kbp mutants (Figure 4.4). These 
rather unusual ensheathments seemed to occur at a very low level in WT larvae. A 
search of the literature reveals many reports of ensheathed or myelinated perikarya:  
in fish (Roberts and Ryan 1976, Kemali and Miralto 1979), amphibians (Rosenbluth 
1966, Kemali and Sada 1973), in chicken (Hess 1965), rodents (Blinzinger, Anzil et 
al. 1972, Hamori, Lakos et al. 1980), cats (Hamori and Silakov 1981),  primates 
(Beal and Cooper 1976, Cooper and Beal 1977, Tigges and Tigges 1980), and 
humans (Suyeoka 1968, Braak, Braak et al. 1977). Interestingly, some of these report 
such features following deafferentiation of the areas examined, suggesting that 
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synaptic input may regulate such aberrant myelination. In any case, it is clear that 
these represent a rare feature that occurs at a very low level in a wildtype situation, 
suggesting the existence of mechanisms that ensure it will mostly not happen during 
development. For instance, somas could display a repulsive cue on their surface, 
whereas axons could display an attractive signal for oligodendrocyte-lineage cells.   
Interestingly, in some instances of WT ensheathed somas, I observed retraction of 
these profiles between 60-96hpf, suggesting the existence of a correction mechanism. 
In mutants, however, these profiles were much more frequent, and I never observed 
any retraction. This suggests that such a correction mechanism is defective in 
mutants, or that it is not sufficient to cope with an increased number of such profiles.  
At first, I thought these profiles could represent one way for oligodendrocyte-lineage 
cells to adapt to the reduced axonal surface present in the milieu: maybe their 
processes were diverted towards neuronal somas if they couldn’t find enough axonal 
targets. This would suggest that neuronal somas are not as repulsive to 
oligodendrocytes as incorrect axons are, since no incorrect axons were myelinated in 
the posterior spinal cord. It would also suggest that oligodendrocytes have a 
minimum amount of myelin that they must make, even if it is on unusual structures 
such as cell bodies. 
However, I subsequently observed that such profiles were also more frequent in the 
anterior spinal cord of kbp mutants. Therefore, similarly to the previous phenotype 
on sheath number per oligodendrocyte, while it remains possible that a decreased 
axonal surface contributes to the formation of ensheathed cell bodies in the posterior 
spinal cord, it is likely that the global lack of kbp in these mutants plays a role. For 
instance, KBP itself could be required in neurons to promote transport of an 
attractive cue to the surface of axons, or alternatively to promote the transport of a 
repulsive cue to the surface of soma and dendrites. In global kbp mutants, 
oligodendrocytes would be able to ensheath neurons in the anterior and posterior 
spinal cord that do not appropriately localize such signals. I will later outline a 
strategy to address the cell autonomy of this phenotype. 
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What is the fate of these ensheathed neurons? Are they functional? It will be very 
interesting to determine the molecular pathways that regulate the formation of these 
profiles, and what ensures they generally do not occur. 
Short-term future directions 
In the short-term, it will be important to disentangle which phenotypes observed in 
the kbp mutant larvae are due to the decrease in axonal surface, and which are due to 
an actual loss of kbp function. A starting point will be to accurately determine at 
single-cell resolution which cell types express kbp in the anterior and posterior spinal 
cord. Specifically, it will be important to determine whether oligodendrocyte-lineage 
cells express kbp in situ, since if they do, they too will be affected by the lack of kbp 
function in the global knockout mutant. 
Furthermore, I have generated a rescue construct, GFP-2A-KBP, in which I fused the 
GFP coding sequence to wildtype kbp cDNA, with the sequence coding for the short 
self-breaking peptide 2A inbetween. Expression of this construct results in a 1:1 
stoichiometric ratio of GFP (labelling the expressing cell) and of wildtype KBP, as 
the 2A peptide undergoes a proteolytic cleavage event during translation. I have 
generated transgenes in which I have placed this construct under the control of the 
huC promoter, which drives its expression in all neurons, and separately also under 
the control of the sox10 promoter, which drives its expression in oligodendrocyte-
lineage cells. I verified that the sox10:GFP-2A-KBP transgene is expressed in 
oligodendrocyte-lineage cells, and that the HuC:GFP-2A-KBP transgene is expressed 
in neurons. Furthermore, I verified that expressing this construct in kbp mutant 
animals rescues the axonal outgrowth of neurons in the posterior lateral line in the 
PNS, which are also affected in these mutants (Figure 4.13), proving that this 
construct is functional in vivo. I have microinjected these constructs in newly 
fertilized eggs of a cross between adult kbpst23/+ heterozygous animals, which are 
now being raised as potential founders. These founders will allow me to generate 
stable transgenic lines in which all of the relevant cells express the transgene.This 
will allow me to restore wildtype KBP function solely to neurons or solely to 
oligodendrocyte-lineage cells in kbp mutant animals, which will help clarify the 




Figure 4.13 – Rescue strategy using GFP-2A-KBP constructs 
(A) Posterior spinal cord and posterior lateral line (pLL) of a 5dpf sox10:mRFP kbp mutant 
larva. Brackets indicate the typical disruption to myelination in the ventral spinal cord. 
Usually, pLL axon outgrowth is more severely disrupted than reticulospinal axon outgrowth 
and pLL axons and myelin are only detectable in a very anterior region. However, this larva 
expresses GFP-2A-KBP in some pLL neurons, which rescued their axonal outgrowth and 
myelination by Schwann cells.  
(B) High magnification of the area boxed in A. Four rescued pLL axons grow into the 
posterior region of the larva (arrowheads indicate three low GFP expressing axons).  
(C) Genotyping assay for the larva depicted in A and B (“#1”). kbpst23 genomic DNA yields 
a PCR product not cleaved by MaeIII, unlike the WT product, which is cleaved into a lower 




I observed that some phenotypes affected only the posterior spinal cord of mutants 
but not the anterior, and therefore could be attributed to a decreased in axon-derived 
signals – particularly, impaired OPC survival (see Chapter 3). OPC proliferation was 
also decreased in the posterior spinal cord; however, I didn’t specifically measure 
this parameter in the anterior spinal cord. Even if mature oligodendrocyte number 
was normal in the anterior spinal cord later on, I cannot formally exclude that OPC 
proliferation was altered in the anterior spinal cord of mutants. For these phenotypes, 
the HuC:GFP-2A-KBP transgenic line should provide a rescue experiment – it 
should restore axonal outgrowth, which should abolish the aforementioned 
phenotypes only if the reduction in target axonal area is the primary cause of these 
phenotypes. In this line, oligodendrocytes remain kbp-. Conversely, the sox10:GFP-
2A-KBP should not rescue these phenotypes, since the axonal outgrowth defect 
should still be present. 
Additionally, these rescue transgenic lines will allow me to resolve the cell autonomy 
of those phenotypes that I observed both in the anterior and posterior spinal cord of 
kbp mutants. If KBP functions in oligodendrocytes to promote sheath extension (for 
instance, by promoting transport of myelin components), in kbp mutants, this 
transport would be disrupted and sheaths would be smaller throughout the animal. 
kbp mutants crossed into the transgenic line sox10:GFP-2A-KBP will have KBP 
function restored in their oligodendrocytes, and this phenotype should disappear. 
Conversely, mutants crossed into the transgenic line HuC:GFP-2A-KBP which have 
KBP function restored only to neurons should still present with the phenotype.  
KBP may function in neurons to localize a signal attractive to OPCs to the axon, 
directing OPCs away from the soma and dendrites. kbp mutant neurons would not 
localize this signal adequately and OPCs would be able to ensheath somas. kbp 
mutants crossed into the transgenic line HuC:GFP-2A-KBP will have KBP function 
restored in their neurons, and this “myelinated soma” phenotype should disappear. 
Conversely, mutants crossed into the transgenic line sox10:GFP-2A-KBP which 
have KBP function restored only to oligodendrocyte-lineage cells should still present 






Figure 4.14 – Single mbp:EGFP-CAAX+ oligodendrocytes, example of a blastula-stage 
transplant experiment  
(A) Lateral views of 4 dpf larvae, offspring of kbpst23/+ incross. These larvae, which include 
wildtype, heterozygous and kbp mutant larva, served as hosts for a transplant experiment in 
which I transplanted blastula stage cells from a Tg(mbp:EGFP-CAAX) embryo (kbp+/+). All 
EGFP-CAAX+ cells originated from the wildtype host. When transplanted into a probable 
mutant host (*=pending genotyping), oligodendrocytes still elaborate fewer and shorter 
myelin sheaths, both in the anterior and posterior spinal cord, suggesting a non-cell 




Another strategy to address the cell autonomy of these phenotypes is to use blastula 
stage transplants. In this approach, I transplant uncommitted cells at the blastula 
stage from a wildtype donor embryo into a mutant host embryo, which results in a 
chimeric animal with sparse wildtype cells interacting with a majority of mutant 
cells. For instance, I can analyse the morphology of individual oligodendrocytes 
from a wildtype mbp:EGFP-CAAX+ donor embryo in an environment composed 
mostly of mutant neurons and glia in a mutant host embryo that does not carry the 
transgene Tg(mbp:EGFP-CAAX). Any EGFP-CAAX+ cells are per force 
oligodendrocytes derived from the wildtype donor and have normal KBP function, 
whereas most neurons and axons will lack KBP function. Preliminary results from 
such an experiment indicate that wildtype oligodendrocytes transplanted into a 
mutant embryo form few and short sheaths (Figure 4.14), suggesting that wildtype 
levels of KBP in oligodendrocytes are not sufficient to ensure normal sheath length, 
and that KBP function is required non cell autonomously to promote sheath growth 
(possibly, in neurons). 
 
Collectively, such findings may provide fairly novel insight into the role of 
cytoskeleton-associated proteins, such as KBP, in oligodendrocyte biology.  
 
4.4.2 Increased axonal surface 
I additionally challenged the oligodendrocyte-lineage cell population by artificially 
increasing the amount of target axonal surface. I generated animals that instead of 
one Mauthner axon on each side of the spinal cord presented with 2-7 on each side, 
in two independent genetic manipulations (Figure 4.5). In both instances, I found that 
oligodendrocyte-lineage cells recognized, ensheathed and robustly myelinated all of 
the supernumerary axons (Figure 4.6 and 4.7). It remains formally possible that 
additional Mauthner axons that did not get myelinated could have remained very 
small or degenerated, but I did not observe signs of degeneration in electron 
micrographs. My results show that I could at least triple the Mauthner axonal surface 
on each side of the spinal cord without detriment to the myelination of nearby axons, 
at least at 9dpf (Figure 4.8). 
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I investigated by which mechanism oligodendrocyte-lineage cells adapted to the 
increased axonal surface. I found that it was not due to an increase in the size of the 
oligodendrocyte population (Figure 4.9), and instead that it was due to an increase in 
the myelin production of each individual oligodendrocyte (Figures 4.10 and 4.11). 
This may at first appear at odds with the results described in Chapter 3, in which the 
opposite manipulation (removing reticulospinal axons) decreased the number of 
oligodendrocyte-lineage cells. However, it should be noted that in the kbp 
manipulation, the entirety of reticulospinal axons are missing, leading to an 80% 
decrease in axonal surface in the ventral spinal cord at 3dpf. Instead, the notch1a 
MO/hoxb1b mRNA  manipulation only significantly increased the number of 
Mauthner axons – in fact, the number of neighbouring myelinated axons is not 
significantly changed in animals injected with notch1a MO or hoxb1b mRNA at 9dpf 
(Figure 4.8 B). Therefore, this is likely to represent a comparatively smaller 
manipulation. The total number of axons in the spinal cord in this manipulation 
might not be drastically altered; it is the number of the very first targets for 
myelination that is, which happen to be of a large-calibre. This may mean a very 
localized increase in axon-derived juxtacrine or paracrine signaling in the ventral 
spinal cord. An earlier study on mice with twice as many RGC axons in the optic 
nerve as normal found an increased number of oligodendrocytes, due to an increase 
in OPC survival and proliferation (Burne, Staple et al. 1996). However, as discussed 
in Chapter 3, the interpretation of results from that study could have been 
confounded by technical limitations. Additionally, my manipulation may simply be a 
qualitatively different manipulation than doubling of total number of axons in the 
nerve, which may have more significantly increased the amount of secreted factors, 
for instance. My manipulations, rather than eliciting large changes in 
oligodendrocyte population size, seem to have deployed a finer means of regulation 
of the myelinating capacity of the oligodendrocyte population.  
Furthermore, in the results described in Chapter 3, the axonal regulation of the 
oligodendrocyte-lineage cell population size occurs by modulating the proliferation 
of OPCs and/or survival of OPCs or oligodendrocytes. It is thought that an excess of 
OPCs competes for limited amounts of pro-survival neurotrophic factors, derived 
from axons in the milieu, and this roughly matches oligodendrocyte number with 
183 
 
target axonal surface (Barres and Raff 1999). However, as discussed in Chapter 3, no 
developmental apoptosis of OPCs was observed in the WT zebrafish spinal cord, 
unlike in other vertebrates. It may be that there is no surplus of OPCs competing for 
axon-derived survival signals in WT zebrafish larvae, if the number of OPCs 
generated is already matched to the axonal surface available. Therefore, my 
manipulation increasing axonal surface and potentially contact-dependent survival 
signals should not increase the number of such competing OPCs further, as no excess 
of OPCs exist in the first place that would die. In regards to OPC proliferation, it 
should be noted that in kbp mutants, the observed proliferation effect was small even 
when removing the entirety of reticulospinal axons. Therefore, increasing only the 
number of Mauthner axons might have had an even smaller effect which may have 
gone undetected, as I focused on the number of oligodendrocytes at 5dpf, and did not 
investigate the number of OPCs.  
My results indicate that the typical ventral oligodendrocytes that associate with 
Mauthner axons are plastic and able to adapt to the axonal environment, since 
supernumerary Mauthner axons were able to induce these oligodendrocytes to make 
more and longer myelin sheaths - that is, they greatly increased their myelinating 
capacity (Figures 4.10 and 4.11). These oligodendrocytes typically maintain only one 
long myelin sheath on the Mauthner axons, of a large calibre, reminiscent of the 
oligodendrocyte type IV described by Pio del Rio-Hortega almost 100 years ago 
(Río-Hortega 1928). However, Mauthner axons are rather unusual axons – in 
addition to their very large calibre, they do not possess nodes of Ranvier. It is 
thought that synaptic boutons at axon collaterals serve the purpose of regenerating 
the Mauthner action potential in other fish species (Funch and Faber 1980, Greeff 
and Yasargil 1980, Yasargil, Greeff et al. 1982). In cross section, these axon 
collaterals and synapses interrupt the myelin sheath, resulting in a partially 
surrounded axon in cross section, another distinctive feature. We have further 
observed, for instance, that the ends of adjacent Mauthner-associated myelin sheaths 
often overlap and interdigitate, rather than forming precise internodes flanked by 
unmyelinated gaps. These rather unique microanatomical features hinted that the 
ventral subset of oligodendrocytes that myelinate the unique Mauthner axon could be 
a distinct subtype of oligodendrocytes. A plastic subset, but nonetheless, such 
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plasticity could be their specific property, rather than a general characteristic of 
oligodendrocytes. In fact, even in our analyses of WT animals, we very occasionally 
observe Mauthner-dedicated oligodendrocytes that simultaneously associate with a 
smaller diameter axon, an arrangement which could be indicative of the plasticity of 
this subset. 
However, I then observed that even dorsal oligodendrocytes, which typically 
myelinate numerous dorsal or medial small-diameter axons, were also affected in the 
presence of supernumerary Mauthner neurons (Figure 4.12). Many dorsal 
oligodendrocytes in these animals were observed to extend processes ventrally and 
myelinate large segments of the supernumerary Mauthner axons, in addition to 
smaller-diameter axons. I have not observed such an arrangement in WT animals. 
This demonstrates that Mauthner axons can also locally induce the ensheathment, 
synthesis and maintenance of myelin sheaths made by oligodendrocytes that 
otherwise would not associate with them.  
 
4.4.3 Conclusions 
My aim was to address how the morphological diversity of oligodendrocytes arises 
during development: whether distinct types of morphologies represent distinct 
intrinsic programs of development within oligodendrocyte-lineage cells, or whether 
all of these cells are initially plastic, and axons regulate the development of their 
final morphology. I found that axons can regulate the extent of oligodendrocyte 
myelination and can also locally promote sheath formation and myelin biosynthesis. 
Could these two aspects be related? In principle, the signalling stimulating myelin 
synthesis could also be responsible for the increase in the extent of myelination of 
the whole cell. Given that some structural components are locally synthesized from 
mRNAs, and assuming that delivery of the remaining components from the cell is 
not rate-limiting in a physiological range, it is possible that the increase in 
myelination extent is simply the byproduct of the action of the axonal molecules that 
locally interact with OPC membrane and promote myelin biosynthesis. Which 
molecules might this be? It is clear that they must act at close-range, likely in a 
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juxtacrine fashion, presented in the axonal surface. The obvious candidate is 
Neuregulin-1, as mentioned in Chapter 1; however, it must act in redundancy with 
other signals, given that its genetic ablation from the CNS does not cause a drastic 
myelination phenotype (Brinkmann, Agarwal et al. 2008, Perlin, Lush et al. 2011). 
An elegant in vitro study proposed that neurotransmitter release at axon-OPC 
synapses plays a major role in stimulating local translation of mbp mRNA and 
myelin synthesis via activation of the Fyn kinase signalling cascade in 
oligodendrocyte-lineage cells (Wake, Lee et al. 2011). While the identity of the 
signalling pathways underlying such regulation remains to be directly verified in 
vivo, our own work has identified a role for synaptic vesicle release in promoting the 
extension of myelin sheaths during developmental myelination in the zebrafish 
embryonic spinal cord (Mensch 2014). We have also previously shown that 
activating Fyn kinase in oligodendrocytes does indeed promote the generation of 
myelin sheaths in vivo, while downregulating it decreases the number of sheaths 
generated by oligodendrocytes (Czopka, Ffrench-Constant et al. 2013), so at least 
that part of the signalling cascade could be correct.  
 
In sum, I have unambiguously demonstrated, in vivo, that axons can regulate the 
myelinating capacity of oligodendrocytes, which can operate at a larger capacity than 
they do in a normal situation; and that axons can locally promote sheath formation 
and myelin biosynthesis, in a process specific manner. These findings raise a number 













5. Intersectional expression of genes of 





While investigating the role of axons during oligodendrocyte-lineage cell 
development and myelination, I sought to live-image OPCs. There is not currently a 
transgenic line that specifically labels OPCs in the spinal cord. A fragment of the 
sox10 promoter drives expression in oligodendrocyte-lineage cells, but also in a 
subset of dorsally-located neurons in the spinal cord, and other neural-crest derived 
cells outwith the spinal cord. A large portion of the olig2 regulatory sequence drives 
expression in oligodendrocyte-lineage cells but also in pMN progenitors and 
terminally differentiated motor neurons. Thus, neither the olig2:GFP transgenic line 
nor the sox10:mRFP line specifically labels oligodendrocyte-lineage cells in the 
spinal cord. However, oligodendrocyte-lineage cells are the only subset of cells that 
specifically express both sox10 and olig2 (motor neurons do not express sox10, and 
the dorsal sox10+ neurons do not express olig2). Therefore, in the double transgenic 
line Tg(olig2:GFP; sox10:mRFP), oligodendrocyte-lineage cells, from an OPC stage, 
are the only double labelled cells, which allowed me to unambiguously identify 
OPCs. However, since I required two separate channels for the imaging of this line, I 
was limited in the number of possible combinations with other relevant transgenic 
lines, which all use green or red fluorescent proteins. I could not, therefore, combine 
imaging of OPCs with oligodendrocytes, or imaging of OPCs with axons. To attempt 
to overcome this difficulty, I adapted a strategy of combinatorial expression that 
would allow me to express a gene-of-interest (GOI), such as GFP, under the control 
of two different promoters. Although I eventually would not use this tool in my own 
experiments, the tool works, and may be used in other contexts. I therefore describe 
here my adaptation of the Drosophila Split Gal4 system for combinatorial expression 




  Introduction 5.1
 
Ectopic expression of genes-of-interest (GOI) in cells is fundamental for 
understanding the function of genes and the biology of cells. Driving ectopic 
expression of a fluorescent protein, for instance, illuminates the target cells’ 
morphology, origin, differentiation and behaviour (Zhang, Campbell et al. 2002). 
Driving expression of calcium indicators or optogenetic tools permits interrogation 
or manipulation of the physiological state of the target cell (Fenno, Yizhar et al. 
2011). Driving expression of a particular mutant allele of a gene helps elucidate its 
relevance in the specification, development or function of target cells or tissues 
(Elliott and Brand 2008). Recently, in an effort to systematically generate mutations 
in each protein-coding gene of the zebrafish genome, it was determined that over 
80% of nonsense or essential splice mutations, representing over 1200 genes, have 
no obvious morphological or behavioural phenotype within 5dpf(Kettleborough, 
Busch-Nentwich et al. 2013). Functional data for many of these genes may arise 
from studies resorting to ectopic expression of their wildtype and mutant forms.   
One manner in which to direct GOI expression to a target cell is by fusing the GOI 
coding sequence to a regulatory element (such as a promoter fragment) known to be 
expressed in the target cell type. The resulting construct is used to generate 
transgenic animals and their offspring assessed for fidelity of expression of the GOI, 
in a pattern similar to that of the endogenous gene.  
An alternative manner is to resort to the use of already existing Gal4/UAS transgenic 
lines. The bipartite Gal4/UAS system is a genetic tool amply used in Drosophila 
(Elliott and Brand 2008) and in zebrafish (Davison, Akitake et al. 2007, Halpern, 
Rhee et al. 2008) to drive GOI expression in particular cell types (Figure 5.1 A). A 
Gal4 driver line expresses the yeast transcription factor Gal4 under the control of a 
regulatory sequence that drives its expression in a known pattern. It is crossed with a 
UAS effector line, where an upstream activating sequence (UAS), specifically 
recognized by Gal4, is cloned upstream of GOI. Directed expression occurs in the 
double transgenic offspring of crosses between driver and effector lines. An 
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advantage of this system is that a variety of Gal4 driver lines already exist, targeting 
expression in different tissues, or targeting expression in a ubiquitous manner but 
under the temporal control of the heatshock promoter hsp70. Researchers can build a 
simple UAS effector line with the GOI coding sequence, and combine it with already 
characterized lines. Similarly, a variety of UAS effector lines already exist. This 
system provides an enormous versatility of manipulations(Elliott and Brand 2008). 
For instance, it allows:  
a) analysis of a single GOI in different tissues and at different time points;  
b) testing gain- or loss-of-function alleles 
c) rescue experiments in mutant animals by reconstituting wildtype or 
downstream effector expression; 
d) temporal control over the expression of toxic proteins or functional 
modulators (such as optogenetic tools).  
A striking limitation of both of these approaches, however, is that GOI expression is 
ultimately under the control of a single promoter, which may not achieve the 
required specificity. In fact, existing Drosophila or zebrafish Gal4 lines, whether 
enhancer-trapped or genetically engineered to be driven by a known promoter, rarely 
confine expression to a single cell type(Suster, Seugnet et al. 2004, Bohm, Welch et 
al. 2010). This may preclude the analysis of cell autonomous effects of GOI, for 
instance, or may not enable visualization of a particular cell type with the specificity 
necessary, if related or nearby cell types also express a reporter protein.  
In order to overcome this limitation, ternary systems such as the SplitGal4 system 
have been developed (Figure 5.1 B)(Luan, Peabody et al. 2006, Pfeiffer, Ngo et al. 
2010). This system takes advantage of the modularity of Gal4, and encodes its DNA-
binding domain separately from its activation domain, in so called ”hemidrivers”. 
Each hemidriver is encoded under the control of a different promoter. Therefore, 
only in those cells in which both promoters are active at the same time will the 
protein for both hemidrivers be produced. Fusion of each hemidriver to a 
heterodimerizing leucine-zipper ensures that if and when co-expression happens, the 
two parts dimerize and reconstitute a functional Gal4. This in turn binds and 
activates expression from an UAS-sequence.   
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This allows GOI expression in the intersection of two expression patterns, when a 
single promoter does not provide enough specificity. It can also be used to 
temporally control ectopic expression in the target cells by combining a cell-type 
specific promoter with the heat-shock promoter, hsp70. One other use of the split 
Gal4 system is to dissect the expression pattern of complex promoters by iterative 
combinations with more specific enhancers.  
Here, I describe an adaptation of the Split Gal4 system for use in zebrafish, which I 
term Split KalTA4, since I based it on the optimized version of Gal4, KalTA4 
(Distel, Wullimann et al. 2009). I provide an example where its use allowed the 
dissection of a complex expression pattern by restricting reporter expression to 





Figure 5.1 – Gal4 vs Split Gal4 system:  
(A) Gal4 system: the gal4 gene encodes the intact transcription factor including DNA-
binding domain (DBD) and the activation domain (AD) in a single ORF, under one promoter 
(prom). Whole Gal4 protein (blue) binds UAS in another transgene and activates 
downstream GOI transcription (pink arrow).  
(B) Split Gal4 system: one transgene encodes Gal4 DBD hemidriver under one promoter 
(P1) and a separate transgene encodes Gal4 AD hemidriver under a different promoter (P2). 
When and where both promoters are active, the two domains assemble, due to a 
heterodimerizing leucine zipper, and reconstitute Gal4 function, activating transcription from 





5.2.1 Design of Split KalTA4 hemidrivers 
In order to generate a conditional expression system in zebrafish where GOI are 
expressed in the intersection of the expression patterns of two regulatory sequences, I 
adapted the split Gal4 system developed in Drosophila (Luan, Peabody et al. 2006). 
In this system, the DNA binding domain (DBD) and the activation domain (AD) of 
the transcription factor Gal4 are encoded in separate genes (“hemidrivers”), which 
can be under the control of different promoters. Each domain is not functional on its 
own, but when co-expressed in the same cell, they reconstitute Gal4 function and 
activate expression of UAS-driven transgenes. To facilitate heterodimerization and 
assembly of a functional transcription factor, (Luan, Peabody et al. 2006) fused a 
heterodimerizing leucine zipper to each hemidriver, and optimized the type of zipper 
used, as well as its site of fusion and length of the spacer (Figure 5.1C). I designed 
hemidrivers based on the original sequences, splitting instead KalTA4, a version of 
Gal4 optimized for zebrafish (Distel, Wullimann et al. 2009). Kalta4 shows a number 
of optimal modifications compared to Gal4: it includes a strong Kozak sequence; 
codon usage optimized for zebrafish expression, and instead of the entire VP16 
activation domain, (Distel, Wullimann et al. 2009) used attenuated repeats of the 
VP16 core sequence, TA4. TA4 is similarly potent in transgene activation as VP16 
and less toxic. I used the sequence encoding residues 1-147 of KalTA4 for the DBD 
hemidriver, and encoding residues 154-192 for the TA4 hemidriver. I added the 
remaining features by extension PCR. In addition to the decaglycine spacer and the 
heterodimerizing leucine zippers, I changed the original nuclear localization signal 
sequence of the AD hemidriver to the shorter SV40 nls sequence. I also included the 
strong Kozak sequence used in KalTA4 in both hemidrivers, and also optimized 
codon-usage in the remaining features of the hemidrivers for expression in 
zebrafish (Figure 5.2D). In my constructs, only the plasmids encoding the intact 
KalTA4 (positive control) included the rabbit beta-globin intron downstream of the 
coding sequence, which is a modification reported to increase expression originally 





Figure 5.2 – Structure of Gal4, KalTA4, Split Gal4 and Split KalTA4 hemidrivers:  
(A-B) A single gene encodes Gal4, or KalTA4.  
(C-D) Two separate genes encode each hemidriver of Split systems.  
K: Kozak sequence; ATG: start codon; TAG: stop codon; zf: zebrafish-optimized sequence; 
Zip+/-: heterodimerizing leucine zipper; nls: nuclear localization signal; gly: 10x glycine 
linker. Number under each feature indicates size in amino acid residues.  
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5.2.2 Expression of both hemidrivers is required to transactivate a 
reporter transgene in vivo 
I generated synthetic mRNA of each hemidriver and of intact KalTA4. To test 
whether split KalTA4 worked as expected, I injected mRNA into Tg(UAS:kaede) 
fertilized eggs. Injection of mRNA results in ubiquitous expression throughout the 
early embryo, and the UAS sequence drives expression of the fluorescent protein 
kaede in this line. When mRNA for each hemidriver is injected alone, no expression 
of kaede is detected throughout the first days of development (Figure 5.3A; DBD: 
0/40 embryos; TA4: 0/60 embryos). When mRNA for both hemidrivers are co-
injected, expression of kaede is detected throughout the embryo from at least 24hpf 
(Figure 5.3B, at 48hpf, 20/31 embryos). Injection of intact KalTA4 mRNA similarly 
results in activation of kaede expression throughout the embryo (Figure 5.3C, 28/41 
embryos). UAS:kaede colony is maintained as a mixture of heterozygous and 
homozygous animals, thus the subset of non-fluorescent embryos likely does not 
contain the reporter transgene (similar in the positive control, intact KalTA4).  
To determine whether I could genetically target the hemidrivers, I first generated 
constructs where the coding DNA for each hemidriver is preceded by the histone 2-α 
promoter, which drives expression in many cell types (Kwan, Fujimoto et al. 2007). 
Similarly to the mRNA microinjections, only co-injection of h2α:DBD with 
h2α:TA4 or injection of the intact h2α:KalTA4 resulted in activation of the 
UAS:kaede reporter (0/20 embryos injected with h2α:DBD; 0/20 embryos injected 
with h2α:TA4; 29/35 embryos co-injected with h2α:DBD and h2α:TA4; and 23/45 
embryos injected with h2α:KalTA4). Thus, recognition of the UAS sequence and 






Figure 5.3 –Split KalTA4 hemidriver mRNA expression reconstitutes KalTA4. 
(A) Injection of DBD or TA4 mRNA alone doesn’t activate the reporter UAS:kaede.  
(B) Injection of both DBD and TA4 mRNA, or intact KalTA4 mRNA is sufficient to 





Figure 5.4 – Genetically targeted split KalTA4 hemidrivers activate UAS:kaede in 
several cell types with similar efficiency to intact KalTA4. 
(A) Split KalTA4 hemidrivers genetically encoded under the h2α promoter are ubiquitously 
expressed. Arrowhead points to expression in posterior lateral line (peripheral) neurons, 
brackets point to spinal cord (central) neurons, boxed areas are displayed at higher 
magnification in C.  
(B) Higher magnification of a Commissural Primary Ascending interneuron (top) and several 
muscle cells (bottom) expressing the reporter transgene.  
(C) Maximum pixel intensity in arbitrary units of 40 randomly selected cells in larvae 
injected with h2α:KalTA4 and 39 cells in larvae co-injected with h2α:DBD and h2α:TA4. 
No significant difference is found (130±65 AU in KalTA4 vs 111±65 AU in DBD+TA4, 




5.2.3 Split KalTA4 functions efficienty in many cell types 
The use of the quasi-ubiquitous h2α promoter and of DNA constructs (which results 
in sparser expression than mRNA injections) enabled me to identify by morphology 
and location the cell types expressing the reporter fluorescent protein kaede. I found 
that, like intact KalTA4, co-injections of the split KalTA4 hemidrivers resulted in 
kaede expression in both central and peripheral neurons (Figure 5.4A), muscle cells 
(Figure 5.4B), skin cells and notochord cells. Thus, the hemidrivers can 
heterodimerize and transactivate the reporter transgene in many cell types. I then 
wondered if reconstituted DBD+TA4 activated the reporter transgene with the same 
efficacy as intact KalTA4. I considered fluorescence intensity as a proxy for the level 
of UAS:kaede expression and thus transactivation efficiency. The maximum pixel 
intensity in randomly selected cells expressing kaede driven by split KalTA4 was 
similar to those in cells where kaede was driven by intact KalTA4 (Figure 5.4C). 
This suggests that the efficiency of Split KalTA4 transactivation of the transgene is 
similar to intact KalTA4 in vivo.  
 
5.2.4 Split KalTA4 restricts broad sox10 expression pattern 
The sox10 regulatory region drives expression of reporter genes in several cell types 
(Dutton, Antonellis et al. 2008). In the Tg(sox10:mRFP) line, a 7.2kbp fragment of 
the sox10 promoter drives expression of mRFP in neural crest, in myelinating glial 
cells and in a subpopulation of dorsal neurons in the embryonic spinal cord. OPCs 
(Figure 5.5A, asterisk) also co-express the transcription factor Olig2, unlike the 
sox10+ dorsal neurons (Figure 5.5A, arrowheads). To exclude the possibility that this 
expression pattern is specific to the Tg(sox10:mRFP) line due to positional effects of 
its transgene insertion, I generated a different stable transgenic line using the same 
sox10 promoter fragment, driving intact KalTA4. When crossed with the reporter 
UAS:kaede, sox10+ cells are mosaically labelled, allowing imaging of their 
morphology and unambiguous identification (Figure 5.5B). This confirmed that in 
the spinal cord, Sox10 is expressed in some dorsal neurons (Figure 5.5B, cell a), 
mature oligodendrocytes (cell b), OPCs (cell c), and in dorsal root ganglia (not 
shown). I observed labeling of the same cell types when I co-injected sox10:DBD 




Figure 5.5 – sox10+ cells in the embryonic and larval zebrafish spinal cord. 
(A) 48hpf Tg(olig2:GFP; sox10:mRFP) embryo, showing sox10:mRFP expression both in 
dorsal neurons (arrowheads) and in OPCs (asterisk, co-expressing olig2:GFP).  
(B) 4dpf Tg(sox10:KalTA4; UAS:kaede) larvae, showing sox10 expression in a neuron (a), 
mature oligodendrocyte (b) and OPC (c). Scalebars: 20µm.  
(C) Venn diagram of expression patterns of sox10 and other promoters specific to some of 




I wondered if I could use the split KalTA4 system to restrict expression of the 
reporter transgene to subtypes of sox10+ cells. Myelinating glial cells 
(oligodendrocytes in the spinal cord and Schwann cells in the periphery) also express 
mbp. Neurons express HuC (an RNA-binding protein used as a pan-neuronal marker 
(Park, Kim et al. 2000)). Additionally, many neurons in the zebrafish spinal cord 
express Contactin1b (Cntn1b) as judged by expression driven by a fragment of its 
promoter (Czopka, Ffrench-Constant et al. 2013). To label cells only in the 
intersection of these expression patterns (Figure 5.5C), I first generated hemidriver 
constructs using fragments of the promoter of the mbp, huC, sox10 and cntn1b 
genes. I then co-injected different combinations of the hemidrivers.  
When I co-injected mbp:DBD and sox10:TA4 hemidrivers in Tg(UAS:kaede; 
sox10:mRFP) fertilized eggs, I observed kaede expression only myelinating glial 
cells. I readily observed kaede+ Schwann cells in the posterior lateral line (pLL, 
Figure 5.6A, top), and in some oligodendrocytes in the spinal cord, but no extensive 
neuronal expression such as in Tg(sox10:KalTA4) or Tg(sox10:mRFP) animals.  
To further dissect the expression pattern of the sox10 promoter, I co-injected 
cntn1b:DBD with sox10:TA4 in Tg(UAS:kaede) fertilized eggs. In these larvae, I 
readily observed labelled neurons, particularly in the dorsal spinal cord (Figure 
5.6B), but no myelinating glial cells, confirming that the sox10+ neurons in the 
dorsal spinal cord also express contactin1b, and that the splitKalTA4 is able to 
restrict a broad expression pattern to its components. I also co-injected huC:DBD 
with sox10:TA4 in Tg(UAS:kaede; sox10:mRFP) fertilized eggs. Most labelled cells 
were neurons, and many of these occupied the dorsal position typical of sox10+ 
neurons; in addition, they co-localized with mRFP expression in the sox10:mRFP 





Figure 5.6 – Split KalTA4 restricts sox10 expression pattern in the larval zebrafish. 
(A) Spinal cord and pLL of 5dpf Tg(UAS:kaede; sox10:mRFP) larvae co-injected with 
mbp:DBD and sox10:TA4. Schwann cells and oligodendrocytes express the kaede reporter.  
(B) Dorsal neurons in the spinal cord of 4dpf Tg(UAS:kaede) larvae co-injected with 
cntn1b:DBD and sox10:TA4.  
(C) Dorsal neurons in the spinal cord of 3dpf Tg(UAS:kaede; sox10:mRFP) larvae co-
injected with HuC:DBD and sox10:TA4. Some sox10:mRFP+ neurons are also labelled by 





In sum, I have adapted a combinatorial expression system, Split Gal4, for use in the 
zebrafish, named Split KalTA4. In this ternary system, only cells in the intersection 
of two expression patterns reconstitute the transcription factor KalTA4. This permits 
the use of two distinct promoters to drive GOI expression only in the subset of cells 
in which both promoters are active. I showed that the modifications I inserted in the 
system work in living zebrafish. These include zebrafish-specific adaptations that 
were part of the KalTA4 optimization, including a substitution of the entire VP16 
activation domain for the minimal activation motif, TA4. The TA4 configuration of 
the core activation repeats can be replaced with configurations less efficient (TA6) or 
more efficient (TA2)(Baron, Gossen et al. 1997), providing an additional level of 
control of the expression of the GOI. 
I have also provided a specific example for the use of this system, in which I 
restricted a broad expression pattern (sox10) to its components (mbp, huC or cntn1b). 
This shows that this system can be used to dissect complex expression patterns. 
In the future, full transgenic lines of the hemidrivers will be generated that will 
permit a more stable, and less mosaic, expression of genes of interest.  
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 Experimental Procedures 5.4
 
5.4.1 Generation of hemidriver constructs  
 
Dna-binding Domain (dbd) hemidriver:  
The original DBD hemidriver consists of a heterodimerizing leucine zipper (Zip) 
fused to a 10xglycine linker (gly), fused to N-terminus of the Gal4 DBD (residues 1-
147; Figure 5.2 C). Residues 1-147 of Gal4 DBD are identical to KalTA4 DBD, 
therefore the splitKalTA4 DBD hemidriver contains the same residues, with codon 
usage optimized for zebrafish. I PCR-amplified the DNA binding domain of KalTA4 
from pCSKalTA4 (Distel, Wullimann et al. 2009) and added the remaining features 
by consecutive extension PCRs. These included the leucine zipper, followed by the 
10x glycine linker, upstream of the DBD sequence. I also included the strong kozak 
sequence used in KalTA4. In the last round of PCR I added attB sites and used BP 
clonase to recombine it with pDONR221 to generate pME-DBD. 
TA4 hemidriver:  
The original Gal4 or VP16 AD hemidrivers consist of a long nuclear localization 
signal (nls) from SV40 fused to the N-terminus of the transcription-activation 
domain of Gal4 or VP16, fused to the N-terminus of a 10x glycine linker, fused to 
the N-terminus of the heterodimerizing leucine zipper complementary to that of the 
DBD hemidriver (Figure 5.2 C). To generate my TA4 hemidriver, I amplified the 
TA4 sequence from pCSKalTA4 (residues 154-192) by PCR and added the 
remaining features by consecutive extension PCRs. These included a short nuclear 
localization signal from SV40 upstream of TA4, and a 10x glycine linker and the 
complementary leucine zipper downstream. I also included the strong kozak 
sequence used in KalTA4. In the last round of PCR I added attB sites and used BP 




5.4.2 Generation of DBD and TA4 synthetic mRNAs: 
The Kozak and coding sequences for DBD and TA4 were PCR-amplified and cloned 
into pCS2+ digested with BamHI and Klenow-blunted. Constructs were verified by 
sequencing. Synthetic mRNA was produced by linearizing the templates with NotI 
and transcribing from the SP6 promoter using SP6 mMessage mMachine (Ambion).   
 
5.4.3 Gateway recombination of split KalTA4 hemidrivers 
I recombined 5’ entry vectors containing a fragment of the h2α(Kwan, Fujimoto et 
al. 2007), sox10(Kirby, Takada et al. 2006), mbp(Almeida, Czopka et al. 2011), 
huC(Park, Kim et al. 2000) or cntn1b(Czopka, Ffrench-Constant et al. 2013) 
promoters; middle entry vectors pME-DBD, pME-TA4 or pME-KalTA4GI; and 3’ 
entry vectors containing a poly adenylation signal in a LR-recombinase mediated 
gateway recombination to generate the constructs used in this study. All entry vectors 
were verified by sequencing and all destination constructs were screened by at least 
three restriction enzyme digestions.  
 
5.4.4 Microinjection 
For synthetic mRNA injections, 100pg of each mRNA in water were microinjected 
in a volume of 1nL into the yolk of fertilized UAS:kaede eggs (eggs injected with 
both hemidrivers contained a total amount of 200pg mRNA). Other injections 
performed as described in Chapter 2. 
 
5.4.5 Imaging 
All image acquisition, processing and analysis, including intensity measurements 
were performed as described in Chapter 2, using a Zeiss LSM710 confocal 
































Figure 6.1 – Summary diagram 
(A) Model of embryonic spinal cord oligodendrocyte development in zebrafish: 
reticulospinal axons provide a mitogenic secreted signal (arrow) to OPCs, and a contact-
dependent survival signal during differentiation. Additionally, axons regulate the formation 
of myelin sheaths in a contact-dependent manner, modulating their myelinating capacity. 
(B) In the absence of reticulospinal axons in the posterior spinal cord of kbp mutants, the 
lack of the axon-derived mitogenic and survival signals reduces proliferation and survival, 
leading to a decreased number of mature oligodendrocytes. Furthermore, the myelinating 
capacity of other oligodendrocytes is reduced (which could be partly due to the lack of kbp). 
(C) In the presence of supernumerary Mauthner axons, contact-dependent axonal signals 
locally promote the formation and extension of myelin sheaths made by individual 





In this thesis, I set out to address whether the diversity of myelinated fibers observed 
in the CNS is a product of axonal regulation. That is, whether axonal signals could 
regulate any steps of oligodendrocyte-lineage cell development in vivo, from their 
specification from neural progenitor cells, to their formation of myelin sheaths. The 
diversity of myelin sheaths observed, for instance in terms of thickness or length, 
tends to be precisely adjusted to the underlying axon and to optimize its function – 
which would suggest it is indeed regulated by axon. However, in vitro work had 
established that oligodendrocyte-lineage cells could essentially develop and form 
myelin in the absence of axons, even if their presence would stimulate particular 
aspects of their development to a degree. Could it be that oligodendrocyte-lineage 
cells do not absolutely require axons for their development, but are still responsive to 
their influence? Previous studies that attempted to remove axons in an in vivo 
context suffered from a number of drawbacks – namely, the fact that the paradigms 
used (transection or enucleation of the optic nerve) are fairly invasive procedures 
with consequences that could have confounding effects. I set out to readdress this 
issue in the larval zebrafish spinal cord, which permits manipulation of the axons and 
live imaging of the behaviour of oligodendrocyte-lineage cells from before they are 
even specified, until their maturation and myelination. My model presents a series of 
advantages: I am able to genetically induce alterations in the axonal compartment by 
manipulating axonal growth, without invasive manipulations, which means that 
oligodendrocyte-lineage cells never have to deal with the confounding effects of 
axonal degeneration. I am also able to image very early events in the development of 
the lineage, namely the specification of OPCs, which in mammals occur before birth. 
Finally, I am able to live-image the behaviour of these cells, and follow the fate of an 
OPC and its myelination fate as it matures, in the same individual animal, at several 
time points. This is in contrast with the static analysis of mammalian models, where 
different animals need to be sacrificed and tissue fixed at each time point. 
I first set out to investigate whether earlier stages of oligodendrocyte-lineage cell 
development required axons (Chapter 3). I analysed a zebrafish mutant (kbpst23) 
where the outgrowth of the first myelinated axons is disrupted from an early age, but 
not completely: whereas in WT these axons extend through the entire length of the 
spinal cord, in the mutants they only extend through the anterior half of the spinal 
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cord, which looks indistinguishable from WT. This allowed me to have an internal 
control for the posterior region, where the axonal surface that normally would get 
myelinated in the ventral spinal cord is 80% reduced. As it turns out, this did not 
affect the early emergence of OPCs from the pMN domain, nor did it affect the 
dorsal migration and distribution of a subset of OPCs. This suggests that 
reticulospinal axons and axonal signals do not regulate OPC specification or 
migratory capacities. Subsequently, by time lapse imaging, I determined that OPCs 
throughout the posterior spinal cord proliferated less when ventral axonal surface 
was absent. This suggests that a (probably secreted) mitogenic signal produced by 
axons normally promotes OPC proliferation. Furthermore, I found that a subset of 
ventral oligodendrocyte-lineage cells underwent apoptosis in the absence of ventral 
target axons, indicating that these axons normally deliver a (probably contact-
dependent) survival signal. Interestingly, despite their confounding factors and lack 
of specific cell type labelling, previous studies manipulating rodent optic nerves had 
predicted this: cell proliferation was reduced when the optic nerve was cut in WT, 
but also in WldS mice, whose axons do not immediately degenerate. This means that 
live axons and their physiological activity or secreted factors were required to 
provide this mitogenic signal. In contrast, cells underwent apoptosis when the optic 
nerve of WT animals was cut, but survived in the cut optic nerve of WldS mice, 
where the disconnected axons are still present. This means that molecules exposed on 
their surface provide this survival signal to oligodendrocyte-lineage cells. A major 
candidate for this signal would be Nrg1 type III, a membrane-anchored adhesion 
molecule whose signalling has shown to be essential for Schwann cell development, 
and capable of regulating oligodendrocyte development in vitro. However, Nrg1 type 
III knockout mice and zebrafish do not exhibit impaired CNS myelination, so likely 
this survival signal is another molecule. 
I found that the combination of the proliferation and the survival defects led to a 
reduction in the number of ventral oligodendrocytes that mature in the ventral spinal 
cord. This could reflect an evolutionarily incipient mechanism regulating the 
matching between target axonal surface and oligodendrocyte-membrane, which 
could be scaled up during evolution as animals and nervous systems became larger.  
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I then sought to address whether later stages of oligodendrocyte-lineage cell 
development could also be regulated by axons – namely the timing of differentiation 
and the extent of myelination. Despite an 80% reduction in ventral axonal surface, 
mature oligodendrocytes are only reduced by 25%. This suggested that some excess 
OPCs existed in the spinal cord in relation to the axonal surface even at the time of 
differentiation. By tracking single cells and following their myelination fate, I found 
that the same proportion of oligodendrocytes differentiated on schedule in the 
presence or absence of target axons – suggesting that axons do not regulate the 
timing of myelination and instead this follows an oligodendrocyte-intrinsic timer, as 
had been predicted from in vitro studies. I found no evidence of prematurely or 
incorrectly myelinated axons. Instead I found that ventral oligodendrocytes made 
fewer myelin sheaths, suggesting that axons regulate the formation or stabilization of 
nascent myelin sheaths, and that ventral oligodendrocytes have a plastic myelinating 
potential. I additionally found that kbp itself may potentially play a role in the growth 
of myelin sheaths, and in their localization to axons and away from neuronal somas.  
In a further challenge to their myelinating capacity, I analysed zebrafish larvae with 
an excess of very large axons that normally are the first myelinated. I found that 
oligodendrocyte-lineage cells adapted perfectly to the extra axonal surface, primarily 
by extending more myelin sheaths and longer sheaths. This further demonstrated that 
axons can regulate the myelinating capacity of oligodendrocytes, which are plastic, 
and are not necessarily myelinating at their full capacity in normal situations. 
Further, I observed that even dorsal oligodendrocytes were affected by this ventral 
stimulus, and also extended more sheaths ventrally, which they normally do not do. 
These dorsal oligodendrocytes myelinate their normal small calibre targets in 
addition to the supernumerary, very large-calibre Mauthner axons. Collectively, 
these results unambiguously demonstrated that a) local axonal signals can influence 
the myelinating capacity of oligodendrocyte processes, b) that oligodendrocytes are 
not predetermined to make the same amount of myelin at the end of every process. 
The classification of oligodendrocyte morphologies into subtypes very likely reflects 
that emergence of cohorts of similar axons at distinct times during development, as 




In sum, the diversity of myelin sheaths and oligodendrocyte morphologies reflects 
the fact that oligodendrocytes are a plastic cell type that locally responds to axonal 
signals.   
 
My results open a number of questions which will be interesting to address in the 
future: 
a) When do axon-derived signals act to regulate myelination, at the level of a single 
OPC? Is there a limited time window during which OPCs can respond to these 
signals? Early OPCs differentiate and form myelin sheaths more efficiently when 
transplanted into myelin-free hosts than late OPCs or oligodendrocytes (Gard and 
Pfeiffer 1989, Warrington, Barbarese et al. 1993, Archer, Cuddon et al. 1997). This 
indicates that the myelinating capacity of oligodendrocyte-lineage cells is maximal 
early on and disappears when cells mature into oligodendrocytes. Interestingly, 
recent work has identified a limited time window of ~5 hours after the formation of 
the first myelin sheath during which the cell will make all of its myelin sheaths 
(Czopka, Ffrench-Constant et al. 2013). After this short window, for the remainder of 
an oligodendrocyte’s life, the complement of myelin sheaths they sustain appears 
fixed. It could be that if such axonal signals are going to have an effect, they must act 
prior to or during this short period.  
b) What happens if there are no such signals? In vivo, if an OPC process is not 
locally stimulated by contact with an axon, does it eventually retract? Alternatively, 
could it myelinate an axon or another structure at a low basal rate in the absence of 
such stimulating signals? If so, which structures do OPCs myelinate? In vitro, in 
neuron-free cultures, oligodendrocytes are able to myelinate inert structures such as 
paraformaldehyde-fixed axons (Rosenberg, Kelland et al. 2008) or nano-fibers  (Lee, 
Leach et al. 2012, Li, Ceylan et al. 2014). In vivo, could they myelinate cell bodies, 
if they are not actively repulsive? Would this at least partly explain the presence of 
such aberrant profiles in the posterior spinal cord of kbp mutants, which lack 
reticulospinal axons? If oligodendrocytes myelinate at a basal rate, is there a 
minimum amount of myelin OPCs make? 
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c) Do the same signals also regulate the formation of myelin sheaths when the adult 
CNS is regenerating, following a demyelinating lesion? Discovering these signals 
may help us understand why remyelinated axons have thinner and shorter myelin 
sheaths, and why remyelination eventually fails. The complex demyelinating 
microenvironment may inhibit the response of oligodendrocyte-lineage cells to these 
signals (Piaton, Gould et al. 2010, Boulanger and Messier 2014). Identifying these 
pathways may open the door for new therapeutical targets for devastating diseases 
like multiple sclerosis. 
d) Are oligodendrocyte-lineage cells generally able to respond to these signals 
throughout the life of an organism? In the adult optic nerve, de novo differentiation 
of oligodendrocytes was observed to result in shorter myelin internodes, suggesting 
that remodelling of myelin occurs throughout life in a healthy CNS (Young, 
Psachoulia et al. 2013). Could it be that with aging, oligodendrocyte-lineage cells 
become limited in the magnitude of their response? Could this underlie the white 
matter alterations that accompany specific motor or cognitive deficits in late life? 
e) Finally, are the same signals recapitulated in the adult CNS during experience-
driven white matter plasticity? Interestingly, a recent technical tour-de-force 
established that individual cortical axons are intermittently myelinated, and the 
length of myelin internodes can vary significantly (Tomassy, Berger et al. 2014), in 
contrast with the textbook description of regularly spaced nodes of Ranvier. This 
opens the door for the existence of plastic remodelling and refinement of myelin 
segments, presumably locally regulated, similarly to the developmental mechanisms 
I identified here. This remodelling would affect the conduction velocity of the axon 
and potentially the functional output of the whole circuit. It will be very interesting to 
determine if the same candidate molecular pathways regulate such a potential 
plasticity mechanism in the adult, which could provide a framework for 
understanding the cellular basis of a range of neuropsychiatric diseases.  
In sum, my results show that axons can regulate OPC proliferation and 
oligodendrocyte survival, and importantly, unambiguously demonstrated that axons 
can locally regulate the myelinating capacity of individual oligodendrocytes in vivo, 
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The vast majority of axons in the vertebrate central nervous system
are eventually myelinated by oligodendrocytes (Hildebrand et al.,
1993), which facilitates rapid saltatory conduction along their
length (Bakiri et al., 2011; Waxman and Swadlow, 1977), ensures
their long-term viability (Nave, 2010) and contributes to functional
regulation of nervous system plasticity (Fields, 2010). Although we
know much about the early development of oligodendrocytes (Li
et al., 2009; Richardson et al., 2006) and that oligodendrocytes can
differentiate and express myelin proteins in the absence of axons
in vitro (Barres et al., 1994; Knapp et al., 1987; Nawaz et al., 2009;
Temple and Raff, 1986), the key question of whether the timing
and extent of myelination in vivo represents intrinsic properties of
oligodendrocytes or is regulated by the axons remains unanswered.
Although it has been known for nearly 100 years that
oligodendrocyte morphology correlates with the caliber of axons
that they myelinate, whereby oligodendrocytes usually associate
with either a small number of large caliber axons or a larger
number of smaller axons (Bunge, 1968; Butt and Berry, 2000; Del
Rio-Hortega, 1921; Del Rio-Hortega, 1928; Remahl and
Hildebrand, 1990), a causal role for axons in establishing these
relationships, although predicted (Ueda et al., 1999), remains to be
formally demonstrated.
Here, we use zebrafish, which have recently become established
as a powerful model for the study of glial cells and myelinated axons
(Brosamle and Halpern, 2002; Buckley et al., 2010; Kazakova et al.,
2006; Kirby et al., 2006; Li et al., 2007; Lyons et al., 2009; Monk et
al., 2009; Pogoda et al., 2006; Takada and Appel, 2010), to study the
role that axons play in regulating CNS myelination in vivo. As is the
case in mammals, we show that single oligodendrocytes in zebrafish
myelinate either a small number of large caliber axons or a larger
number of smaller axons. We identify the very first axon myelinated
in the zebrafish CNS as the very large caliber Mauthner axon, and
show that increasing the number of Mauthner axons in vivo
dramatically regulates myelination by single oligodendrocytes. In the
presence of supernumerary Mauthner axons we observe
oligodendrocytes that usually myelinate just one Mauthner axon
myelinating many Mauthner axons. In addition, we observed
oligodendrocytes that usually myelinate only smaller caliber axons
readily myelinating both large caliber Mauthner axons as well as
axons of much smaller caliber, which happens very rarely in wild
types. These results show that oligodendrocytes can myelinate axons
of very different size and that individual axons can regulate the




We used the following standard zebrafish strains and lines: AB, Golden and
Tg(sox10(7.2):mRFP) (Kirby et al., 2006). For this study, we also
generated Tg(mbp:EGFP-CAAX) and Tg(mbp:EGFP). All animals were
maintained in accordance with UK Home Office guidelines.
Plasmid construction
A 2 kb fragment of mbp regulatory sequence (Jung et al., 2010) was
amplified from genomic DNA of the AB strain using the following primers
that contain att recombination sites (underlined): attB4_mbpF, GGGGA-
CAACTTTGTATAGAAAAGTTGCAGATGCTGAGATGTGACTACT-
GCAAATGA; attB1R_mbpR, GGGGACTGCTTTTTTGTACAAA -
CTTGGTTGATCTGTTCAGTGGTCTACAGTCTGGA.
Purified PCR products were recombined with pDONRP4-P1R
(Invitrogen) using BP clonase (Invitrogen) to generate the 59 element clone
p5E_mbp. Tol2 transgenesis constructs were generated by recombination
of the abovementioned and other donor clones, all of which are
components of the Tol2kit (Kwan et al., 2007), with pDEST_Tol2_CG2
using LR clonase II Plus (Invitrogen).
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SUMMARY
The majority of axons in the central nervous system (CNS) are eventually myelinated by oligodendrocytes, but whether the timing
and extent of myelination in vivo reflect intrinsic properties of oligodendrocytes, or are regulated by axons, remains
undetermined. Here, we use zebrafish to study CNS myelination at single-cell resolution in vivo. We show that the large caliber
Mauthner axon is the first to be myelinated (shortly before axons of smaller caliber) and that the presence of supernumerary
large caliber Mauthner axons can profoundly affect myelination by single oligodendrocytes. Oligodendrocytes that typically
myelinate just one Mauthner axon in wild type can myelinate multiple supernumerary Mauthner axons. Furthermore,
oligodendrocytes that exclusively myelinate numerous smaller caliber axons in wild type can readily myelinate small caliber axons
in addition to the much larger caliber supernumerary Mauthner axons. These data indicate that single oligodendrocytes can
myelinate diverse axons and that their myelinating potential is actively regulated by individual axons.
KEY WORDS: CNS Myelination, In vivo imaging, Oligodendrocyte, Zebrafish
Individual axons regulate the myelinating potential of single
oligodendrocytes in vivo













DNA injections and generation of transgenic zebrafish
Fertilised eggs were co-injected with 1 nl of a solution containing 10 ng/ml
plasmid DNA and 25 ng/ml tol2 transposase mRNA. Injected fish were
analysed as mosaics or grown to adulthood to raise stable transgenic lines.
notch1a morpholino injection
We injected zebrafish embryos with 500 pg of a morpholino directed
against a notch1a-specific splice junction (Ma and Jiang, 2007) to
temporarily abrogate embryonic notch1a expression. We carried out RT-
PCR to assay notch1a mRNA expression levels using the primers 59-
CTTCTGCACTTTCTGGAGATTTAAAGAAG-39 (Ma and Jiang, 2007)
and 59-CACACGTCTGACCTGTGAAGC-39.
hoxb1 mRNA injection
We injected zebrafish embryos with 50 pg of hoxb1 mRNA. The majority
of hoxb1 mRNA-injected animals were morphologically normal and
typically had two Mauthner axons on one side of the CNS and one on the
contralateral side. A subset of hoxb1 mRNA-injected animals had
morphological abnormalities as have been previously described (Hale et
al., 2004), and were therefore excluded from further study.
Immunohistochemistry
Whole-mount antibody labelling was carried out using standard protocols.
Anti-3A10 (Developmental Studies Hybridoma Bank) was used at a
concentration of 1:200.
Confocal imaging
Embryonic and larval zebrafish were embedded in 1.5% low melting point
agarose (Sigma) in embryo medium with tricaine. Imaging was performed
at a Zeiss LSM710 confocal microscope. Quantification of cell and myelin
sheath number was carried out on confocal z-stacks using unbiased
stereological methods.
Transmission electron microscopy
Preparation of tissue was as carried out as described previously (Lyons et
al., 2008). Microwave stimulation during tissue processing was carried out
using a Panasonic microwave with ‘Inverter’ technology. Images were
taken with a Phillips CM120 Biotwin. Data analyses were carried out using
Adobe Photoshop and ImageJ.
RESULTS
CNS myelination proceeds according to
stereotyped gradients in vivo
To define CNS myelination in vivo at single cell resolution, we
generated transgenic constructs and stable transgenic lines to drive
gene expression in myelinating glial cells of the zebrafish (Fig. 1A;
see Fig. S1 in the supplementary material). Time-course analyses
of fluorescent reporter lines generated using previously identified
regulatory sequences of the myelin basic protein (mbp) gene (Jung
et al., 2010) showed that the very first axon to be myelinated in the
CNS is that of the large Mauthner neuron (Fig. 1B). The Mauthner
cell is an individually identifiable reticulospinal neuron; each fish
has two Mauthner neurons, one on each side of the midline of
rhombomere 4 (Kimmel et al., 1982) and each Mauthner neuron
projects a very large caliber axon along a stereotyped path in the
ventral spinal cord (Jontes et al., 2000; Kimmel et al., 1982).
mbp:EGFP-CAAX (which drives a membrane-tethered variant of
EGFP) was first detected along proximal (anterior) parts of the
Mauthner axon from about 60 hours post-fertilisation (hpf) and
proceeded progressively towards more distal (posterior) parts of the
axon over time (Fig. 1B,C). Myelination of axons in more dorsal
regions of the spinal cord occurred soon after the appearance of
myelination of the ventral Mauthner axon (Fig. 1C). Myelination
of these more dorsally located axons also occurred in an anterior to
posterior gradient (data not shown). These observations show that
myelination occurs according to stereotyped anterior-posterior and
ventral-dorsal gradients at the level of axonal tracts and individual
axons.
Individual myelinating oligodendrocytes have
diverse morphologies in vivo
In order to visualise individual myelinating oligodendrocytes in
vivo we injected wild-type embryos with plasmid DNA encoding
mbp:EGFP or mbp:EGFP-CAAX and imaged them between 3 and
9 days post-fertilisation (dpf). We observed that the
oligodendrocytes that associate with the very large Mauthner axon
typically associate only with this axon (Fig. 2A). The vast majority
of such cells (103/133) associated with just one Mauthner axon,
whereas the remaining cells associated with the Mauthner axon on
both sides of the embryonic midline (Fig. 2A). We also found that
a very small proportion of wild-type oligodendrocytes (5%, 11/204)
were capable of myelinating the Mauthner axon as well as axons
of much smaller caliber (Fig. 2B). The position of oligodendrocytes
that associate with the Mauthner axons was very stereotyped: the
cell bodies always resided in the ventral spinal cord, almost always
ventral to the Mauthner axon itself (Fig. 1B,C; Fig. 2A,B).
As expected, the vast majority of oligodendrocytes in the spinal
cord extended multiple myelinating processes that associated with
numerous axons of relatively small caliber compared with the
Mauthner axons. These cells exhibited striking morphological
diversity with respect to the number and length of their individual
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Fig. 1. Transgenic reporters reveal first axon myelinated in vivo in zebrafish CNS. (A)"Lateral view of a stable Tg(mbp:EGFP-CAAX) zebrafish
at 8 dpf. Myelinating glia of the CNS and PNS are labelled, as is the heart, which serves as a marker of transgenesis. (A9)"Lateral view of the spinal
cord (area indicated by box in A). Prominent myelinated tracts myelinated in the dorsal spinal cord and ventral spinal cord are apparent. (B)"Lateral
views of a stable Tg(mbp:EGFP-CAAX) zebrafish at 60 hpf show that the very first axon to be myelinated is the large Mauthner axon in the ventral
spinal cord, which is first myelinated in the anterior spinal cord. (C)"Lateral views of a stable Tg(mbp:EGFP-CAAX) zebrafish at 70 hpf. Myelination of
the Mauthner axon has now commenced in the more posterior part of the spinal cord. At this stage, oligodendrocytes have started to myelinate











myelin sheaths (Fig. 2C-E). At 4 dpf, we found that the majority
of such cells (14 of 22) had 11-14 myelinating processes, although
process number varied between 4 and 22 (Fig. 2D). Also, the
length of individual nascent myelin sheaths per cell was highly
variable and ranged from 6 mm to 49 mm (Fig. 2E). The number of
myelin sheaths per oligodendrocyte was relatively stable from 3-7
dpf, but average myelin sheath length per cell increased almost
twofold over the same time period (Fig. 2F-G).
Supernumerary Mauthner axons are robustly
myelinated in vivo
In order to test how individual large caliber axons might regulate
CNS myelination, we generated animals with supernumerary
Mauthner neurons using two independent genetic manipulations.
Previous studies have shown that disruption of notch1a causes a
mild neurogenic phenotype in zebrafish, characterised in part by
the appearance of multiple Mauthner neurons (Gray et al., 2001).
Such extra Mauthner neurons are born between 9 and 12 hpf, as in
wild type, and extend axons to the posterior spinal cord, as in wild
type (Liu et al., 2003). It is important to point out that the birth of
these neurons and their axonal growth occurs long before the
appearance of oligodendrocytes. Because Notch1 has been
associated with oligodendrocyte development and myelination
(Genoud et al., 2002; Hu et al., 2003; Park and Appel, 2003; Park
et al., 2005; Wang et al., 1998), we sought to only temporarily
reduce Notch1a function, and found that injection of 500 pg of a
previously published morpholino (Ma and Jiang, 2007) was
sufficient to generate animals with supernumerary Mauthner
neurons and axons (Fig. 3A,B). The level of notch1a mRNA in
such morphants is reduced relative to control at 10 hpf (when
Mauthner neurons are born) but is indistinguishable from controls
by 3 dpf (when extensive myelination commences) (Fig. 3D). In
order to have an independent method to generate extra Mauthner
axons we injected embryos with hoxb1 mRNAs (Fig. 3C), which
has previously been shown to be capable of generating animals
with ectopic Mauthner neurons by duplicating rhombomere 4
identity in the hindbrain (Hale et al., 2004).
Examination of notch1a morphants and embryos injected with
hoxb1 mRNA between 3 and 9 dpf using transgenic reporters
(sox10:mRFP and mbp:EGFP-CAAX) and transmission electron
microscopy showed that normal and supernumerary Mauthner
axons were covered by glial membrane and robustly myelinated
(Fig. 3; Fig. 4; data not shown). The Mauthner axon, like many
axons in situ, is not circular in cross-sectional profile (Fig. 4). We
therefore quantified the circumference(s) of Mauthner axon(s) in
our analyses, because this variable (in combination with axon
length) reflects the axonal surface available for potential
interactions with oligodendrocytes. We saw that the summed
circumference(s) of all Mauthner axon(s) per hemi-spinal cord
increased almost linearly with the number of Mauthner axons
present (Fig. 4D). In control animals that have one Mauthner axon
on each side of the spinal cord, the average circumference per axon
was 13.5±0.8 mm (mean±s.d., n 12) at 9 dpf. In animals with two
Mauthner axons on one side of the spinal cord, the combined
circumference was approximately doubled (26±3.5 mm, n 11,
P<0.0001) and those with three on each side nearly tripled (35±5
mm, n 3, P<0.0001). In animals with even more Mauthner axons,
their total circumference increased even further.
In order to test whether myelination of extra Mauthner axons
occurred at the expense of other axons, we counted the total
number of myelinated axons (excluding the Mauthner axons) in
control and experimental ventral spinal cords (Fig. 4E). Control
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Fig. 2. Single-cell analysis reveals morphological diversity of individual CNS oligodendrocytes. (A)"Lateral views of single mbp:EGFP-
expressing oligodendrocytes associating with one Mauthner axon (top) and both Mauthner axons (bottom). (B)"Lateral view of a single mbp:EGFP-
expressing oligodendrocyte associating with the large Mauthner axon (left) and an axon of much smaller caliber (right). (C)"Lateral views of single
oligodendrocytes associating with multiple axons in the dorsal spinal cord (top) and ventral spinal cord (bottom). (D)"Myelin sheath number per
oligodendrocyte (excluding those that myelinate the Mauthner axons) at 4 dpf. (E)"Myelin sheath length in four sample oligodendrocytes (that do
not associate with the Mauthner axon) at 4 dpf. (F)"Average myelin sheath number per cell over time. This does not include oligodendrocytes that
myelinate the Mauthner axon. (G)"Average myelin sheath length per cell over time. This does not include oligodendrocytes that myelinate the













animals with one Mauthner axon on each side of the spinal cord
had an average of 23 additional myelinated axons (±4, n 10). In
animals with two Mauthner axons on each side of the spinal cord
there were 22 additional axons myelinated (±4, n 10, P 0.58) as
was also the case in animals with three Mauthner axons (n 3,
P 0.71). These data show that the presence of even a threefold
increase in Mauthner axon circumference does not affect the
number of other axons myelinated in the ventral spinal cord. There
was, however, a slight decrease in the number of myelinated axons
when there were four or more Mauthner axons present in one side
of the ventral spinal cord (15±3, n 4, P 0.0038).
Together, our results show that in two genetically independent
manipulations oligodendrocytes can myelinate extra large caliber
axons that are not present in their normal wild-type environment
and can do so without affecting myelination of other axons. These
observations beg the question as to how oligodendrocytes respond
to the presence of extra axons and their consequent additional
axonal surface area.
Supernumerary Mauthner axons do not regulate
myelinating oligodendrocyte number
In order to test whether additional Mauthner axons regulate early
stages of oligodendrocyte development, we examined the number
and distribution of oligodendrocytes in notch1 morphants and
animals with hoxb1 mRNA overexpression. We found no
significant differences in oligodendrocyte number in the spinal
cords of animals with supernumerary Mauthner axons relative to
controls over a 425 mm stretch of the spinal cord centred at the
mid-trunk level: control animals had an average of 66 mbp:EGFP-
expressing oligodendrocytes (±6, n 6) at 5 dpf; notch1a morphants
an average of 67 (±5, n 10, P 0.72); and hoxb1 mRNA-injected
animals an average of 63 (±8, n 9, P 0.45) (Fig. 5). Wild-type and
supernumerary Mauthner axons are localised to the ventral spinal
cord, as are the oligodendrocytes that typically myelinate them
(Fig. 1), and given that the Mauthner axon is the first myelinated,
we wanted to test the possibility that the distribution of
oligodendrocytes within the spinal cord might be affected by the
presence of supernumerary Mauthner axons in the ventral spinal
cord. We saw, however, that the number of oligodendrocyte cell
bodies located specifically in the dorsal spinal cord was almost
identical in wild type as in animals with extra Mauthner axons
(control: 25±3, n 6; notch1a morphants: 23±4, n 10, P 0.31;
hoxb1 mRNA-injected animals: 21±7, n 9, P 0.21) (Fig. 5D).
Supernumerary Mauthner axons regulate the
morphology of single oligodendrocytes
In order to elucidate precisely how supernumerary Mauthner axons
regulate single myelinating oligodendrocytes, we injected plasmid
DNA encoding mbp:EGFP or mbp:EGFP-CAAX into notch1a
morphants and into embryos injected with hoxb1 mRNA. Whereas
~80% of the oligodendrocytes that myelinated the Mauthner axon
in wild type associated with only one Mauthner axon, we found no
such oligodendrocytes in notch1a morphants. Instead, we saw that
all oligodendrocytes associated with at least two Mauthner axons
(n 22) and that the majority of these associated with at least three
Mauthner axons (15/22) (Fig. 6). In one case, we saw an
oligodendrocyte that associated with seven Mauthner axons (Fig.
6C). In animals injected with hoxb1 mRNA we also found that the
vast majority of oligodendrocytes associated with more than one
Mauthner axon (16/21) (Fig. 6). In wild-type animals, the average
total length of myelin sheaths along Mauthner axon(s) made by
single oligodendrocytes was 150±47 mm, in notch1a morphants
was 256±57 mm (P<0.0001) and in hoxb1 mRNA-injected animals
was 187±85 mm (P 0.05) at 5 dpf. By 9 dpf, the average total
lengths were 192±53 mm in wild type, 419±95 mm (P<0.0001) in
notch1a morphants and 249±107 mm (P 0.09) in hoxb1 mRNA-
injected animals. Together with the fact that the total circumference
of supernumerary Mauthner axons far exceeds the circumference
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Fig. 3. Supernumerary Mauthner axons are ensheathed by myelinating glia. (A-C)"Ventral views of the hindbrains of wild-type (A), notch1a
morphant (B) and hoxb1 mRNA-injected (C) larvae at 5 dpf labelled with the 3A10 antibody, which recognises neurofilament-associated proteins.
Mauthner axons are indicated by arrowheads. Scale bar: 20"mm. (A9-C0) Analysis of Tg(sox10:mRFP) (A9-C9) and Tg(mbp:EGFP-CAAX) (A0-C0) shows
that wild-type (A9,A0), notch1a morphant (B9,B0) and hoxb1-injected (C9,C0) Mauthner axons are all ensheathed and myelinated. Arrowheads
indicate Mauthner axons. Scale bars: 20"mm. (D)"RT-PCR analyses show that levels of notch1a mRNA are reduced in morpholino (MO)-injected












of individual wild-type Mauthner axons (Fig. 4D), it is clear that
individual oligodendrocytes in animals with supernumerary
Mauthner axons myelinate a far greater axonal surface area than do
wild-type oligodendrocytes.
In addition to identifying oligodendrocytes that myelinated a
greater number of Mauthner axons than normal, we observed
that oligodendrocytes in the ventral spinal cord can myelinate
supernumerary Mauthner axons as well as axons of relatively
smaller caliber (data not shown). Remarkably, we also saw
oligodendrocytes located in dorsal regions of the spinal cord,
which typically only ever myelinate small caliber axons, extend
processes to the ventral spinal cord to associate with
supernumerary Mauthner axons, and in many cases also
myelinate much smaller caliber axons (Fig. 7). This was never
observed in wild-type animals but occurred readily in both
notch1 morphants and embryos injected with hoxb1 mRNA, and
at both 5 dpf and 9 dpf, which shows this was a stable
association. This dramatic observation shows that individual
oligodendrocytes can readily myelinate axons of very different
size and that axons profoundly affect the myelination capacity of
single oligodendrocytes.
DISCUSSION
Here, we use zebrafish to characterise and manipulate CNS
myelination in vivo. Zebrafish are ideally suited to cellular
analyses at high resolution owing to their small size, optical
transparency, rapid early development, accessibility and relative
simplicity compared with mammals, in which the vast majority
of studies of myelinated axons have been carried out. By
analysing the morphology of single zebrafish oligodendrocytes
in vivo using fluorescent transgenes we recapitulate key
observations made in mammals nearly 100 years ago by Pio Del
Rio-Hortega (Del Rio-Hortega, 1921; Del Rio-Hortega, 1928),
which showed that oligodendrocytes typically myelinate either a
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Fig. 4. Supernumerary Mauthner axons are
robustly myelinated. (A-C9) Transmission
electron microscope images of transverse
sections through the spinal cord of wild-type
(A,A9), notch1a morphant (B,B9) and hoxb1
mRNA-injected (C,C9) zebrafish larvae at 9 dpf
shows that all Mauthner axons are robustly
myelinated (A-C) and that there is a similar
number of axons myelinated in the ventral
spinal cord despite the presence of
supernumerary Mauthner (M) axons (A9-C9).
Scale bars: 2"mm. (D)"Total circumference of
Mauthner axon(s) as a function of the number
of Mauthner axons present per hemi-spinal
cord. (E)"Number of myelinated axons,
excluding Mauthner axon(s), present in the
ventral spinal cord as a function of the number
of Mauthner axons present per hemi-spinal
cord. Error bars represent s.d.
Fig. 5. Presence of supernumerary Mauthner axons does not affect oligodendrocyte number or distribution. (A-C)"Lateral views of the
spinal cords in Tg(mbp:EGFP)-expressing wild-type (A), notch1a morphant (B) and hoxb1 mRNA-injected (C) animals shows that oligodendrocyte
number and distribution are not affected by the presence of supernumerary Mauthner axons. Arrows point to oligodendrocytes in the dorsal spinal
cord with projections to the ventral spinal cord. Compare with Fig. 7B. Scale bar: 20"mm. (D). Total oligodendrocyte number per 425"mm length of
tissue in the mid-trunk spinal cord of wild-type, notch1a morphant and hoxb1 mRNA-injected animals and, in grey, the number of oligodendrocytes












small number of large caliber axons or a larger number of
smaller caliber axons in situ. By virtue of being able to visualise
myelination from its very onset at single cell resolution in vivo,
we identify the large caliber Mauthner axon as the first to be
myelinated in the zebrafish CNS, and show that this individual
axon is myelinated along a proximal to distal gradient. We make
use of two independent genetic manipulations to generate
animals that have extra large caliber Mauthner axons and show
that these axons can dramatically affect oligodendrocyte
behaviour. Our manipulation of large caliber axon number shows
that individual oligodendrocytes can readily myelinate axons of
vastly different caliber in vivo and that myelination cues are,
therefore, independent of axon subtype, a result that was
predicted by previous transplantation studies in which
oligodendrocytes derived from the optic nerve (which contains
primarily small caliber axons) were capable of myelinating
axons in the spinal cord (which contains axons of different sizes)
(Fanarraga et al., 1998).
Our data that the presence of supernumerary large caliber
Mauthner axons does not affect oligodendrocyte number are, at
first glance, at odds with a previous study which showed that an
increase in optic nerve axon number caused a concomitant increase
in oligodendrocyte number (Burne et al., 1996). Indeed, although
recent evidence has suggested that cell-cell interactions between
neighbouring oligodendrocytes might contribute to regulation of
their distribution and number (Kirby et al., 2006), there is extensive
evidence from previous studies that axons can regulate
oligodendrocyte number by affecting their proliferation and
survival (Barres and Raff, 1999). However, it is important to point
out that in the study of Burne et al. total axonal number was
increased nearly twofold, whereas our manipulation simply
increases the number of very large caliber axons during the onset
of myelination and has a negligible effect on overall axon number.
We do not, therefore, rule out a general role for axons in regulating
oligodendrocyte number, but show instead that individual axons
can dramatically regulate the myelination potential of single
oligodendrocytes.
Although our data indicate that individual axons regulate CNS
myelination in vivo, we do not know the identity of the causative
axonal signal(s). Previous molecular characterisation has suggested
that removal of inhibitory axonal cues is a pre-requisite for CNS
myelination. Axons initially express high levels of polysialylated
neural cell adhesion molecule (PSA-NCAM) on their surfaces, and
myelination commences only when PSA-NCAM levels are
reduced (Charles et al., 2000; Fewou et al., 2007; Jakovcevski et
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Fig. 6. Individual oligodendrocytes myelinate multiple
supernumerary Mauthner axons. (A-F)"All images are of live single
mbp:EGFP-expressing oligodendrocytes in the spinal cord of larvae at 5
dpf (A-C) and 9 dpf (D-F). (A,D)"Wild-type oligodendrocytes associated
with single Mauthner axons. (B,E)"Oligodendrocytes in hoxb1 mRNA-
injected animals with myelin sheaths on two Mauthner axons.
(C,F)"Oligodendrocytes in notch1a morphants that make seven (C) and
five (F) myelin sheaths on supernumerary Mauthner axons. Maximum
intensity projections and individual confocal z-sections are indicated for
clarity. Individual myelin sheaths indicated by brackets. Scale bars:
20"mm.
Fig. 7. Individual oligodendrocytes readily myelinate
supernumerary Mauthner axons and smaller caliber axons. (A)"In
wild type, oligodendrocytes in the dorsal spinal cord myelinate only
small caliber axons. (B)"Oligodendrocytes in the dorsal spinal cords of
animals with supernumerary Mauthner axons can myelinate the large
Mauthner axons in the ventral spinal cord in addition to smaller caliber












al., 2007; Keirstead et al., 1999). Analyses of the transmembrane
protein Lingo1 (Lee et al., 2007; Mi et al., 2005) also suggest that
it too might function on axons to inhibit myelination. In the
peripheral nervous system (PNS) there is strong evidence that
axonal Neuregulin 1 type III serves as an instructive cue for
myelination (Michailov et al., 2004; Taveggia et al., 2005).
Although Neuregulin 1 type III is not required for CNS
myelination in vivo, it can stimulate hypermyelination of CNS
axons in vivo (Brinkmann et al., 2008), which indicates that
oligodendrocytes can respond to instructive axonal cues. It will be
interesting to see whether future studies will identify instructive
axonal signals required for CNS myelination.
Our data that single oligodendrocytes faced with supernumerary
large caliber Mauthner axons can myelinate a larger axonal surface
area than they normally do during development prompts the
question of whether there is a maximum amount of axonal surface
that any single oligodendrocyte can myelinate. If single
oligodendrocytes myelinate close to their maximum capacity, e.g.
by adulthood, then unless every oligodendrocyte is replaced
following demyelination after injury or disease, incomplete repair
might be inevitable. Our demonstration that axon size can regulate
oligodendrocyte morphology is also relevant to the remyelination
of axons. Given the significant cross-sectional growth of
myelinated axons that takes place after the onset of myelination, it
is likely that the caliber of any axon demyelinated long after
development will be significantly larger than when it was first
myelinated. This discrepancy in target caliber might mean that the
morphology of remyelinating oligodendrocytes will be different
than during development. It is possible that during remyelination
more individual oligodendrocytes make fewer myelin sheaths on
such larger caliber axons (Blakemore, 1974). If this is indeed the
case, remyelination might necessitate the employment of a greater
number of oligodendrocytes than are required to myelinate the
same complement of axons during development. It is, however,
also possible that oligodendrocytes faced with such relatively large
caliber axons during remyelination do not regulate their
morphology dramatically, but rather extend less myelin around
individual axons. This possibility could explain the fact that
remyelinated axon profiles are often surrounded by thin myelin
(Blakemore, 1974). Future studies of demyelination and
remyelination may benefit from high-resolution analyses that can
assess precisely how much axonal surface is myelinated or how
much myelin is made by individual oligodendrocytes.
In summary, our study shows that individual axons can
profoundly regulate the myelinating potential of single
oligodendrocytes, which has implications for the formation and
regulation of myelinated axons throughout life and for mechanisms
that may need to be considered during their repair.
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Abstract—The myelination of axons in the central nervous
system (CNS) is essential for nervous system formation,
function and health. CNS myelination continues well into
adulthood, but not all axons become myelinated. Unlike the
peripheral nervous system, where we know of numerous
axon–glial signals required for myelination, we have a poor
understanding of the nature or identity of such molecules
that regulate which axons are myelinated in the CNS. Recent
studies have started to elucidate cell behavior during myeli-
nation in vivo and indicate that the choice of which axons are
myelinated is made prior to myelin sheath generation. Here
we propose that interactions between axons and the explor-
atory processes of oligodendrocyte precursor cells (OPCs)
lead tomyelination andmay be similar to those between den-
drites and axons that prefigure and lead to synapse forma-
tion. Indeed axons and OPCs form synapses with striking
resemblance to those of neurons, suggesting a similar mode
of formation. We discuss families of molecules with specific
functions at different stages of synapse formation and
address studies that implicate the same factors during
axon–OPC synapse formation and myelination. We also
address the possibility that the function of such synapses
might directly regulate the myelinating behavior of oligoden-
drocyte processes in vivo. In the future it may be of benefit to
consider these similarities when taking a candidate-based
approach to dissect mechanisms of CNS myelination.
This article is part of a Special Issue entitled: The CNS
White Matter. Ó 2013 IBRO. Published by Elsevier Ltd.
All rights reserved.
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Myelination of axons in the central nervous system (CNS,
brain and spinal cord) by oligodendrocytes (OLs)
facilitates rapid impulse conduction and provides
metabolic and trophic support to the axons (Sherman
and Brophy, 2005; Nave, 2010a,b; Fünfschilling et al.,
2012; Lee et al., 2012b). It is an ongoing process that
starts around birth and continues at least into the fourth
decade in humans (Miller et al., 2012, see Wang and
Young, this issue). Myelination of specific axons and
axonal tracts is highly regulated throughout life. During
early development certain axonal tracts are myelinated
ahead of others and this is true in all species studied
(Remahl and Hildebrand, 1982; Schreyer and Jones,
1982; Schwab and Schnell, 1989; Baumann and Pham-
Dinh, 2001; Almeida et al., 2011). Furthermore,
myelination of specific brain areas can be regulated by
social experience (Liu et al., 2012; Makinodan et al.,
2012) and activity-dependent myelination of specific
axons or specific axonal tracts may represent an
important form of nervous system plasticity (Zatorre
et al., 2012). Remarkably, our knowledge of the key
molecules that control the initiation of myelination and
may be responsible for temporal and spatial regulation
of myelination in the CNS remains incomplete.
Myelin in the peripheral nervous system (PNS) has a
similar structure and fulfills similar functions as CNS
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myelin, yet surprisingly there are fundamental differences
in its formation, best underscored by the fact that crucial
molecular regulators of axon–Schwann cell interactions
are by and large not required for axon–OL interactions
e.g. (Brinkmann et al., 2008; Monk et al., 2009).
Furthermore, the cell–cell interactions that lead to
myelination of peripheral nerves by Schwann cells are
quite distinct from those in the CNS. Schwann cells
require axons for almost all stages of their early
development, including myelination in vitro and in vivo
(Jessen and Mirsky, 2005). In contrast, OLs can
develop and differentiate in cell culture in the absence
of axons (Knapp et al., 1987) and can myelinate inert
structures including paraformaldehyde-fixed axons
(Rosenberg et al., 2008) and polystyrene nanofibers
(Lee et al., 2012a). Schwann cells myelinate only one
segment of one axon along a nerve that they are in
close proximity to throughout their entire development,
whereas OLs typically make many myelin sheaths on
many different axons in territories that their myelinating
processes first explore following the end of the cell’s
migration. The molecular and cellular mechanisms of
PNS myelination have been reviewed extensively
elsewhere (Jessen and Mirsky, 2005; Pereira et al.,
2012) and we will focus here on the less understood
regulation of CNS myelination.
Whether to ensure normal development or to fine-tune
specific nervous system function, it is clear that
the myelination of CNS axons in vivo requires intimate
communication between the axons themselves and the
OLs that myelinate them (Emery, 2010a; Simons and
Lyons, 2013). To date, we have learned much about the
early development of axons (Chao et al., 2009; Tojima
et al., 2011; Jung et al., 2012) and of the early stages of
OL development (Richardson et al., 2006, 2011; Li
et al., 2009; Emery, 2010b). However, we know much
less about the interactions between axons and
oligodendrocyte precursor cells (OPCs) and later
interactions between axons and OLs that regulate CNS
myelination in vivo. A number of ligands and receptors
have been implicated in OPC to OL differentiation and
myelination, including Jagged, Contactin1 and Notch
(Wang et al., 1998; Genoud et al., 2002; Hu et al.,
2003), Neuregulin1–ErbB (Brinkmann et al., 2008;
Taveggia et al., 2008; Makinodan et al., 2012), Wnt
(Fancy et al., 2009), Lingo (Mi et al., 2004, 2005; Lee
et al., 2007), Gpr17 (Chen et al., 2009, reviewed in He
and Lu, 2013). Axon–OL signals regulating the
thickness of CNS myelin sheaths have also been
identified, including Neuregulin1–ErbB (Brinkmann et al.,
2008; Makinodan et al., 2012) and Fibroblast Growth
Factor Receptor (FGFR) signaling (Furusho et al.,
2012). However, we know of essentially no signals
between axons and OPCs or OLs that are absolutely
required for CNS myelination in vivo. Here we will
review recent data that are starting to elucidate
interactions between axons and cells of the
oligodendrocyte lineage during myelination in vivo and
speculate on the similarities between such interactions
and axon–dendrite interactions during synapse
formation. We also speculate on how the principles of
the molecular regulation of synapse formation might be
repurposed to coordinate the initiation events of CNS
myelination in vivo.
BEFORE MYELINATION: OPC–OPC
INTERACTIONS CAN REGULATE OL NUMBER
AND DENSITY
OPCs are specified in discrete progenitor cell domains
throughout the CNS (Richardson et al., 2006) from
where they undergo extensive cell migration and
proliferation toward specific axonal tracts. Upon
reaching axonal tracts, the number and distribution of
OPCs are regulated ahead of myelination and this is
thought to involve axon–OPC interactions (Barres and
Raff, 1999), and also, as recent studies indicate, OPC–
OPC interactions (Kirby et al., 2006; Hughes et al.,
2013). Elegant time-lapse imaging of OPC behavior in
the zebrafish spinal cord shows that post-migratory
OPCs extend exploratory processes over a wide
territory. When the processes of neighboring OPCs
come into contact, they withdraw, suggesting repulsive
cell–cell interactions. When individual or small numbers
of OPCs are ablated, neighboring OPCs either
proliferate and/or migrate to colonize the vacated
territory. Subsequently, they again extend exploratory
processes that collapse upon meeting those of
neighboring cells (Kirby et al., 2006). A more recent
study documented similar behavior of OPCs in the adult
mouse brain (Hughes et al., 2013), suggesting that this
tiling mechanism is retained throughout life. The
molecular basis of this mechanism, which regulates
OPC number and distribution, is not known. Lessons
may be learned from considering similar events in
neurons. In the visual system of Drosophila, separate
studies showed that homophilic interactions between
immunoglobulin superfamily members (Dscam2 and
Turtle) mediate tiling between neighboring neurons of
the same class (Millard et al., 2007; Ferguson et al.,
2009). It would be interesting to investigate whether
such molecules or principles of repulsive homophilic
interactions regulate the tiling behavior of an altogether
different cell type, the OPC.
AT THE ONSET OF MYELINATION: RAPID
TRANSITION OF OPC TO OL
Following establishment of their number and distribution
in the vicinity of axons, many OPCs differentiate into
myelinating OLs. Several transcription factors
responsible for driving OPC to OL differentiation have
been identified (Emery, 2010b), but our understanding
of how OPCs or OLs select which axons in their territory
to myelinate and which to avoid is incomplete. Many
areas of the CNS and many axonal tracts contain
functionally distinct axons, some of which are
myelinated and some which are not (Leenen et al.,
1985). Furthermore, neighboring axons in axonal tracts
may develop at different times and be at distinct
maturation states, even if they are all eventually
myelinated. To understand how OPCs transition to
R. G. Almeida, D. A. Lyons /Neuroscience 276 (2014) 98–108 99
myelinating OLs in vivo, Czopka et al. recently carried out
time-lapse imaging of cell behavior during myelination of
the larval zebrafish spinal cord (Czopka et al., 2013).
This work showed that each individual cell, irrespective
of its location in the spinal cord or its precise time of
differentiation, generated its final new myelin sheath on
average just 5 h after generating its first myelin sheath.
Long-term imaging showed that mature OLs never
generated a new myelin sheath, suggesting that OLs
have only a few hours in which to generate all of their
myelin sheaths. This mirrors a previous in vitro study of
rodent co-cultures in which mammalian OLs also make
their myelin sheaths in a short period: about 12 h
(Watkins et al., 2008). One possible mechanism to
regulate which axons are myelinated and which are not
would be to generate nascent myelin sheaths around
numerous axons indiscriminately and later prune away
the sheaths made on the incorrect axons. However,
about 75% of all nascent myelin sheaths made by a
single OL were maintained long term and about 25%
retracted within two days, even at a time point when
most axons (>90%) in the embryonic zebrafish spinal
cord remain unmyelinated (Czopka et al., 2013; Liu
et al., 2013). This indicates that OLs are accurate when
ensheathing axons, rather than doing so in a purely
stochastic manner. Therefore, the mechanisms and
events that regulate axon choice during myelination
must occur prior to sheath formation. At that earlier
point, the processes of OPCs have a distinct growth
cone-like morphology as observed in live imaging
studies in zebrafish and characterized in rodents (Fox
et al., 2006; Czopka et al., 2013). Here, we explore the
hypothesis that the decisions that regulate the
myelination fate of specific axons are mediated by
interactions between those axons and the exploratory
processes of OPCs; and that these interactions may
resemble the formation of nascent synapses between
axons and dendrites.
In this review, we will refer to cells with
exploratory processes but no nascent myelin sheaths
as OPCs (often referred to as NG2 cells due to their
expression of the cell surface proteoglycan NG2), and
to cells that have already made their first myelin
sheath as OLs.
SIMILARITIES BETWEEN AXON–OPC
INTERACTIONS DURING MYELINATION AND
AXON–DENDRITE INTERACTIONS DURING
SYNAPSE FORMATION
The exploratory processes of post-migratory OPCs
engage their targets in a local and restricted territory.
Therefore, we believe it is informative to compare the
behavior of OPC processes interacting with target axons
with that of prospective dendrites interacting with axons
just prior to synapse formation.
Multiple studies have elucidated the initial stages of
synaptogenesis. Dynamic dendritic filopodia, the
precursors of dendritic spines, initially contact growing
axons (Dailey and Smith, 1996; Jontes and Smith,
2000; Shen and Cowan, 2010; Shen and Scheiffele,
2010). Live imaging of the zebrafish embryonic spinal
cord, for instance, has identified such filopodia in
individual motor neurons which contact the growing
Mauthner axon, a large-diameter projection axon that
innervates them en passant (Jontes et al., 2000). Such
brief, transient interactions can induce pre- and
postsynaptic differentiations. Interestingly, some
postsynaptic transmembrane molecules such as
neuroligin (Scheiffele et al., 2000), EphB (Kayser et al.,
2008), SynCAM (Biederer, 2002) and Netrin-G ligand
(Kim et al., 2006), can trigger presynaptic membrane
specializations in adjacent neurons, even when
expressed in non-neuronal cells in culture, revealing
their role as synaptic organizers. The formation of pre-
and postsynaptic complexes can stabilize the
interaction, promoting synapse maturation (Jontes and
Smith, 2000). Strengthening of nascent synapses
stabilizes axon growth (Meyer and Smith, 2006) and the
dynamic filopodia, which mature into dendritic spines
(Niell et al., 2004) (Fig. 1A). A mature synapse is
identifiable by the rigid parallel apposition of the pre and
postsynaptic membranes. On the presynaptic side,
neurotransmitter-filled vesicles cluster, dock to the
membrane, fuse and release neurotransmitter across
the synaptic cleft. On the postsynaptic side, an electron-
dense postsynaptic density is often found which
corresponds to the accumulation of cell-adhesion
molecules, neurotransmitter receptors, ion channels,
scaffolding proteins and signaling molecules (Emes and
Grant, 2012).
Intriguingly, synapses between axons and OPCs,
bearing striking resemblance to classical neuronal
synapses, have been documented in the CNS. They
have been documented electrophysiologically by
patching OPCs (NG2 cells) in the juvenile and adult
optic nerve and in organotypic slices. Excitatory
postsynaptic currents in these cells were detected in
response to both spontaneous and evoked firing of
glutamatergic axons in the corpus callosum (Kukley
et al., 2007; Ziskin et al., 2007), including during
remyelination (Etxeberria et al., 2010), optic nerve
(Kukley et al., 2007), cerebellum (Lin et al., 2005;
Káradóttir et al., 2008), barrel cortex (Li et al., 2012),
auditory pathway (Müller et al., 2009) and
hippocampus (Bergles et al., 2000; Haberlandt et al.,
2011), as well as firing of GABAergic axons in the
hippocampus (Lin and Bergles, 2003; Jabs et al.,
2005). Several lines of evidence indicate that
postsynaptic currents in OPCs result from direct
synapses with axons, in response to action potentials,
reviewed comprehensively in (Bergles et al., 2010). A
variety of neurotransmitter receptors are known to be
expressed by OPCs and OLs (Karadottir and Attwell,
2007), which are well poised to directly mediate such
transmission. Pharmacological inhibition of AMPA
receptors suggests that they are the major
contributors to OPC postsynaptic currents in response
to glutamatergic synapses (Bergles et al., 2010).
Axon–OPC synapses have also been identified in
electron micrographs using the same morphological
criteria as for classical synapses, including presynaptic
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accumulation of vesicles, electron-dense material in the
synaptic cleft and recently, the existence of a
postsynaptic density in the OPC membrane
(Haberlandt et al., 2011). In addition, markers for pre
and postsynaptic specializations such as GAD65 (Lin
and Bergles, 2003), VGlut1 (Ziskin et al., 2007), GRIP
(Stegmüller et al., 2003) and synaptophysin (Kukley
et al., 2007) have been shown to localize in puncta
where axons are closely apposed to OPC processes.
Importantly, the existence of axon–OPC synapses has
been confirmed in vivo (Bergles et al., 2000), but their
functions are not yet known. Recently, in addition to
calcium-permeable AMPA receptors (Zonouzi et al.,
2011), the presence of functional voltage-gated
calcium channels in OPCs was confirmed (Haberlandt
et al., 2011). These proteins may enable calcium
entry following axon–OPC synapse activity and
subsequent activation of intracellular signaling
cascades. In fact, small calcium increases were
detected in OPC somas directly following tetanic
stimulation of GABAergic interneurons or glutamatergic
CA3 hippocampal neurons (Haberlandt et al., 2011).
At more physiological firing rates, the calcium
increases may be restricted to the OPC processes
and not reach the soma (Chan et al., 2013). These
findings provide evidence of a physiological substrate
by which the axon–OPC synapse may regulate OPC
process behavior via calcium signaling, in similar ways
to which the activation of postsynaptic calcium
signaling can regulate dendrite behavior (Kennedy
et al., 2005; Flavell and Greenberg, 2008; Greer and
Greenberg, 2008). Intriguingly local calcium transients
in OPC processes have also recently been implicated
in the direct regulation of myelination in vitro, which
we discuss below (Wake et al., 2011).
The resemblance of axon–OPC synapses to classical
axon–dendrite synapses implies a similar mode of
formation. It suggests that the same molecular adhesion
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Fig. 1. Models of cell–cell interactions during synapse formation and myelination in the CNS. (A) A neuron (yellow) extends an exploratory dendrite
(d) expressing matchmaker molecules (e.g. teneurins/cadherins) toward a target axon (blue). Because the target axon expresses the same
molecules, the initial homophilic interactions are strengthened and synaptic organizers (e.g. SynCAM) induce pre and postsynaptic differentiation.
(B) An OPC (green) extends an exploratory process toward a target axon. Because the OPC process and axon express similar matchmaker
molecules this leads to the formation of an axon–OPC synapse, which matures into a myelin sheath. (C) An OPC (green) extends an exploratory
process toward a target axon. Because the OPC process and axon express similar matchmaker molecules this leads to the formation of a myelin
sheath. (D) An OPC (green) extends an exploratory process toward a target axon. Because the OPC process and axon express similar matchmaker
molecules this leads to the formation of an axon–OPC synapse, which signals to other OPCs/OLs to myelinate the target axon. (E) An OPC (green)
extends an exploratory process toward a target axon. Because the OPC process and axon express similar matchmaker molecules this leads to the
formation of an axon–OPC synapse, which performs functions unrelated to myelination.
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mechanisms that ensure specific contacts between an
axon and its correct postsynaptic dendritic target may
also ensure target matching in axon–OPC interactions
(Fig. 1A–E, top panels). Given the recent evidence that
this axonal selection occurs prior to myelin sheath
formation, we suggest that during the period when OPCs
are extending exploratory processes and contacting
axons, they are doing so in an analogous way to how
dendritic filopodia interact with target axons. In classical
synapses, a plethora of mechanisms may guide target
matching (extensively reviewed in (Sanes and Yamagata,
2009; Margeta and Shen, 2010; Shen and Scheiffele,
2010; Williams et al., 2010). One mechanism that can
confer almost single-cell specificity is chemoaffinity, i.e.
the molecular recognition of specific markers in targets
(Zipursky and Sanes, 2010). Several molecules have
been implicated in promoting regional or local specificity
between axons and their targets, such as EphA and
EphrinA (Cheng et al., 1995; Feldheim et al., 2000),
Dscam and Sidekick (Yamagata and Sanes, 2008;
Cvetkovska et al., 2013), and Capricious (Shinza-
Kameda et al., 2006; Kurusu et al., 2008), among others.
More recently, Cadherins (Osterhout et al., 2011;
Williams et al., 2011) and Teneurins (Hong et al., 2012;
Mosca et al., 2012) have been demonstrated to be
crucial in the matching of individual axons with their
specific dendritic targets at the level of individual
synapses.
During synaptogenesis, after such matchmaking
molecules (e.g. cadherins and teneurins) drive the
correct axon–dendrite pairing, the initial contact must be
stabilized, through the recruitment of pre- and
postsynaptic protein complexes. Adhesion molecules
such as Neurexin–Neuroligin (Krueger et al., 2012)
Netrin-G ligands (Woo et al., 2009), SynCAMs
(Biederer, 2002) and Cadherins (Arikkath and Reichardt,
2008; Rebsam and Mason, 2011), are examples of
synaptic organizers that play essential roles in the
maturation of the presynaptic release machinery and
postsynaptic signaling apparatus.
Here we would like to ask: can the same matchmaking
molecules regulate interactions between specific axons
and OPC processes? Can synaptic organizers also
stabilize the axon–OPC synapse? Can axon–OPC
synapses mature into myelin sheaths or are such
synapses an alternative differentiated state to a myelin
sheath?
We will address the first two of these questions by
discussing recent evidence for the roles of synaptic
matchmakers (teneurins and cadherins) and organizers
(SynCAMs and Neurexins) during myelination.
SYNAPTIC MATCHMAKERS
Teneurins
Teneurins (ten) are transmembrane glycoproteins
containing epidermal growth factor (EGF)-like repeats
followed by a globular domain in their C-terminal
extracellular domain, and an N-terminal cytoplasmic
domain that can undergo cleavage and translocate to
the nucleus to regulate gene expression (Tucker et al.,
2007). This phylogenetically conserved family is present
both in invertebrates and vertebrates, which strongly
express all four of their teneurins in the nervous system
(Tucker and Chiquet-Ehrismann, 2006).
In Drosophila, ten-a and ten-m have recently been
shown to mediate direct target choice through
homophillic interactions both in olfactory neuron
synapses (Hong et al., 2012) and at the neuromuscular
junction (Mosca et al., 2012). In addition to their putative
role as transcriptional regulators, teneurins also regulate
the cytoskeleton through alpha-spectrin (Mosca et al.,
2012), which suggests a structural role in organizing the
synapse.
Teneurins may also determine which axons in a milieu
an OPC contacts prior to myelination. Global disruption of
ten-4 has been shown to abolish the myelination of some
axons in the CNS of mice (Suzuki et al., 2012). Suzuki
et al. show that this is likely due to the loss of ten-4
function in OPCs, which fail to differentiate. Precisely
when ten-4 functions in a single OPC during transition
to myelination remains unclear. It is tempting to
speculate that ten-4 is also expressed on axons
destined to be myelinated and that loss of ten-4
homophillic interactions between axons and OPCs might
disrupt the initial adhesion, with the secondary
consequence of preventing OPC differentiation and
myelination. Further studies that manipulate ten-4
function while visualizing the dynamics of OPC process
extension and axonal contact would test whether such a
mechanism underlies the role for this class of proteins in
axon–OPC interactions and myelination.
Cadherins
The cadherin (cdh) superfamily of adhesion proteins has
been implicated in many aspects of synapse formation
and function. Classical cadherins contain an
extracellular calcium-binding domain that mediates
mostly homophilic interactions, a single transmembrane
domain and a cytoplasmic domain that binds several
proteins, most notably catenins. This latter intracellular
interaction permits the adhesion complex to signal to
several pathways and regulate the actin cytoskeleton.
Multiple cadherins are expressed in the nervous system,
with remarkable spatial and developmental regulation
(Takeichi, 2007; Arikkath and Reichardt, 2008).
Recently, Osterhout et al. demonstrated that classical
cadherins likely mediate specific recognition of targets in
the mammalian visual system: cdh3-expressing retinal
ganglion cells synapse specifically with cdh6-expressing
retinorecipient target nuclei, a specificity that is lost in
cdh6 knockout (Osterhout et al., 2011). Also, Williams
et al. showed that cdh9 homophilic interactions match
dentate gyrus axons to CA3 pyramidal dendrites at the
level of the individual synapse (Williams et al., 2011).
Given the diversity of cadherins expressed in the
nervous system, sometimes in a single neuron, the
concept of a ‘cadherin’ code, possibly combinatorial, has
been suggested to explain synaptic matchmaking in the
developing CNS (Rebsam and Mason, 2011).
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Interestingly, N-cadherin was shown to be expressed
in OPCs and OLs in vitro, and to localize to the major
processes originating from the soma (Payne et al.,
1996). It was also shown to increase OPC adhesion
in vitro (Schnadelbach et al., 2000), and in experiments
where OPCs are co-cultured with dorsal root ganglia
neurons and N-cadherin function is blocked, OPCs
made fewer contacts with axons. In organotypic rat
cerebellar slice cultures treated in the same way,
myelinated axon number is reduced, despite the timely
differentiation of OLs (Schnadelbach, 2001). This
suggests that cadherins might mediate the initial
interaction and recognition between OPCs and axons,
but the potential role(s) of this large group of diverse
molecules in CNS myelination remain to be fully tested
in vivo.
That synaptic matchmakers such as teneurins and
cadherins are expressed in OPCs and function in
myelination reveals an intriguing parallel to axon–
dendrite synapse formation. It hints that the initial
adhesion of an OPC process to an axon might require
the same type of homophilic interactions that a nascent
synapse does (Fig. 1B–E, top panel). Some of the
additional families of molecules proposed to guide target
matching (e.g. DSCAM in invertebrates and
Protocadherins in vertebrates), are encoded in large,
complex genomic loci with alternative promoters, and
messenger RNA (mRNA) that undergoes extensive
alternative splicing to generate many isoforms with
different extracellular domains. Each cell expresses a
complement of isoforms that is apparently stochastic
(Zipursky and Sanes, 2010), and this creates enough
variety for a combinatorial code to specifically label
almost every individual cell. In this way, the remarkable
precision and specificity of connection between
individual axons and individual dendrites can be
achieved. In contrast, axon–OPC interactions may
require less elaborate specificity. OPCs are more
promiscuous – OLs that typically only myelinate small-
diameter axons can readily myelinate large-diameter
axons, for instance, following transplantation from the
optic nerve into the spinal cord (Fanarraga et al., 1998)
or when supernumerary large-diameter axons are
introduced in the ventral spinal cord (Almeida et al.,
2011). This indicates that individual OLs are capable of
myelinating any competent axon, and in turn that
specific axons do not need to be myelinated by a
particular subtype of OL. Thus, matchmaking prior to
myelination more likely involves a simple ‘yes’, ‘no’, or
‘not yet’ decision. Therefore, it is more likely that a
smaller number of molecules and a ‘‘simpler’’ family of
adhesion molecules are required. Interestingly, in a
microarray-based transcriptome analysis of acutely
dissociated neurons and glia in the CNS, transcripts of
dscam and dscamL1 (mRNAs with few alternatively
spliced isoforms in vertebrates), several individual
pcdhs, ephA/ephrinA and ephB/ephrinB genes were
found to be expressed in OPCs at a similar or higher
level than neurons. Moreover, expression of some of
these genes is downregulated as OPCs mature into
myelinating OLs – pcdh20, which is encoded in a simple
locus distinct from clustered protocadherins, is
downregulated about 50-fold, ephA5 about 11-fold,
ephrinB2 about 8.5-fold and dscam eightfold (Cahoy
et al., 2008). This further suggests that even in a CNS
interaction involving different cell types (neurons and
OPCs), the same molecular toolkit may be recurrently




SynCAMs, or Nectin-like molecules (Necl) belong to the
immunoglobulin superfamily of cell-adhesion molecules
and are highly expressed in the vertebrate brain, where
they assemble across the synaptic cleft both homo- and
heterophilically. Co-expression of SynCAM1 and
glutamate receptors in HEK293 cells is sufficient to
trigger the formation of an active synapse with co-
cultured hippocampal neurons (Biederer, 2002; Sara,
2005). In agreement with a central role in organizing the
synapse, the cytosolic tail of SynCAM is predicted to
interact with PDZ domain-containing proteins such as
postsynaptic scaffolds, and with 4.1 family proteins
which assemble the actin cytoskeleton (Biederer, 2006).
Indeed, SynCAM disruption affects synaptic
maintenance and plasticity (Robbins et al., 2010).
Interestingly, SynCAM1 (Necl2) was found to be
expressed in OPCs in the perinatal mouse brain
(Galuska et al., 2010), where it is a target of
polysialylation, a modification that drastically modulates
its functional interactions. Another polysialylated but
axonal cell-adhesion molecule, NCAM, needs to be
downregulated in the surface of maturing axons in order
for myelination to proceed (Charles et al., 2000; Fewou
et al., 2007; Jakovcevski et al., 2007). Polysialylation of
SynCAM1 may serve a similar function to Polysialylated
Neural Cell Adhesion Molecule (PSA–NCAM) in axons,
and control the precise timing of myelination of specific
axons.
SynCAM2 (Necl3) and SynCAM3 (Necl1) are instead
expressed in neurons in the rodent CNS, where they
can accumulate at contact sites between axons and
OLs (Pellissier et al., 2007). Interestingly, knockout mice
for SynCAM3 show normal neuronal and glial
development, but a delay in myelination of the optic
nerve and spinal cord (Park et al., 2008). SynCAM4
(Necl4) is expressed in neurons and myelinating glia of
both CNS (Zhu et al., 2013) and PNS (Spiegel et al.,
2007). It has been shown to regulate myelination in vitro
(Maurel et al., 2007; Spiegel et al., 2007), and recently,
examination of SynCAM4 knockout mice determined
that in its absence, Schwann cells myelinate with a
slight delay and generate many myelin sheaths with
multiple abnormalities (Golan et al., 2013). Altogether,
these results suggest a role for the SynCAM family of
adhesion molecules in mediating axonal-glial adhesion
and the timing of myelination. Given that OPCs express
several glutamate receptors, it is possible that the
localization of SynCAMs and such receptors is sufficient
to drive formation of a minimal axon–OPC synapse.
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Contactin-associated protein Caspr
In addition, molecules related to synaptic organizers are
known to function during the formation of myelin
sheaths. Caspr, for example, is a homolog of Drosophila
Neurexin IV, a member of a well-established group of
molecules that organize the synapse. Presynaptic
neurexins are transmembrane proteins whose
extracellular domain (containing EGF and LamininG
repeats) mediates binding to postsynaptic neuroligins.
This heterophilic interaction results in bi-directional
signaling – neurexins can induce postsynaptic
differentiation by clustering of neurotransmitter receptors
and intracellular scaffolds, and they also interact with
the presynaptic actin cytoskeleton and may modulate
synaptic vesicle recycling (Krueger et al., 2012).
Caspr is initially localized along the axon, but as soon
as the axon is contacted by an OPC process Caspr
becomes clustered (Soetaert and Lyons, unpublished
observation). Moreover, Caspr also forms a complex
with axonal contactin1 and glial neurofascin155 at the
tips of growing myelin sheaths (Zonta et al., 2008). This
complex of proteins maintains tight contact between the
myelin sheath and the underlying axon. The intracellular
domain of Caspr, as that of neurexins, interacts with the
4.1 protein family, which mediates adhesion to the axon
cytoskeleton, stabilizing the axon–glial contact (Gollan
et al., 2002). Interestingly, disruption of this complex by
deletion of glial neurofascin155 delays CNS myelination
(Zonta et al., 2008). Although Caspr is not ultimately
necessary for myelin sheath formation (Bhat et al.,
2001; Gollan et al., 2003), it would be interesting to
test whether its disruption delayed myelination to the
same extent as that of neurofascin155, which would
indicate a role for this specific axon–OL molecular
interaction in regulating the precise timing of CNS
myelination.
In addition to the aforementioned families of synaptic
organizers, many other canonical postsynaptic
constituents are found to be expressed in OPCs.
Transcripts of the scaffold proteins of the Discs large
homolog family (of which Dlg4/PSD-95 is the major
scaffold of excitatory synapses), the scaffold proteins
Shank3 and Gephyrin (the main scaffold protein of
inhibitory synapses), ADAM22, a known PSD-95
interactor, calcium/calmodulin-dependent protein kinase
II (highly enriched in neuronal synapses), among others,
are all expressed in OPCs (Cahoy et al., 2008), as
reported for synaptic matchmakers. It would be
interesting to test the functional significance of their
presence, e.g. by conditional deletion in OPCs in vivo.
CAN AN AXON–OPC SYNAPSE TURN INTO A
MYELIN SHEATH?
Synaptic activity has been shown to regulate numerous
stages of synapse formation, morphology, maintenance
and function and the molecular basis of these roles is
beginning to be elucidated (Cohen and Greenberg,
2008; Greer and Greenberg, 2008; West and
Greenberg, 2011). Neuronal activity has also long been
proposed to regulate myelination (Zalc and Fields, 2000;
Fields, 2005, 2010), but how this might occur,
particularly in vivo, has remained quite unclear. A recent
in vitro study has suggested that communication via the
axon–OPC/OL synapse directly regulates the
myelinating capacity of the synapse-bearing process
(Wake et al., 2011).
In an OPC–dorsal root ganglia (DRG) co-culture
system, Wake et al. found that electrode-stimulation of
DRGs causes vesicle release from axons resulting in
calcium spikes in OPCs. When this stimulus-evoked
axonal vesicle release was inhibited pharmacologically,
OLs later made fewer myelin sheaths, despite
differentiating normally (Wake et al., 2011). Wake et al.
further demonstrated that the local translation of the
major myelin protein, MBP, in OL processes is
enhanced by axonal stimulation, and that this is blocked
by inhibition of N-methyl-D-aspartate receptor (NMDAR)
or metabotropic glutamate receptor signaling. However,
knockout of the obligate NR1 subunit of NMDARs
specifically in the oligodendrocyte lineage does not
affect myelination in vivo (De Biase et al., 2011; Guo
et al., 2012), implying that alternative signals may be
required in vivo. It is important to note that Wake et al.
did not actually assess myelination status in their in vitro
system following inhibition of glutamate receptor
signaling – they focused only on its role in promoting
mbp mRNA translation (Wake et al., 2011).
Interestingly, if mbp mRNA transport to distal OPC
processes is disrupted in vivo (by mutation of the
kinesin motor protein essential for its localization) the
majority of myelin sheaths are still made (Lyons et al.,
2009). This suggests that local mbp mRNA translation
may not be strictly required for the formation of a myelin
sheath, but that activity-dependent regulation of local
translation (mediated through glutamate receptor
signaling) might fine-tune the timing or extent of
myelination along particular axons, perhaps in specific
brain areas, or later in life.
Such a mechanism would rely on the maintenance
and function of axon–OPC synapses through
differentiation of OPCs into OLs and formation of myelin
sheaths. However, although it appears that at early
postnatal stages essentially all OPCs have synaptic
input (Kukley et al., 2008; Ge et al., 2009), as soon as
these cells start differentiating into NG2-PLP+ cells and
acquiring a myelinating morphology, the size of the
currents and the expression of the operant
neurotransmitter receptors become reduced (De Biase
et al., 2010; Kukley et al., 2010). After a demyelinating
injury, newly born OPCs also receive synaptic input
from unmyelinated glutamatergic axons, and as these
OPCs differentiate and the axons get remyelinated,
synaptic connectivity is lost (Etxeberria et al., 2010).
Given the short period of myelin sheath formation by
individual cells in vivo, it remains unclear whether such
synapses are actually restricted to the OPC stage as we
have defined it here, or whether they also exist during
the brief time in which OLs generate their myelin
sheaths. To elucidate the relationship between such
synapses and myelination in vivo, one would need to
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visualize individual axon–OPC synapses in vivo and track
their fate over time to determine whether they can
transform into myelin sheaths.
Such imaging-based approaches would help to
address multiple outstanding questions: are transient
axon–OPC synapses formed along the length of all
axons, only the specific axons destined for myelination,
or axons fated to remain unmyelinated? Could selective
strengthening of axon–OPC synapses prefigure the
formation of individual myelin sheaths? If such synapses
directly transform into myelin sheaths (Fig. 1B), the
underlying molecular mechanisms of synapse formation
may indeed decide which specific axons get myelinated
at a particular time. It also remains possible that after
the initial synaptogenic-like interaction between an axon
and an OPC process, myelin sheaths form without ever
resembling synapses (Fig. 1C). Alternatively, synapses
may not directly transform into sheaths but may still play
a role in regulating myelination by monitoring the
functional state of axons and recruiting other OPCs or
OLs to form the myelin sheath(s) (Fig. 1D). Axon–OPC
synapses may be a differentiated structure that cannot
transform into a myelin sheath and which does not
regulate myelination at all (Fig. 1E). Instead, axon–OPC
synapses may perform other tasks unrelated to
myelination, but which are essential for healthy nervous
system function, plasticity, and perhaps repair. Some
suggested roles include process motility, migration, tract
fasciculation, monitoring the health state of neurons and
release of neurotrophic molecules – these are outside
the scope of this review and have been excellently
reviewed elsewhere (Gallo et al., 2008; Mangin and
Gallo, 2011; Sakry et al., 2011).
CONCLUSION
We suggest that the early events of axon–dendritic
interactions mirror the early events of axon–OL
interactions that prefigure myelination. We propose that
some of the same molecular machinery that regulates
the initial specificity of axon–dendrite interactions is
important for regulating specific axon–OPC interactions.
Mechanisms that strengthen axon–dendrite interactions
may do the same at axon–OPC synapses, and such
synapses may play a role in the transformation of an
exploratory process into a myelin sheath. Our
knowledge of the molecular regulators of CNS
myelination is currently poor. We propose that a
candidate-based approach to elucidating the genetic
basis of CNS myelination might include consideration of
the mechanisms and molecules discussed here.
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